1	r	NN	O	r	nsubj	3	SENT_1	[p1l40t359r147b475],
2	‘	CD	NUMBER	‘	dep	3	SENT_1	[p1l40t359r147b475],
3	\	NN	O	\	_	0	SENT_1	[p1l40t359r147b475],
4	.	.	O	.	_	0	SENT_1	[p1l40t359r147b475],
5	'	''	O	'	_	0	SENT_1	[p1l40t359r147b475],

1	:	:	O	:	_	0	SENT_2	[p1l40t359r147b475],
2	'	''	O	'	_	0	SENT_2	[p1l40t359r147b475],
3	~	NN	O	~	_	0	SENT_2	[p1l40t359r147b475],
4	.	.	O	.	_	0	SENT_2	[p1l40t359r147b475],

1	“	SYM	O	“	dep	13	SENT_3	[p1l40t359r147b475],
2	-	:	O	-	_	0	SENT_3	[p1l40t359r147b475],
3	‘	CD	NUMBER	‘	nn	4	SENT_3	[p1l164t412r208b473],
4	C.	NNP	O	C.	dep	13	SENT_3	[p1l164t412r208b473],
5	"	``	O	"	punct	4	SENT_3	[p1l243t376r381b479],
6	e	LS	O	e	dep	7	SENT_3	[p1l243t376r381b479],
7	E	NN	O	e	dep	4	SENT_3	[p1l408t469r417b473, p1l29t513r68b563],
8	LS	NN	O	l	prep	7	SENT_3	[p1l80t512r162b563],
9	EVI	NN	ORGANIZATION	evus	dep	8	SENT_3	[p1l176t512r301b563],
10	E	NN	ORGANIZATION	e	nn	11	SENT_3	[p1l316t512r355b562],
11	R	NN	ORGANIZATION	r	dep	4	SENT_3	[p1l370t512r416b562],
12	Schizophrenia	NNP	ORGANIZATION	Schizophrenia	nn	13	SENT_3	[p1l1129t523r1454b575],
13	Research	NNP	ORGANIZATION	Research	dep	18	SENT_3	[p1l1472t523r1681b563],
14	52	CD	NUMBER	52	number	15	SENT_3	[p1l1700t523r1754b564],
15	(	CD	NUMBER	(	num	13	SENT_3	[p1l1775t524r1923b573],
16	2001	CD	DATE	2001	dep	13	SENT_3	[p1l1775t524r1923b573],
17	)	CD	NUMBER	)	num	18	SENT_3	[p1l1775t524r1923b573],
18	139-142	CD	NUMBER	139-142	_	0	SENT_3	[p1l1948t524r2148b564],

1	Letter	NN	O	letter	_	0	SENT_4	[p1l1285t600r1492b658],
2	to	TO	O	to	_	0	SENT_4	[p1l1518t608r1582b658],
3	the	DT	O	the	det	4	SENT_4	[p1l1611t599r1714b658],
4	Editors	NNS	O	editor	prep_to	1	SENT_4	[p1l1742t599r1987b658],

1	Effect	NN	O	effect	_	0	SENT_5	[p1l7t702r186b753],
2	of	IN	O	of	_	0	SENT_5	[p1l241t702r304b753],
3	the	DT	O	the	det	5	SENT_5	[p1l354t703r447b753],
4	CYPZD6	NN	O	cypzd6	nn	5	SENT_5	[p1l504t702r762b753],
5	genotype	NN	O	genotype	prep_of	1	SENT_5	[p1l817t706r1088b767],
6	on	IN	O	on	_	0	SENT_5	[p1l1145t718r1218b753],
7	prolactin	NN	O	prolactin	prep_on	5	SENT_5	[p1l1274t702r1550b767],
8	al.	FW	O	al.	dep	1	SENT_5	[p1l1726t703r1806b762],
9	,	,	O	,	_	0	SENT_5	[p1l1726t703r1806b762],
10	1995	CD	DATE	1995	num	11	SENT_5	[p1l1868t702r2038b765],
11	)	NN	O	)	appos	8	SENT_5	[p1l1868t702r2038b765],
12	,	,	O	,	_	0	SENT_5	[p1l1868t702r2038b765],
13	or	CC	O	or	advmod	11	SENT_5	[p1l2094t718r2152b753],

1	SCHIZOPHRENIA	NN	O	schizophrenia	_	0	SENT_6	[p1l930t1341r2146b1452],

1	RESEARCH	NN	O	research	_	0	SENT_7	[p1l1340t1546r2131b1659],

1	WWW.elsevier.corn/locate/schres	NNS	O	www.elsevier.corn/locate/schres	nsubj	2	SENT_8	[p1l655t1984r2144b2066],
2	decrease	VBP	O	decrease	_	0	SENT_8	[p1l6t2327r490b2427],
3	enzyme	NN	O	enzyme	nn	4	SENT_8	[p1l597t2358r1038b2457],
4	activity	NN	O	activity	dobj	2	SENT_8	[p1l1147t2327r1597b2457],
5	,	,	O	,	_	0	SENT_8	[p1l1147t2327r1597b2457],
6	i.e.	FW	O	i.e.	appos	4	SENT_8	[p1l1708t2327r1871b2427],
7	the	DT	O	the	det	8	SENT_8	[p1l1982t2327r2153b2426],
8	concentration	NN	O	concentration	dep	6	SENT_8	[p1l9t2485r591b2554],
9	in	IN	O	in	_	0	SENT_8	[p1l655t2485r735b2553],
10	schizophrenic	JJ	O	schizophrenic	amod	11	SENT_8	[p1l801t2485r1382b2573],
11	patients	NNS	O	patient	prep_in	2	SENT_8	[p1l1447t2485r1780b2573],
12	treated	VBN	O	treat	partmod	11	SENT_8	[p1l1845t2486r2146b2554],
13	with	IN	O	with	_	0	SENT_8	[p1l9t2603r192b2674],
14	haloperidol	NN	O	haloperidol	prep_with	12	SENT_8	[p1l225t2603r708b2693],

1	Hyperprolactinemia	NN	O	hyperprolactinemia	nsubjpass	4	SENT_9	[p1l108t2852r904b2942],
2	has	VBZ	O	have	aux	4	SENT_9	[p1l957t2852r1085b2922],
3	been	VBN	O	be	auxpass	4	SENT_9	[p1l1141t2852r1328b2922],
4	assumed	VBN	O	assume	dep	16	SENT_9	[p1l1385t2852r1723b2922],
5	to	TO	O	to	aux	9	SENT_9	[p1l1778t2863r1851b2922],
6	be	VB	O	be	cop	9	SENT_9	[p1l1907t2852r1999b2922],
7	an	DT	O	a	det	9	SENT_9	[p1l2057t2875r2146b2922],
8	inevitable	JJ	O	inevitable	amod	9	SENT_9	[p1l8t2970r399b3041],
9	consequence	NN	O	consequence	xcomp	4	SENT_9	[p1l428t2993r932b3061],
10	of	IN	O	of	_	0	SENT_9	[p1l961t2971r1047b3040],
11	treatment	NN	O	treatment	prep_of	9	SENT_9	[p1l1067t2981r1443b3040],
12	with	IN	O	with	_	0	SENT_9	[p1l1469t2971r1642b3040],
13	typical	JJ	O	typical	amod	15	SENT_9	[p1l1670t2971r1938b3061],
14	antipsychotic	JJ	O	antipsychotic	amod	15	SENT_9	[p1l1968t2971r2143b3040, p1l7t3090r385b3180],
15	agents	NNS	O	agent	prep_with	11	SENT_9	[p1l428t3101r675b3180],
16	(	VBP	O	(	_	0	SENT_9	[p1l721t3091r973b3180],
17	Petty	NNP	O	Petty	nsubj	16	SENT_9	[p1l721t3091r973b3180],
18	,	,	O	,	_	0	SENT_9	[p1l721t3091r973b3180],
19	1999	CD	DATE	1999	num	20	SENT_9	[p1l1025t3091r1264b3176],
20	)	NN	O	)	appos	17	SENT_9	[p1l1025t3091r1264b3176],
21	.	.	O	.	_	0	SENT_9	[p1l1025t3091r1264b3176],

1	The	DT	O	the	det	3	SENT_10	[p1l1309t3090r1460b3160],
2	major	JJ	O	major	amod	3	SENT_10	[p1l1500t3090r1731b3180],
3	effects	NNS	O	effect	nsubj	8	SENT_10	[p1l1770t3090r2024b3160],
4	of	IN	O	of	_	0	SENT_10	[p1l2067t3090r2153b3160],
5	hyperprolactinemia	NN	O	hyperprolactinemia	prep_of	3	SENT_10	[p1l8t3209r782b3299],
6	in	IN	O	in	_	0	SENT_10	[p1l835t3209r911b3278],
7	women	NNS	O	woman	prep_in	5	SENT_10	[p1l965t3231r1253b3279],
8	include	VBP	O	include	_	0	SENT_10	[p1l1308t3209r1598b3279],
9	amenorrhea	NN	O	amenorrhea	dobj	8	SENT_10	[p1l1655t3209r2142b3291],
10	,	,	O	,	_	0	SENT_10	[p1l1655t3209r2142b3291],
11	galactorrhea	NN	O	galactorrhea	appos	9	SENT_10	[p1l10t3328r519b3418],
12	,	,	O	,	_	0	SENT_10	[p1l10t3328r519b3418],
13	cessation	NN	O	cessation	appos	9	SENT_10	[p1l552t3328r913b3397],
14	of	IN	O	of	_	0	SENT_10	[p1l941t3328r1026b3397],
15	normal	JJ	O	normal	amod	18	SENT_10	[p1l1046t3328r1325b3397],
16	cyclic	JJ	O	cyclic	amod	18	SENT_10	[p1l1354t3328r1587b3418],
17	ovarian	JJ	O	ovarian	amod	18	SENT_10	[p1l1617t3328r1912b3397],
18	function	NN	O	function	prep_of	13	SENT_10	[p1l1939t3328r2142b3397, p1l8t3447r182b3530],
19	,	,	O	,	_	0	SENT_10	[p1l1939t3328r2142b3397, p1l8t3447r182b3530],
20	loss	NN	O	loss	appos	9	SENT_10	[p1l235t3447r383b3517],
21	of	IN	O	of	_	0	SENT_10	[p1l435t3447r521b3517],
22	libido	NN	O	libido	prep_of	20	SENT_10	[p1l563t3447r814b3530],
23	,	,	O	,	_	0	SENT_10	[p1l563t3447r814b3530],
24	occasional	JJ	O	occasional	amod	25	SENT_10	[p1l867t3447r1284b3517],
25	hirsutism	NN	O	hirsutism	appos	9	SENT_10	[p1l1333t3447r1702b3517],
26	and	CC	O	and	_	0	SENT_10	[p1l1751t3447r1891b3517],
27	longterm	JJ	O	longterm	amod	28	SENT_10	[p1l1939t3447r2142b3537, p1l8t3577r190b3636],
28	risk	NN	O	risk	conj_and	25	SENT_10	[p1l221t3566r370b3636],
29	of	IN	O	of	_	0	SENT_10	[p1l403t3566r489b3636],
30	osteoporosis	NN	O	osteoporosis	nn	32	SENT_10	[p1l517t3566r1007b3656],
31	(	CD	NUMBER	(	num	32	SENT_10	[p1l1046t3566r1337b3652],
32	Rubin	NNP	PERSON	Rubin	prep_of	25	SENT_10	[p1l1046t3566r1337b3652],
33	,	,	O	,	_	0	SENT_10	[p1l1046t3566r1337b3652],
34	1987	CD	DATE	1987	appos	32	SENT_10	[p1l1384t3566r1594b3648],
35	;	:	O	;	_	0	SENT_10	[p1l1384t3566r1594b3648],
36	Petty	NNP	O	Petty	dep	9	SENT_10	[p1l1632t3568r1855b3656],
37	,	,	O	,	_	0	SENT_10	[p1l1632t3568r1855b3656],
38	1999	CD	DATE	1999	num	39	SENT_10	[p1l1902t3566r2141b3651],
39	)	NN	O	)	appos	36	SENT_10	[p1l1902t3566r2141b3651],
40	.	.	O	.	_	0	SENT_10	[p1l1902t3566r2141b3651],

1	The	DT	O	the	det	2	SENT_11	[p1l8t3685r160b3754],
2	effects	NNS	O	effect	nsubj	5	SENT_11	[p1l195t3685r450b3754],
3	in	IN	O	in	_	0	SENT_11	[p1l486t3685r561b3753],
4	men	NNS	O	man	prep_in	2	SENT_11	[p1l594t3707r763b3754],
5	include	VBP	O	include	_	0	SENT_11	[p1l797t3685r1086b3754],
6	impotence	NN	O	impotence	dobj	5	SENT_11	[p1l1122t3685r1555b3775],
7	,	,	O	,	_	0	SENT_11	[p1l1122t3685r1555b3775],
8	loss	NN	O	loss	appos	6	SENT_11	[p1l1593t3685r1742b3754],
9	of	IN	O	of	_	0	SENT_11	[p1l1779t3685r1864b3754],
10	libido	NN	O	libido	prep_of	8	SENT_11	[p1l1891t3685r2142b3767],
11	,	,	O	,	_	0	SENT_11	[p1l1891t3685r2142b3767],

1	and	CC	O	and	dep	4	SENT_12	[p2l10t21r150b91],
2	hypospermatogenesis	NN	O	hypospermatogenesis	nn	4	SENT_12	[p2l177t21r1029b111],
3	(	CD	NUMBER	(	num	4	SENT_12	[p2l1062t21r1354b108],
4	Rubin	NNP	PERSON	Rubin	_	0	SENT_12	[p2l1062t21r1354b108],
5	,	,	O	,	_	0	SENT_12	[p2l1062t21r1354b108],
6	1987	CD	DATE	1987	appos	4	SENT_12	[p2l1395t22r1604b104],
7	;	:	O	;	_	0	SENT_12	[p2l1395t22r1604b104],
8	Petty	NNP	O	Petty	dep	4	SENT_12	[p2l1637t23r1860b111],
9	,	,	O	,	_	0	SENT_12	[p2l1637t23r1860b111],
10	1999	CD	DATE	1999	num	11	SENT_12	[p2l1902t22r2141b107],
11	)	NN	O	)	appos	8	SENT_12	[p2l1902t22r2141b107],
12	.	.	O	.	_	0	SENT_12	[p2l1902t22r2141b107],

1	On	IN	O	on	_	0	SENT_13	[p2l10t140r127b210],
2	the	DT	O	the	det	4	SENT_13	[p2l161t140r279b209],
3	other	JJ	O	other	amod	4	SENT_13	[p2l316t140r518b209],
4	hand	NN	O	hand	prep_on	14	SENT_13	[p2l550t139r762b222],
5	,	,	O	,	_	0	SENT_13	[p2l550t139r762b222],
6	the	DT	O	the	det	8	SENT_13	[p2l801t140r919b209],
7	prolactin	NN	O	prolactin	nn	8	SENT_13	[p2l953t140r1306b230],
8	response	NN	O	response	nsubjpass	14	SENT_13	[p2l1339t162r1684b230],
9	to	TO	O	to	_	0	SENT_13	[p2l1719t150r1793b209],
10	antipsychotic	JJ	O	antipsychotic	amod	11	SENT_13	[p2l1830t140r2143b230, p2l9t259r247b329],
11	drugs	NNS	O	drug	prep_to	8	SENT_13	[p2l281t259r495b349],
12	has	VBZ	O	have	aux	14	SENT_13	[p2l526t259r654b329],
13	been	VBN	O	be	auxpass	14	SENT_13	[p2l685t259r871b329],
14	regarded	VBN	O	regard	_	0	SENT_13	[p2l901t259r1248b349],
15	as	IN	O	as	mark	24	SENT_13	[p2l1279t282r1355b329],
16	an	DT	O	a	det	17	SENT_13	[p2l1389t282r1479b329],
17	index	NN	O	index	nsubj	24	SENT_13	[p2l1508t259r1726b329],
18	of	IN	O	of	_	0	SENT_13	[p2l1758t259r1843b329],
19	antidopaminergic	JJ	O	antidopaminergic	amod	20	SENT_13	[p2l1869t259r2142b329, p2l7t378r452b468],
20	activity	NN	O	activity	prep_of	17	SENT_13	[p2l511t378r805b468],
21	of	IN	O	of	_	0	SENT_13	[p2l861t378r947b448],
22	antipsychotic	JJ	O	antipsychotic	amod	23	SENT_13	[p2l996t378r1520b468],
23	drugs	NNS	O	drug	prep_of	20	SENT_13	[p2l1578t378r1792b468],
24	(	VBP	O	(	advcl	14	SENT_13	[p2l1851t378r2142b464],
25	Rubin	NNP	PERSON	Rubin	dobj	24	SENT_13	[p2l1851t378r2142b464],
26	,	,	O	,	_	0	SENT_13	[p2l1851t378r2142b464],
27	1987	CD	DATE	1987	num	28	SENT_13	[p2l18t497r257b582],
28	)	NN	O	)	appos	25	SENT_13	[p2l18t497r257b582],
29	.	.	O	.	_	0	SENT_13	[p2l18t497r257b582],

1	Recently	RB	DATE	recently	advmod	7	SENT_14	[p2l316t497r689b587],
2	,	,	O	,	_	0	SENT_14	[p2l316t497r689b587],
3	this	DT	O	this	nsubjpass	7	SENT_14	[p2l746t497r884b566],
4	has	VBZ	O	have	aux	7	SENT_14	[p2l939t497r1067b566],
5	been	VBN	O	be	auxpass	7	SENT_14	[p2l1122t497r1309b566],
6	partially	RB	O	partially	advmod	7	SENT_14	[p2l1360t497r1691b587],
7	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_14	[p2l1746t497r2147b566],
8	by	IN	O	by	_	0	SENT_14	[p2l7t616r104b706],
9	a	DT	O	a	det	11	SENT_14	[p2l179t639r220b686],
10	PET	NN	O	pet	nn	11	SENT_14	[p2l291t618r464b685],
11	study	NN	O	study	agent	7	SENT_14	[p2l541t616r748b706],
12	indicating	VBG	O	indicate	xcomp	7	SENT_14	[p2l821t616r1217b706],
13	a	DT	O	a	det	15	SENT_14	[p2l1292t639r1333b686],
14	close	JJ	O	close	amod	15	SENT_14	[p2l1405t616r1605b686],
15	relationship	NN	O	relationship	dobj	12	SENT_14	[p2l1677t616r2145b706],
16	between	IN	O	between	_	0	SENT_14	[p2l7t735r338b805],
17	prolactin	NN	O	prolactin	nn	18	SENT_14	[p2l363t735r716b825],
18	response	NN	O	response	prep_between	15	SENT_14	[p2l741t757r1085b825],
19	and	CC	O	and	_	0	SENT_14	[p2l1115t735r1254b805],
20	dopamine	NN	O	dopamine	nn	22	SENT_14	[p2l1280t735r1669b825],
21	D2	NN	O	d2	nn	22	SENT_14	[p2l1696t737r1796b820],
22	receptor	NN	O	receptor	conj_and	18	SENT_14	[p2l1821t746r2148b825],
23	occupancy	NN	O	occupancy	nn	25	SENT_14	[p2l10t876r431b944],
24	(	CD	NUMBER	(	num	25	SENT_14	[p2l480t854r938b939],
25	Nordstrom	NNP	ORGANIZATION	Nordstrom	dep	18	SENT_14	[p2l480t854r938b939],
26	and	CC	O	and	_	0	SENT_14	[p2l984t854r1124b923],
27	Farde	NNP	PERSON	Farde	conj_and	18	SENT_14	[p2l1168t854r1413b936],
28	,	,	O	,	_	0	SENT_14	[p2l1168t854r1413b936],
29	1998	CD	DATE	1998	num	30	SENT_14	[p2l1471t854r1710b939],
30	)	NN	O	)	appos	27	SENT_14	[p2l1471t854r1710b939],
31	.	.	O	.	_	0	SENT_14	[p2l1471t854r1710b939],

1	Thus	RB	O	thus	advmod	11	SENT_15	[p2l1761t854r1978b936],
2	,	,	O	,	_	0	SENT_15	[p2l1761t854r1978b936],
3	the	DT	O	the	det	5	SENT_15	[p2l2026t854r2145b923],
4	prolactin	NN	O	prolactin	nn	5	SENT_15	[p2l7t973r361b1063],
5	response	NN	O	response	nsubjpass	11	SENT_15	[p2l404t996r748b1063],
6	to	TO	O	to	_	0	SENT_15	[p2l794t984r868b1043],
7	antipsychotic	JJ	O	antipsychotic	amod	8	SENT_15	[p2l915t973r1440b1063],
8	drugs	NNS	O	drug	prep_to	5	SENT_15	[p2l1487t973r1702b1063],
9	should	MD	O	should	aux	11	SENT_15	[p2l1752t973r2011b1043],
10	be	VB	O	be	auxpass	11	SENT_15	[p2l2054t973r2145b1043],
11	evaluated	VBN	O	evaluate	_	0	SENT_15	[p2l9t1092r409b1174],
12	,	,	O	,	_	0	SENT_15	[p2l9t1092r409b1174],
13	not	RB	O	not	neg	14	SENT_15	[p2l458t1102r584b1161],
14	only	RB	O	only	preconj	11	SENT_15	[p2l629t1092r801b1182],
15	from	IN	O	from	_	0	SENT_15	[p2l847t1092r1038b1161],
16	the	DT	O	the	det	17	SENT_15	[p2l1082t1092r1201b1161],
17	clinical	JJ	O	clinical	prep_from	11	SENT_15	[p2l1247t1092r1537b1161],
18	but	CC	O	but	_	0	SENT_15	[p2l1582t1092r1709b1161],
19	also	RB	O	also	advmod	11	SENT_15	[p2l1754t1092r1910b1161],
20	from	IN	O	from	_	0	SENT_15	[p2l1956t1092r2147b1161],
21	the	DT	O	the	det	23	SENT_15	[p2l8t1211r127b1281],
22	pharmacological	JJ	O	pharmacological	amod	23	SENT_15	[p2l159t1211r822b1301],
23	point	NN	O	point	conj_but	17	SENT_15	[p2l854t1211r1058b1301],
24	of	IN	O	of	_	0	SENT_15	[p2l1091t1211r1176b1281],
25	view	NN	O	view	prep_of	23	SENT_15	[p2l1202t1211r1412b1281],
26	.	.	O	.	_	0	SENT_15	[p2l1202t1211r1412b1281],

1	Haloperidol	NNP	O	Haloperidol	nsubj	8	SENT_16	[p2l108t1330r580b1420],
2	is	VBZ	O	be	cop	8	SENT_16	[p2l617t1330r678b1400],
3	the	DT	O	the	det	8	SENT_16	[p2l716t1330r834b1400],
4	most	RBS	O	most	advmod	6	SENT_16	[p2l871t1341r1063b1400],
5	widely	RB	O	widely	advmod	6	SENT_16	[p2l1099t1330r1364b1420],
6	used	VBN	O	use	amod	8	SENT_16	[p2l1401t1330r1581b1400],
7	antipsychotic	JJ	O	antipsychotic	amod	8	SENT_16	[p2l1619t1330r2144b1420],
8	drug	NN	O	drug	_	0	SENT_16	[p2l9t1449r186b1539],
9	in	IN	O	in	_	0	SENT_16	[p2l247t1449r322b1517],
10	the	DT	O	the	det	11	SENT_16	[p2l381t1449r500b1518],
11	treatment	NN	O	treatment	prep_in	8	SENT_16	[p2l560t1459r936b1518],
12	of	IN	O	of	_	0	SENT_16	[p2l995t1449r1081b1518],
13	schizophrenia	NN	O	schizophrenia	nn	17	SENT_16	[p2l1137t1449r1685b1539],
14	and	CC	O	and	_	0	SENT_16	[p2l1746t1449r1885b1518],
15	other	JJ	O	other	nn	17	SENT_16	[p2l1946t1449r2148b1518],
16	psychiatric	JJ	O	psychiatric	amod	17	SENT_16	[p2l7t1568r441b1658],
17	disorders	NNS	O	disorder	prep_of	11	SENT_16	[p2l491t1568r870b1638],
18	.	.	O	.	_	0	SENT_16	[p2l491t1568r870b1638],

1	Haloperidol	NNP	O	Haloperidol	nsubj	2	SENT_17	[p2l923t1568r1395b1658],
2	undergoes	VBZ	O	undergo	ccomp	24	SENT_17	[p2l1441t1568r1845b1658],
3	oxidative	JJ	O	oxidative	amod	6	SENT_17	[p2l1895t1568r2143b1638, p2l8t1687r155b1757],
4	N	NN	O	n	nn	6	SENT_17	[p2l192t1687r808b1777],
5	—	NN	O	—	nn	6	SENT_17	[p2l192t1687r808b1777],
6	dealkylation	NN	O	dealkylation	nsubj	19	SENT_17	[p2l192t1687r808b1777],
7	,	,	O	,	_	0	SENT_17	[p2l192t1687r808b1777],
8	oxidation	NN	O	oxidation	appos	6	SENT_17	[p2l849t1687r1221b1757],
9	to	TO	O	to	dep	8	SENT_17	[p2l1257t1697r1331b1757],
10	a	DT	O	a	det	17	SENT_17	[p2l1370t1709r1411b1757],
11	pyridinium	NN	O	pyridinium	nn	17	SENT_17	[p2l1444t1687r1886b1777],
12	metabolite	NN	O	metabolite	nn	17	SENT_17	[p2l1921t1698r2142b1757, p2l7t1806r254b1888],
13	,	,	O	,	_	0	SENT_17	[p2l1921t1698r2142b1757, p2l7t1806r254b1888],
14	glucuronidation	NN	O	glucuronidation	nn	17	SENT_17	[p2l353t1806r980b1896],
15	and	CC	O	and	_	0	SENT_17	[p2l1076t1806r1215b1875],
16	carbonyl	NN	O	carbonyl	nn	17	SENT_17	[p2l1309t1806r1653b1896],
17	reduction	NN	O	reduction	dep	8	SENT_17	[p2l1746t1806r2142b1888],
18	,	,	O	,	_	0	SENT_17	[p2l1746t1806r2142b1888],
19	yielding	VBG	O	yield	dep	2	SENT_17	[p2l8t1925r332b2015],
20	a	DT	O	a	det	22	SENT_17	[p2l401t1948r442b1995],
21	major	JJ	O	major	amod	22	SENT_17	[p2l507t1925r739b2015],
22	metabolite	NN	O	metabolite	dobj	19	SENT_17	[p2l805t1925r1245b2008],
23	,	,	O	,	_	0	SENT_17	[p2l805t1925r1245b2008],
24	reduced	VBD	O	reduce	_	0	SENT_17	[p2l1315t1925r1628b1995],
25	haloperidol	NN	O	haloperidol	iobj	24	SENT_17	[p2l1694t1925r2145b2015],
26	(	CD	NUMBER	(	num	27	SENT_17	[p2l12t2044r281b2134],
27	Tsang	NNP	PERSON	Tsang	dobj	24	SENT_17	[p2l12t2044r281b2134],
28	et	FW	O	et	nn	29	SENT_17	[p2l319t2054r389b2113],
29	al.	FW	O	al.	nsubj	24	SENT_17	[p2l427t2044r540b2126],
30	,	,	O	,	_	0	SENT_17	[p2l427t2044r540b2126],
31	1994	CD	DATE	1994	num	32	SENT_17	[p2l589t2044r828b2129],
32	)	NN	O	)	appos	29	SENT_17	[p2l589t2044r828b2129],
33	.	.	O	.	_	0	SENT_17	[p2l589t2044r828b2129],

1	Reduced	VBN	O	reduce	amod	2	SENT_18	[p2l870t2044r1216b2113],
2	haloperidol	NN	O	haloperidol	nsubj	3	SENT_18	[p2l1252t2044r1703b2134],
3	undergoes	VBZ	O	undergo	_	0	SENT_18	[p2l1739t2044r2144b2134],
4	oxidation	NN	O	oxidation	dobj	3	SENT_18	[p2l10t2163r383b2233],
5	back	RB	O	back	advmod	3	SENT_18	[p2l447t2163r636b2233],
6	to	TO	O	to	_	0	SENT_18	[p2l700t2174r773b2233],
7	haloperidol	NN	O	haloperidol	prep_to	5	SENT_18	[p2l840t2163r1313b2253],
8	,	,	O	,	_	0	SENT_18	[p2l840t2163r1313b2253],
9	hydroxylation	NN	O	hydroxylation	prep_to	5	SENT_18	[p2l1383t2163r1939b2253],
10	and	CC	O	and	_	0	SENT_18	[p2l2007t2163r2147b2233],
11	glucuronidation	NN	O	glucuronidation	nn	13	SENT_18	[p2l10t2282r636b2372],
12	(	CD	NUMBER	(	num	13	SENT_18	[p2l678t2283r947b2372],
13	Tsang	NNP	PERSON	Tsang	prep_to	5	SENT_18	[p2l678t2283r947b2372],
14	et	FW	O	et	nn	15	SENT_18	[p2l987t2292r1056b2352],
15	al.	FW	O	al.	tmod	3	SENT_18	[p2l1095t2282r1209b2364],
16	,	,	O	,	_	0	SENT_18	[p2l1095t2282r1209b2364],
17	1994	CD	DATE	1994	num	18	SENT_18	[p2l1260t2282r1499b2368],
18	)	NN	O	)	appos	15	SENT_18	[p2l1260t2282r1499b2368],
19	.	.	O	.	_	0	SENT_18	[p2l1260t2282r1499b2368],

1	In	FW	O	in	nn	2	SENT_19	[p2l1543t2284r1623b2351],
2	vivo	FW	O	vivo	nsubj	5	SENT_19	[p2l1661t2282r1833b2352],
3	studies	NNS	O	study	dep	2	SENT_19	[p2l1876t2282r2144b2352],
4	have	VBP	O	have	aux	5	SENT_19	[p2l8t2401r193b2470],
5	suggested	VBN	O	suggest	_	0	SENT_19	[p2l235t2401r621b2491],
6	that	IN	O	that	complm	14	SENT_19	[p2l657t2401r806b2470],
7	cytochrome	NN	O	cytochrome	nn	8	SENT_19	[p2l843t2401r1308b2491],
8	P450	NN	O	p450	nsubjpass	14	SENT_19	[p2l1346t2400r1547b2471],
9	(	CD	NUMBER	(	num	10	SENT_19	[p2l1587t2401r1837b2486],
10	CYP	NN	O	cyp	dep	8	SENT_19	[p2l1587t2401r1837b2486],
11	)	CD	NUMBER	)	num	12	SENT_19	[p2l1587t2401r1837b2486],
12	2D6	NN	O	2d6	dep	8	SENT_19	[p2l1879t2401r2044b2471],
13	is	VBZ	O	be	auxpass	14	SENT_19	[p2l2082t2401r2144b2470],
14	involved	VBN	O	involve	ccomp	5	SENT_19	[p2l8t2520r348b2590],
15	in	IN	O	in	_	0	SENT_19	[p2l376t2520r451b2589],
16	the	DT	O	the	det	17	SENT_19	[p2l479t2520r596b2590],
17	metabolism	NN	O	metabolism	prep_in	14	SENT_19	[p2l625t2520r1080b2590],
18	of	IN	O	of	_	0	SENT_19	[p2l1110t2520r1195b2590],
19	haloperidol	NN	O	haloperidol	nn	21	SENT_19	[p2l1216t2520r1658b2610],
20	(	CD	NUMBER	(	num	21	SENT_19	[p2l1690t2521r2050b2606],
21	LLerena	NNP	PERSON	LLerena	prep_of	17	SENT_19	[p2l1690t2521r2050b2606],
22	et	FW	O	et	nn	23	SENT_19	[p2l2078t2531r2148b2590],
23	al.	FW	O	al.	dep	21	SENT_19	[p2l10t2639r122b2721],
24	,	,	O	,	_	0	SENT_19	[p2l10t2639r122b2721],
25	1992a	CD	NUMBER	1992a	num	26	SENT_19	[p2l180t2639r437b2725],
26	)	NN	O	)	appos	21	SENT_19	[p2l180t2639r437b2725],
27	and	CC	O	and	_	0	SENT_19	[p2l487t2639r624b2709],
28	reduced	VBD	O	reduce	conj_and	14	SENT_19	[p2l668t2639r976b2709],
29	haloperidol	NN	O	haloperidol	nn	31	SENT_19	[p2l1020t2639r1463b2729],
30	(	CD	NUMBER	(	num	29	SENT_19	[p2l1512t2640r1872b2725],
31	LLerena	NNP	PERSON	LLerena	iobj	28	SENT_19	[p2l1512t2640r1872b2725],
32	et	FW	O	et	nn	33	SENT_19	[p2l1916t2649r1986b2709],
33	al.	FW	O	al.	dobj	28	SENT_19	[p2l2031t2639r2143b2721],
34	,	,	O	,	_	0	SENT_19	[p2l2031t2639r2143b2721],
35	1992b	CD	NUMBER	1992b	num	36	SENT_19	[p2l18t2758r280b2843],
36	)	NN	O	)	dobj	28	SENT_19	[p2l18t2758r280b2843],
37	after	IN	O	after	_	0	SENT_19	[p2l304t2758r480b2827],
38	a	DT	O	a	det	41	SENT_19	[p2l500t2780r540b2827],
39	single	JJ	O	single	amod	41	SENT_19	[p2l562t2758r789b2848],
40	oral	JJ	O	oral	amod	41	SENT_19	[p2l810t2758r958b2827],
41	dose	NN	O	dose	prep_after	36	SENT_19	[p2l978t2758r1154b2827],
42	of	IN	O	of	_	0	SENT_19	[p2l1174t2758r1259b2827],
43	haloperidol	NN	O	haloperidol	prep_of	41	SENT_19	[p2l1271t2758r1732b2848],
44	.	.	O	.	_	0	SENT_19	[p2l1271t2758r1732b2848],

1	The	DT	O	the	det	2	SENT_20	[p2l1757t2758r1906b2827],
2	activity	NN	O	activity	nsubjpass	7	SENT_20	[p2l1928t2758r2144b2828, p2l8t2877r109b2967],
3	of	IN	O	of	_	0	SENT_20	[p2l145t2877r230b2947],
4	CYPZD6	NN	O	cypzd6	prep_of	2	SENT_20	[p2l259t2877r611b2947],
5	is	VBZ	O	be	auxpass	7	SENT_20	[p2l647t2877r707b2947],
6	genetically	RB	O	genetically	advmod	7	SENT_20	[p2l744t2877r1168b2967],
7	determined	VBN	O	determine	_	0	SENT_20	[p2l1205t2877r1662b2960],
8	,	,	O	,	_	0	SENT_20	[p2l1205t2877r1662b2960],
9	and	CC	O	and	_	0	SENT_20	[p2l1701t2877r1838b2947],
10	several	JJ	O	several	nsubj	11	SENT_20	[p2l1876t2877r2146b2947],
11	mutated	VBN	O	mutate	conj_and	7	SENT_20	[p2l8t2996r322b3065],
12	alleles	NNS	O	allele	dobj	11	SENT_20	[p2l347t2996r590b3065],
13	of	IN	O	of	_	0	SENT_20	[p2l616t2995r701b3065],
14	the	DT	O	the	det	16	SENT_20	[p2l716t2996r833b3065],
15	CYPZD	NN	O	cypzd	nn	16	SENT_20	[p2l861t2996r1152b3066],
16	locus	NN	O	locus	prep_of	12	SENT_20	[p2l1175t2996r1376b3065],
17	that	WDT	O	that	nsubj	18	SENT_20	[p2l1401t2996r1548b3065],
18	inhibit	VBP	O	inhibit	rcmod	12	SENT_20	[p2l1569t2996r1822b3065],
19	enzyme	NN	O	enzyme	dobj	18	SENT_20	[p2l1844t3018r2146b3086],
20	activity	NN	O	activity	dep	19	SENT_20	[p2l10t3115r319b3205],
21	,	,	O	,	_	0	SENT_20	[p2l10t3115r319b3205],
22	i.e.	FW	O	i.e.	dep	19	SENT_20	[p2l423t3115r535b3185],
23	CYPZD6	FW	O	cypzd6	nn	24	SENT_20	[p2l645t3115r988b3186],
24	*	FW	O	*	amod	43	SENT_20	[p2l1013t3130r1051b3173],
25	3	CD	NUMBER	3	num	26	SENT_20	[p2l1079t3116r1158b3202],
26	(	NN	O	(	npadvmod	29	SENT_20	[p2l1079t3116r1158b3202],
27	>	JJR	PERCENT	>	dep	28	SENT_20	[p2l1186t3130r1224b3173],
28	%	NN	PERCENT	%	amod	26	SENT_20	[p2l1186t3130r1224b3173],
29	<	JJR	O	<	amod	43	SENT_20	[p2l1186t3130r1224b3173],
30	3	CD	NUMBER	3	number	31	SENT_20	[p2l1252t3116r1351b3202],
31	)	NN	O	)	dep	29	SENT_20	[p2l1252t3116r1351b3202],
32	,	,	O	,	_	0	SENT_20	[p2l1252t3116r1351b3202],
33	CYPZD6	NN	O	cypzd6	dep	29	SENT_20	[p2l1460t3115r1805b3186],
34	>	JJR	O	>	dep	33	SENT_20	[p2l1828t3130r1866b3173],
35	I	PRP	O	I	npadvmod	36	SENT_20	[p2l1828t3130r1866b3173],
36	<	JJR	O	<	dep	33	SENT_20	[p2l1828t3130r1866b3173],
37	4	CD	NUMBER	4	num	38	SENT_20	[p2l1893t3116r1974b3202],
38	(	NN	O	(	npadvmod	39	SENT_20	[p2l1893t3116r1974b3202],
39	>	JJR	O	>	dep	36	SENT_20	[p2l2001t3130r2040b3173],
40	I	PRP	O	I	npadvmod	41	SENT_20	[p2l2001t3130r2040b3173],
41	<	JJR	O	<	dep	39	SENT_20	[p2l2001t3130r2040b3173],
42	4	CD	NUMBER	4	dep	29	SENT_20	[p2l2066t3116r2145b3201],
43	)	NN	O	)	dep	19	SENT_20	[p2l2066t3116r2145b3201],
44	(	CD	NUMBER	(	num	45	SENT_20	[p2l12t3234r258b3320],
45	Heim	NNP	PERSON	Heim	dep	43	SENT_20	[p2l12t3234r258b3320],
46	and	CC	O	and	_	0	SENT_20	[p2l295t3234r432b3304],
47	Meyer	NNP	PERSON	Meyer	dobj	18	SENT_20	[p2l468t3236r742b3324],
48	,	,	O	,	_	0	SENT_20	[p2l468t3236r742b3324],
49	1990	CD	DATE	1990	num	50	SENT_20	[p2l791t3234r1028b3320],
50	)	NN	O	)	appos	19	SENT_20	[p2l791t3234r1028b3320],
51	,	,	O	,	_	0	SENT_20	[p2l791t3234r1028b3320],
52	CYPZD6	NN	O	cypzd6	amod	19	SENT_20	[p2l1072t3234r1416b3304],
53	>	JJR	O	>	dep	52	SENT_20	[p2l1439t3249r1478b3291],
54	!	.	O	!	_	0	SENT_20	[p2l1439t3249r1478b3291],

1	<	JJR	O	<	_	0	SENT_21	[p2l1439t3249r1478b3291],
2	5	CD	NUMBER	5	num	3	SENT_21	[p2l1506t3235r1585b3320],
3	(	NN	O	(	npadvmod	4	SENT_21	[p2l1506t3235r1585b3320],
4	>	JJR	O	>	amod	1	SENT_21	[p2l1613t3249r1651b3291],
5	I	PRP	O	I	npadvmod	6	SENT_21	[p2l1613t3249r1651b3291],
6	<	JJR	O	<	dep	1	SENT_21	[p2l1613t3249r1651b3291],
7	5	CD	NUMBER	5	num	8	SENT_21	[p2l1679t3235r1756b3320],
8	)	NN	O	)	dep	12	SENT_21	[p2l1679t3235r1756b3320],
9	(	CD	NUMBER	(	dep	8	SENT_21	[p2l1797t3234r2042b3320],
10	Steen	NNP	PERSON	Steen	dep	12	SENT_21	[p2l1797t3234r2042b3320],
11	et	FW	O	et	nn	12	SENT_21	[p2l2078t3245r2148b3304],
12	CYPZD6	FW	O	cypzd6	dep	18	SENT_21	[p2l12t3352r357b3422],
13	>	JJR	O	>	dep	12	SENT_21	[p2l381t3367r419b3409],
14	I	PRP	O	I	dep	18	SENT_21	[p2l381t3367r419b3409],
15	<	JJR	O	<	dep	18	SENT_21	[p2l381t3367r419b3409],
16	Io	NNP	O	Io	dep	18	SENT_21	[p2l450t3353r575b3438],
17	(	CD	NUMBER	(	num	16	SENT_21	[p2l450t3353r575b3438],
18	>	JJR	O	>	dep	6	SENT_21	[p2l603t3367r642b3409],
19	I	PRP	O	I	dep	23	SENT_21	[p2l603t3367r642b3409],
20	<	JJR	O	<	dep	19	SENT_21	[p2l603t3367r642b3409],
21	10	CD	NUMBER	10	num	22	SENT_21	[p2l672t3353r795b3438],
22	)	NN	O	)	dep	23	SENT_21	[p2l672t3353r795b3438],
23	(	CD	NUMBER	(	dep	33	SENT_21	[p2l861t3352r1290b3438],
24	Johansson	NNP	PERSON	Johansson	dep	23	SENT_21	[p2l861t3352r1290b3438],
25	et	FW	O	et	nn	26	SENT_21	[p2l1350t3363r1421b3421],
26	al.	FW	O	al.	nsubjpass	33	SENT_21	[p2l1481t3352r1593b3435],
27	,	,	O	,	_	0	SENT_21	[p2l1481t3352r1593b3435],
28	1994	CD	DATE	1994	num	29	SENT_21	[p2l1667t3353r1904b3438],
29	)	NN	O	)	appos	26	SENT_21	[p2l1667t3353r1904b3438],
30	,	,	O	,	_	0	SENT_21	[p2l1667t3353r1904b3438],
31	have	VBP	O	have	aux	33	SENT_21	[p2l1967t3352r2150b3422],
32	been	VBN	O	be	auxpass	33	SENT_21	[p2l6t3471r191b3541],
33	reported	VBN	O	report	ccomp	18	SENT_21	[p2l221t3471r565b3561],
34	.	.	O	.	_	0	SENT_21	[p2l221t3471r565b3561],

1	We	PRP	O	we	nsubj	20	SENT_22	[p2l602t3473r737b3541],
2	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_22	[p2l772t3471r1167b3541],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_22	[p2l1202t3471r1604b3561],
4	effects	NNS	O	effect	dobj	2	SENT_22	[p2l1636t3471r1886b3541],
5	of	IN	O	of	_	0	SENT_22	[p2l1922t3471r2007b3541],
6	the	DT	O	the	det	9	SENT_22	[p2l2032t3471r2149b3541],
7	C	NN	O	c	nn	9	SENT_22	[p2l12t3591r74b3660],
8	YPZD6	NN	O	ypzd6	nn	9	SENT_22	[p2l78t3590r357b3659],
9	genotype	NN	O	genotype	prep_of	4	SENT_22	[p2l385t3600r740b3680],
10	on	IN	O	on	_	0	SENT_22	[p2l773t3612r869b3659],
11	the	DT	O	the	det	16	SENT_22	[p2l898t3590r1015b3659],
12	steady	JJ	O	steady	amod	16	SENT_22	[p2l1051t3590r1504b3680],
13	—	NN	O	—	nn	16	SENT_22	[p2l1051t3590r1504b3680],
14	state	NN	O	state	nn	16	SENT_22	[p2l1051t3590r1504b3680],
15	plasma	NN	O	plasma	nn	16	SENT_22	[p2l1535t3590r1812b3680],
16	concentrations	NNS	O	concentration	prep_on	2	SENT_22	[p2l1843t3612r2147b3659, p2l7t3709r295b3779],
17	of	IN	O	of	_	0	SENT_22	[p2l322t3709r407b3779],
18	haloperidol	NN	O	haloperidol	prep_of	16	SENT_22	[p2l422t3709r865b3799],
19	and	CC	O	and	_	0	SENT_22	[p2l891t3709r1029b3779],
20	reduced	VBD	O	reduce	conj_and	2	SENT_22	[p2l1051t3709r1361b3779],
21	haloperidol	NN	O	haloperidol	nn	23	SENT_22	[p2l1382t3709r1826b3799],
22	(	CD	NUMBER	(	num	23	SENT_22	[p2l1852t3709r2150b3795],
23	Suzuki	NNP	PERSON	Suzuki	dobj	20	SENT_22	[p2l1852t3709r2150b3795],
24	et	FW	O	et	nn	25	SENT_22	[p3l8t32r78b90],
25	al.	FW	O	al.	dep	23	SENT_22	[p3l127t21r239b103],
26	,	,	O	,	_	0	SENT_22	[p3l127t21r239b103],
27	1997	CD	DATE	1997	appos	23	SENT_22	[p3l299t22r506b103],
28	;	:	O	;	_	0	SENT_22	[p3l299t22r506b103],
29	Mihara	NNP	PERSON	Mihara	dep	23	SENT_22	[p3l559t21r842b90],
30	et	FW	O	et	nn	31	SENT_22	[p3l889t32r960b90],
31	al.	FW	O	al.	dep	29	SENT_22	[p3l1009t21r1120b103],
32	,	,	O	,	_	0	SENT_22	[p3l1009t21r1120b103],
33	1999	CD	DATE	1999	num	34	SENT_22	[p3l1181t22r1417b107],
34	)	NN	O	)	appos	31	SENT_22	[p3l1181t22r1417b107],
35	.	.	O	.	_	0	SENT_22	[p3l1181t22r1417b107],

1	However	RB	O	however	advmod	8	SENT_23	[p3l1471t23r1848b103],
2	,	,	O	,	_	0	SENT_23	[p3l1471t23r1848b103],
3	to	TO	O	to	_	0	SENT_23	[p3l1899t32r1972b90],
4	our	PRP$	O	we	poss	5	SENT_23	[p3l2024t43r2152b90],
5	knowledge	NN	O	knowledge	prep_to	8	SENT_23	[p3l6t140r455b230],
6	,	,	O	,	_	0	SENT_23	[p3l6t140r455b230],
7	there	EX	O	there	expl	8	SENT_23	[p3l480t140r673b209],
8	is	VBZ	O	be	_	0	SENT_23	[p3l695t140r757b209],
9	no	DT	O	no	det	10	SENT_23	[p3l780t162r876b209],
10	information	NN	O	information	nsubj	8	SENT_23	[p3l899t140r1358b209],
11	concerning	VBG	O	concern	_	0	SENT_23	[p3l1381t140r1811b230],
12	the	DT	O	the	det	13	SENT_23	[p3l1833t140r1951b209],
13	relationship	NN	O	relationship	prep_concerning	10	SENT_23	[p3l1972t140r2148b209, p3l7t259r317b349],
14	between	IN	O	between	_	0	SENT_23	[p3l345t259r671b329],
15	prolactin	NN	O	prolactin	nn	16	SENT_23	[p3l698t259r1045b349],
16	response	NN	O	response	prep_between	13	SENT_23	[p3l1071t281r1411b349],
17	to	TO	O	to	_	0	SENT_23	[p3l1438t270r1512b329],
18	haloperidol	NN	O	haloperidol	prep_to	16	SENT_23	[p3l1540t259r1982b349],
19	and	CC	O	and	_	0	SENT_23	[p3l2013t259r2151b329],
20	the	DT	O	the	det	23	SENT_23	[p3l7t378r124b447],
21	C	NN	O	c	nn	23	SENT_23	[p3l149t379r212b448],
22	YPZD6	NN	O	ypzd6	nn	23	SENT_23	[p3l216t377r495b447],
23	genotype	NN	O	genotype	prep_to	16	SENT_23	[p3l511t389r885b468],
24	.	.	O	.	_	0	SENT_23	[p3l511t389r885b468],

1	The	DT	O	the	det	2	SENT_24	[p3l910t378r1060b447],
2	aim	NN	O	aim	nsubj	6	SENT_24	[p3l1083t378r1227b447],
3	of	IN	O	of	_	0	SENT_24	[p3l1247t378r1332b447],
4	this	DT	O	this	det	5	SENT_24	[p3l1344t378r1482b447],
5	study	NN	O	study	prep_of	2	SENT_24	[p3l1506t378r1710b468],
6	is	VBZ	O	be	_	0	SENT_24	[p3l1731t378r1793b447],
7	to	TO	O	to	aux	8	SENT_24	[p3l1814t389r1886b447],
8	examine	VB	O	examine	xcomp	6	SENT_24	[p3l1908t400r2147b447, p3l7t497r125b567],
9	the	DT	O	the	det	10	SENT_24	[p3l169t497r286b567],
10	effect	NN	O	effect	dobj	8	SENT_24	[p3l331t497r547b567],
11	of	IN	O	of	_	0	SENT_24	[p3l591t497r676b567],
12	the	DT	O	the	det	14	SENT_24	[p3l713t497r831b567],
13	CYPZD6	NN	O	cypzd6	nn	14	SENT_24	[p3l880t497r1224b568],
14	genotype	NN	O	genotype	prep_of	10	SENT_24	[p3l1266t508r1621b587],
15	on	IN	O	on	_	0	SENT_24	[p3l1667t520r1763b567],
16	prolactin	NN	O	prolactin	nn	17	SENT_24	[p3l1804t497r2151b587],
17	concentrations	NNS	O	concentration	prep_on	8	SENT_24	[p3l8t616r572b686],
18	in	IN	O	in	_	0	SENT_24	[p3l605t616r679b685],
19	schizophrenic	JJ	O	schizophrenic	amod	20	SENT_24	[p3l713t616r1247b706],
20	patients	NNS	O	patient	prep_in	17	SENT_24	[p3l1279t616r1580b706],
21	treated	VBN	O	treat	partmod	20	SENT_24	[p3l1612t616r1877b686],
22	with	IN	O	with	_	0	SENT_24	[p3l1907t616r2079b686],
23	a	DT	O	a	det	26	SENT_24	[p3l2111t638r2151b686],
24	ﬁXed	JJ	O	ﬁxed	amod	26	SENT_24	[p3l9t735r411b804],
25	—	NN	O	—	nn	26	SENT_24	[p3l9t735r411b804],
26	dose	NN	O	dose	prep_with	21	SENT_24	[p3l9t735r411b804],
27	of	IN	O	of	_	0	SENT_24	[p3l439t735r524b804],
28	haloperidol	NN	O	haloperidol	prep_of	26	SENT_24	[p3l543t735r1004b825],
29	.	.	O	.	_	0	SENT_24	[p3l543t735r1004b825],

1	The	DT	O	the	det	2	SENT_25	[p3l107t854r259b924],
2	subjects	NNS	O	subject	nsubj	4	SENT_25	[p3l326t854r639b944],
3	were	VBD	O	be	cop	4	SENT_25	[p3l705t877r895b924],
4	76	CD	NUMBER	76	dep	25	SENT_25	[p3l960t854r1055b924],
5	in	IN	O	in	_	0	SENT_25	[p3l1119t854r1537b944],
6	—	CD	NUMBER	—	num	7	SENT_25	[p3l1119t854r1537b944],
7	patients	NNS	O	patient	prep_in	4	SENT_25	[p3l1119t854r1537b944],
8	(	IN	O	(	_	0	SENT_25	[p3l1606t855r1728b940],
9	28	CD	NUMBER	28	num	10	SENT_25	[p3l1606t855r1728b940],
10	men	NNS	O	man	prep_(	7	SENT_25	[p3l1795t877r1987b937],
11	,	,	O	,	_	0	SENT_25	[p3l1795t877r1987b937],
12	48	CD	NUMBER	48	num	13	SENT_25	[p3l2053t855r2146b924],
13	women	NNS	O	woman	dep	14	SENT_25	[p3l8t974r352b1059],
14	)	RB	O	)	amod	7	SENT_25	[p3l8t974r352b1059],
15	,	,	O	,	_	0	SENT_25	[p3l8t974r352b1059],
16	each	DT	O	each	nsubj	20	SENT_25	[p3l424t973r603b1043],
17	of	IN	O	of	_	0	SENT_25	[p3l672t973r758b1043],
18	whom	WP	O	whom	prep_of	16	SENT_25	[p3l819t973r1065b1043],
19	had	VBD	O	have	aux	20	SENT_25	[p3l1131t973r1274b1043],
20	participated	VBN	O	participate	rcmod	7	SENT_25	[p3l1339t973r1811b1063],
21	in	IN	O	in	_	0	SENT_25	[p3l1878t973r1953b1042],
22	our	PRP$	O	we	poss	24	SENT_25	[p3l2021t995r2152b1043],
23	previous	JJ	O	previous	amod	24	SENT_25	[p3l6t1092r345b1182],
24	studies	NNS	O	study	prep_in	20	SENT_25	[p3l392t1092r661b1161],
25	(	VBP	O	(	_	0	SENT_25	[p3l708t1092r1011b1177],
26	Suzuki	NNP	PERSON	Suzuki	dobj	25	SENT_25	[p3l708t1092r1011b1177],
27	et	FW	O	et	nn	28	SENT_25	[p3l1054t1102r1125b1161],
28	al.	FW	O	al.	nsubj	25	SENT_25	[p3l1168t1092r1281b1174],
29	,	,	O	,	_	0	SENT_25	[p3l1168t1092r1281b1174],
30	1997	CD	DATE	1997	appos	28	SENT_25	[p3l1336t1092r1546b1174],
31	;	:	O	;	_	0	SENT_25	[p3l1336t1092r1546b1174],
32	Mihara	NNP	PERSON	Mihara	dep	30	SENT_25	[p3l1591t1092r1879b1161],
33	et	FW	O	et	nn	34	SENT_25	[p3l1921t1102r1990b1161],
34	al.	FW	O	al.	dep	32	SENT_25	[p3l2033t1092r2146b1174],
35	,	,	O	,	_	0	SENT_25	[p3l2033t1092r2146b1174],
36	1999	CD	DATE	1999	num	37	SENT_25	[p3l17t1211r256b1296],
37	)	NN	O	)	appos	34	SENT_25	[p3l17t1211r256b1296],
38	.	.	O	.	_	0	SENT_25	[p3l17t1211r256b1296],

1	The	DT	O	the	det	2	SENT_26	[p3l289t1211r441b1281],
2	mean	NN	O	mean	_	0	SENT_26	[p3l470t1233r684b1281],
3	:	:	O	:	_	0	SENT_26	[p3l719t1217r778b1276],
4	SD	NN	O	sd	nsubj	8	SENT_26	[p3l816t1211r935b1281],
5	of	IN	O	of	_	0	SENT_26	[p3l966t1211r1052b1281],
6	age	NN	O	age	prep_of	4	SENT_26	[p3l1076t1233r1209b1301],
7	was	VBD	O	be	cop	8	SENT_26	[p3l1238t1233r1387b1281],
8	49.0	CD	NUMBER	49.0	dep	2	SENT_26	[p3l1417t1211r1588b1282],
9	:	:	O	:	_	0	SENT_26	[p3l1624t1217r1683b1276],
10	11.0	CD	DURATION	11.0	num	11	SENT_26	[p3l1728t1211r1889b1281],
11	years	NNS	NUMBER	year	dep	8	SENT_26	[p3l1917t1233r2146b1301],
12	,	,	O	,	_	0	SENT_26	[p3l1917t1233r2146b1301],
13	and	CC	O	and	_	0	SENT_26	[p3l9t1330r149b1399],
14	that	DT	O	that	nsubj	19	SENT_26	[p3l210t1330r359b1399],
15	of	IN	O	of	_	0	SENT_26	[p3l421t1330r506b1399],
16	body	NN	O	body	nn	17	SENT_26	[p3l560t1330r757b1420],
17	weight	NN	O	weight	prep_of	14	SENT_26	[p3l820t1330r1089b1420],
18	was	VBD	O	be	cop	19	SENT_26	[p3l1151t1352r1300b1400],
19	57.0	CD	NUMBER	57.0	dep	2	SENT_26	[p3l1365t1330r1535b1400],
20	i	FW	O	i	dep	19	SENT_26	[p3l1570t1335r1629b1395],
21	9.1	CD	NUMBER	9.1	num	22	SENT_26	[p3l1666t1330r1777b1400],
22	kg	NN	O	kg	dep	20	SENT_26	[p3l1813t1330r1931b1420],
23	.	.	O	.	_	0	SENT_26	[p3l1813t1330r1931b1420],

1	The	DT	O	the	det	2	SENT_27	[p3l1997t1330r2149b1399],
2	subjects	NNS	O	subject	nsubj	3	SENT_27	[p3l11t1449r323b1539],
3	fulﬁlled	VBD	O	fulﬁlled	_	0	SENT_27	[p3l356t1449r670b1519],
4	the	DT	O	the	det	5	SENT_27	[p3l700t1449r819b1519],
5	DSM	NNP	ORGANIZATION	DSM	dobj	3	SENT_27	[p3l851t1450r1200b1519],
6	.	.	O	.	_	0	SENT_27	[p3l851t1450r1200b1519],

1	—	NN	O	—	_	0	SENT_28	[p3l851t1450r1200b1519],
2	.	.	O	.	_	0	SENT_28	[p3l851t1450r1200b1519],

1	IV	CD	NUMBER	iv	num	2	SENT_29	[p3l851t1450r1200b1519],
2	criteria	NNS	O	criterion	_	0	SENT_29	[p3l1232t1449r1514b1519],
3	for	IN	O	for	_	0	SENT_29	[p3l1544t1449r1659b1519],
4	schizophrenia	NN	O	schizophrenia	prep_for	2	SENT_29	[p3l1691t1449r2147b1539, p3l7t1568r128b1638],
5	(	CD	NUMBER	(	num	4	SENT_29	[p3l181t1568r602b1654],
6	American	JJ	ORGANIZATION	american	amod	2	SENT_29	[p3l181t1568r602b1654],
7	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	8	SENT_29	[p3l654t1568r1093b1658],
8	Association	NNP	ORGANIZATION	Association	tmod	6	SENT_29	[p3l1147t1568r1636b1650],
9	,	,	O	,	_	0	SENT_29	[p3l1147t1568r1636b1650],
10	1994	CD	DATE	1994	num	11	SENT_29	[p3l1701t1568r1940b1654],
11	)	NN	O	)	appos	8	SENT_29	[p3l1701t1568r1940b1654],
12	.	.	O	.	_	0	SENT_29	[p3l1701t1568r1940b1654],

1	The	DT	O	the	det	3	SENT_30	[p3l1997t1568r2149b1638],
2	study	NN	O	study	nn	3	SENT_30	[p3l11t1687r219b1777],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_30	[p3l244t1687r574b1777],
4	was	VBD	O	be	auxpass	5	SENT_30	[p3l600t1709r749b1757],
5	approved	VBN	O	approve	_	0	SENT_30	[p3l779t1687r1145b1777],
6	by	IN	O	by	_	0	SENT_30	[p3l1168t1687r1265b1777],
7	the	DT	O	the	det	9	SENT_30	[p3l1292t1687r1410b1756],
8	Ethics	NNPS	ORGANIZATION	Ethics	nn	9	SENT_30	[p3l1436t1687r1682b1756],
9	Committee	NNP	ORGANIZATION	Committee	agent	5	SENT_30	[p3l1709t1687r2149b1757],
10	of	IN	ORGANIZATION	of	_	0	SENT_30	[p3l8t1806r94b1876],
11	Hirosaki	NNP	ORGANIZATION	Hirosaki	nn	13	SENT_30	[p3l118t1806r456b1876],
12	University	NNP	ORGANIZATION	University	nn	13	SENT_30	[p3l488t1806r906b1896],
13	Hospital	NNP	ORGANIZATION	Hospital	prep_of	9	SENT_30	[p3l938t1806r1272b1896],
14	and	CC	O	and	_	0	SENT_30	[p3l1306t1806r1446b1876],
15	written	VBN	O	write	conj_and	5	SENT_30	[p3l1477t1806r1756b1876],
16	informed	JJ	O	informed	amod	17	SENT_30	[p3l1787t1806r2150b1876],
17	consent	NN	O	consent	dobj	15	SENT_30	[p3l8t1936r310b1995],
18	to	TO	O	to	aux	19	SENT_30	[p3l342t1936r416b1995],
19	participate	VB	O	participate	xcomp	15	SENT_30	[p3l450t1925r869b2015],
20	was	VBD	O	be	auxpass	21	SENT_30	[p3l905t1947r1054b1995],
21	obtained	VBN	O	obtain	ccomp	19	SENT_30	[p3l1091t1925r1432b1995],
22	from	IN	O	from	_	0	SENT_30	[p3l1465t1925r1656b1995],
23	the	DT	O	the	det	24	SENT_30	[p3l1689t1925r1807b1995],
24	patients	NNS	O	patient	prep_from	21	SENT_30	[p3l1841t1925r2147b2015],
25	and	CC	O	and	_	0	SENT_30	[p3l9t2044r149b2113],
26	their	PRP$	O	they	poss	27	SENT_30	[p3l183t2044r365b2113],
27	families	NNS	O	family	prep_from	21	SENT_30	[p3l399t2044r738b2113],
28	.	.	O	.	_	0	SENT_30	[p3l399t2044r738b2113],

1	All	DT	O	all	det	2	SENT_31	[p3l778t2044r901b2112],
2	subjects	NNS	O	subject	nsubj	3	SENT_31	[p3l941t2044r1254b2134],
3	received	VBD	O	receive	_	0	SENT_31	[p3l1290t2044r1628b2113],
4	a	DT	O	a	det	7	SENT_31	[p3l1664t2066r1704b2113],
5	ﬁXed	JJ	O	ﬁxed	amod	7	SENT_31	[p3l1740t2044r2150b2113],
6	—	NN	O	—	nn	7	SENT_31	[p3l1740t2044r2150b2113],
7	dose	NN	O	dose	dobj	3	SENT_31	[p3l1740t2044r2150b2113],
8	of	IN	O	of	_	0	SENT_31	[p3l8t2163r94b2233],
9	12	CD	NUMBER	12	num	11	SENT_31	[p3l120t2163r207b2232],
10	mg/day	JJ	O	mg/day	amod	11	SENT_31	[p3l235t2163r530b2253],
11	haloperidol	NN	O	haloperidol	prep_of	7	SENT_31	[p3l555t2163r1007b2253],
12	for	IN	O	for	_	0	SENT_31	[p3l1031t2163r1146b2233],
13	at	IN	DURATION	at	quantmod	15	SENT_31	[p3l1170t2174r1239b2233],
14	least	JJS	DURATION	least	mwe	13	SENT_31	[p3l1261t2163r1444b2233],
15	two	CD	DURATION	two	num	16	SENT_31	[p3l1466t2174r1611b2233],
16	weeks	NNS	NUMBER	week	prep_for	11	SENT_31	[p3l1636t2163r1880b2233],
17	in	IN	O	in	_	0	SENT_31	[p3l1905t2163r1980b2232],
18	two	CD	NUMBER	two	num	21	SENT_31	[p3l2003t2174r2148b2233],
19	equally	RB	O	equally	advmod	21	SENT_31	[p3l8t2282r297b2372],
20	divided	VBN	O	divide	amod	21	SENT_31	[p3l334t2282r630b2352],
21	doses	NNS	O	dose	prep_in	3	SENT_31	[p3l664t2282r878b2351],
22	at	IN	O	at	_	0	SENT_31	[p3l916t2292r985b2351],
23	8:00	CD	TIME	8:00	num	24	SENT_31	[p3l1022t2282r1191b2352],
24	AM	NNP	TIME	AM	prep_at	21	SENT_31	[p3l1225t2282r1382b2351],
25	and	CC	O	and	_	0	SENT_31	[p3l1418t2282r1557b2351],
26	8:00	CD	TIME	8:00	num	27	SENT_31	[p3l1595t2282r1764b2352],
27	PM	NN	TIME	pm	conj_and	24	SENT_31	[p3l1799t2283r1959b2351],
28	.	.	O	.	_	0	SENT_31	[p3l1799t2283r1959b2351],

1	The	DT	O	the	det	4	SENT_32	[p3l1997t2282r2149b2351],
2	mean	NN	O	mean	nn	4	SENT_32	[p3l7t2424r221b2471],
3	elimination	NN	O	elimination	nn	4	SENT_32	[p3l307t2401r760b2471],
4	half	NN	O	half	nsubj	10	SENT_32	[p3l845t2401r1218b2471],
5	—	JJ	O	—	amod	6	SENT_32	[p3l845t2401r1218b2471],
6	lives	NNS	O	life	_	0	SENT_32	[p3l845t2401r1218b2471],
7	of	IN	O	of	_	0	SENT_32	[p3l1307t2401r1392b2471],
8	haloperidol	NN	O	haloperidol	prep_of	6	SENT_32	[p3l1470t2401r1923b2491],
9	and	CC	O	and	_	0	SENT_32	[p3l2011t2401r2151b2471],
10	reduced	VBD	O	reduce	conj_and	6	SENT_32	[p3l6t2520r321b2590],
11	haloperidol	NN	O	haloperidol	nsubjpass	14	SENT_32	[p3l354t2520r805b2610],
12	have	VBP	O	have	aux	14	SENT_32	[p3l840t2520r1025b2590],
13	been	VBN	O	be	auxpass	14	SENT_32	[p3l1059t2520r1246b2590],
14	reported	VBN	O	report	ccomp	10	SENT_32	[p3l1279t2520r1611b2610],
15	to	TO	O	to	aux	20	SENT_32	[p3l1644t2531r1718b2590],
16	be	VB	O	be	cop	20	SENT_32	[p3l1751t2520r1844b2590],
17	22	CD	NUMBER	22	num	20	SENT_32	[p3l1880t2520r1974b2589],
18	and	CC	O	and	_	0	SENT_32	[p3l2011t2520r2151b2590],
19	34	CD	NUMBER	34	num	20	SENT_32	[p3l10t2639r103b2709],
20	h	NN	O	h	xcomp	14	SENT_32	[p3l131t2639r200b2721],
21	,	,	O	,	_	0	SENT_32	[p3l131t2639r200b2721],
22	respectively	RB	O	respectively	dep	24	SENT_32	[p3l240t2639r721b2729],
23	(	CD	NUMBER	(	num	24	SENT_32	[p3l763t2640r1032b2729],
24	Tsang	NNP	PERSON	Tsang	dep	20	SENT_32	[p3l763t2640r1032b2729],
25	et	FW	O	et	nn	26	SENT_32	[p3l1073t2649r1143b2708],
26	al.	FW	O	al.	dep	24	SENT_32	[p3l1181t2639r1295b2721],
27	,	,	O	,	_	0	SENT_32	[p3l1181t2639r1295b2721],
28	1994	CD	DATE	1994	num	29	SENT_32	[p3l1346t2639r1586b2724],
29	)	NN	O	)	appos	24	SENT_32	[p3l1346t2639r1586b2724],
30	.	.	O	.	_	0	SENT_32	[p3l1346t2639r1586b2724],

1	Accordingly	RB	O	accordingly	advmod	8	SENT_33	[p3l1629t2639r2146b2729],
2	,	,	O	,	_	0	SENT_33	[p3l1629t2639r2146b2729],
3	plasma	NN	O	plasma	nn	4	SENT_33	[p3l6t2758r288b2848],
4	concentrations	NNS	O	concentration	nsubj	8	SENT_33	[p3l325t2758r902b2828],
5	of	IN	O	of	_	0	SENT_33	[p3l943t2758r1028b2828],
6	both	DT	O	both	det	7	SENT_33	[p3l1057t2758r1233b2828],
7	compounds	NNS	O	compound	prep_of	4	SENT_33	[p3l1271t2758r1725b2848],
8	reached	VBD	O	reach	_	0	SENT_33	[p3l1762t2758r2072b2828],
9	a	DT	O	a	det	12	SENT_33	[p3l2110t2781r2151b2828],
10	steady	JJ	O	steady	amod	12	SENT_33	[p3l11t2877r475b2967],
11	—	NN	O	—	nn	12	SENT_33	[p3l11t2877r475b2967],
12	state	NN	O	state	dobj	8	SENT_33	[p3l11t2877r475b2967],
13	before	IN	O	before	_	0	SENT_33	[p3l500t2877r754b2947],
14	blood	NN	O	blood	nn	15	SENT_33	[p3l779t2877r1005b2947],
15	sampling	NN	O	sampling	prep_before	8	SENT_33	[p3l1035t2877r1414b2967],
16	.	.	O	.	_	0	SENT_33	[p3l1035t2877r1414b2967],

1	The	DT	O	the	det	2	SENT_34	[p3l1446t2877r1598b2947],
2	patients	NNS	O	patient	nsubj	4	SENT_34	[p3l1624t2877r1930b2967],
3	were	VBD	O	be	aux	4	SENT_34	[p3l1959t2899r2149b2947],
4	receiving	VBG	O	receive	_	0	SENT_34	[p3l6t2996r375b3086],
5	no	DT	O	no	det	7	SENT_34	[p3l456t3018r552b3065],
6	other	JJ	O	other	amod	7	SENT_34	[p3l634t2996r837b3065],
7	medication	NN	O	medication	dobj	4	SENT_34	[p3l915t2996r1357b3065],
8	except	IN	O	except	_	0	SENT_34	[p3l1438t3006r1697b3086],
9	biperiden	NN	O	biperiden	prep_except	7	SENT_34	[p3l1775t2996r2150b3086],
10	(	CD	NUMBER	(	num	9	SENT_34	[p3l11t3115r198b3201],
11	3-6	CD	NUMBER	3-6	num	12	SENT_34	[p3l11t3115r198b3201],
12	mg/day	NN	O	mg/day	dep	9	SENT_34	[p3l226t3115r544b3205],
13	,	,	O	,	_	0	SENT_34	[p3l226t3115r544b3205],
14	n	NN	O	n	prep_except	7	SENT_34	[p3l605t3139r651b3184],
15	=	JJ	O	=	amod	17	SENT_34	[p3l686t3142r753b3167],
16	71	CD	NUMBER	71	tmod	15	SENT_34	[p3l789t3116r916b3200],
17	)	NN	O	)	dep	14	SENT_34	[p3l789t3116r916b3200],
18	and	CC	O	and	_	0	SENT_34	[p3l977t3115r1117b3185],
19	ﬂunitrazepam	NN	O	ﬂunitrazepam	prep_except	7	SENT_34	[p3l1175t3115r1721b3205],
20	(	CD	NUMBER	(	num	19	SENT_34	[p3l1781t3115r1969b3201],
21	1-6	CD	NUMBER	1-6	num	22	SENT_34	[p3l1781t3115r1969b3201],
22	mg	NN	O	mg	dep	19	SENT_34	[p3l1997t3115r2152b3205],
23	/	:	O	/	punct	24	SENT_34	[p3l1997t3115r2152b3205],
24	day	NN	DURATION	day	dep	7	SENT_34	[p3l8t3234r169b3324],
25	,	,	O	,	_	0	SENT_34	[p3l8t3234r169b3324],
26	n	NN	O	n	appos	24	SENT_34	[p3l201t3258r247b3303],
27	=	JJ	O	=	amod	29	SENT_34	[p3l281t3261r348b3286],
28	62	CD	NUMBER	62	tmod	27	SENT_34	[p3l385t3234r535b3319],
29	)	NN	O	)	dep	7	SENT_34	[p3l385t3234r535b3319],
30	,	,	O	,	_	0	SENT_34	[p3l385t3234r535b3319],
31	neither	DT	O	neither	nsubj	40	SENT_34	[p3l565t3234r842b3303],
32	of	IN	O	of	_	0	SENT_34	[p3l869t3234r955b3303],
33	which	WDT	O	which	prep_of	31	SENT_34	[p3l976t3234r1216b3304],
34	affects	VBZ	O	affect	rcmod	29	SENT_34	[p3l1245t3234r1500b3303],
35	plasma	NN	O	plasma	nn	36	SENT_34	[p3l1528t3234r1810b3324],
36	concentration	NN	O	concentration	dobj	34	SENT_34	[p3l1838t3256r2147b3303, p3l7t3353r266b3423],
37	of	IN	O	of	_	0	SENT_34	[p3l299t3353r385b3423],
38	haloperidol	NN	O	haloperidol	prep_of	36	SENT_34	[p3l411t3353r863b3443],
39	or	CC	O	or	_	0	SENT_34	[p3l899t3376r980b3423],
40	reduced	VBN	O	reduce	conj_or	34	SENT_34	[p3l1010t3353r1324b3423],
41	haloperidol	NN	O	haloperidol	nn	43	SENT_34	[p3l1357t3353r1809b3443],
42	(	CD	NUMBER	(	num	43	SENT_34	[p3l1846t3353r2149b3439],
43	Suzuki	NNP	PERSON	Suzuki	dobj	40	SENT_34	[p3l1846t3353r2149b3439],
44	et	FW	O	et	nn	45	SENT_34	[p3l8t3483r78b3541],
45	al.	FW	O	al.	dep	43	SENT_34	[p3l113t3472r227b3554],
46	,	,	O	,	_	0	SENT_34	[p3l113t3472r227b3554],
47	1997	CD	DATE	1997	appos	43	SENT_34	[p3l275t3472r485b3554],
48	;	:	O	;	_	0	SENT_34	[p3l275t3472r485b3554],
49	Mihara	NNP	PERSON	Mihara	dep	43	SENT_34	[p3l524t3472r811b3541],
50	et	FW	O	et	nn	51	SENT_34	[p3l845t3483r916b3541],
51	al.	FW	O	al.	dep	49	SENT_34	[p3l951t3472r1065b3554],
52	,	,	O	,	_	0	SENT_34	[p3l951t3472r1065b3554],
53	1999	CD	DATE	1999	num	54	SENT_34	[p3l1113t3472r1352b3557],
54	)	NN	O	)	appos	51	SENT_34	[p3l1113t3472r1352b3557],
55	.	.	O	.	_	0	SENT_34	[p3l1113t3472r1352b3557],

1	The	DT	O	the	det	2	SENT_35	[p3l1393t3472r1544b3541],
2	doses	NNS	O	dose	nsubjpass	9	SENT_35	[p3l1581t3472r1796b3541],
3	of	IN	O	of	_	0	SENT_35	[p3l1834t3472r1920b3541],
4	these	DT	O	these	prep_of	2	SENT_35	[p3l1947t3472r2148b3541],
5	coadministered	VBN	O	coadminister	partmod	4	SENT_35	[p3l8t3591r615b3660],
6	drugs	NNS	O	drug	dobj	5	SENT_35	[p3l649t3591r863b3681],
7	were	VBD	O	be	auxpass	9	SENT_35	[p3l899t3613r1088b3660],
8	also	RB	O	also	advmod	9	SENT_35	[p3l1124t3591r1278b3660],
9	ﬁxed	VBN	O	ﬁxed	_	0	SENT_35	[p3l1314t3591r1509b3660],
10	for	IN	O	for	_	0	SENT_35	[p3l1542t3591r1657b3660],
11	at	IN	DURATION	at	quantmod	13	SENT_35	[p3l1690t3601r1758b3660],
12	least	JJS	DURATION	least	mwe	11	SENT_35	[p3l1790t3591r1972b3660],
13	two	CD	DURATION	two	num	14	SENT_35	[p3l2003t3601r2148b3661],
14	weeks	NNS	NUMBER	week	prep_for	9	SENT_35	[p3l8t3710r250b3780],
15	before	IN	O	before	_	0	SENT_35	[p3l288t3710r541b3780],
16	blood	NN	O	blood	nn	17	SENT_35	[p3l578t3710r803b3780],
17	sampling	NN	O	sampling	prep_before	9	SENT_35	[p3l844t3710r1222b3800],
18	.	.	O	.	_	0	SENT_35	[p3l844t3710r1222b3800],

1	Drug	NN	O	drug	nn	2	SENT_36	[p3l1265t3712r1465b3800],
2	compliance	NN	O	compliance	nsubjpass	4	SENT_36	[p3l1504t3710r1961b3800],
3	was	VBD	O	be	auxpass	4	SENT_36	[p3l1999t3733r2148b3780],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_36	[p4l8t21r409b91],
5	by	IN	O	by	_	0	SENT_36	[p4l461t21r558b111],
6	nursing	VBG	O	nurse	agent	4	SENT_36	[p4l612t21r906b111],
7	staff	NN	O	staff	dobj	6	SENT_36	[p4l965t21r1150b91],
8	.	.	O	.	_	0	SENT_36	[p4l965t21r1150b91],

1	Blood	NN	O	blood	nn	2	SENT_37	[p4l1210t21r1451b91],
2	samplings	NNS	O	sampling	nsubjpass	4	SENT_37	[p4l1507t21r1903b111],
3	were	VBD	O	be	auxpass	4	SENT_37	[p4l1959t43r2149b91],
4	performed	VBN	O	perform	_	0	SENT_37	[p4l6t140r420b230],
5	at	IN	O	at	_	0	SENT_37	[p4l460t150r529b209],
6	8:00	CD	TIME	8:00	num	7	SENT_37	[p4l569t140r739b210],
7	AM	NNP	TIME	AM	prep_at	4	SENT_37	[p4l777t140r934b209],
8	just	RB	TIME	just	advmod	7	SENT_37	[p4l963t140r1114b230],
9	before	IN	TIME	before	_	0	SENT_37	[p4l1149t140r1402b209],
10	the	DT	TIME	the	det	12	SENT_37	[p4l1441t140r1559b209],
11	morning	NN	TIME	morning	nn	12	SENT_37	[p4l1598t140r1932b230],
12	dose	NN	O	dose	prep_before	7	SENT_37	[p4l1971t140r2150b209],
13	after	IN	O	after	_	0	SENT_37	[p4l9t258r189b327],
14	30	CD	DURATION	30	num	16	SENT_37	[p4l231t258r324b327],
15	min	NN	DURATION	min	nn	16	SENT_37	[p4l352t258r505b326],
16	rest	NN	O	rest	prep_after	4	SENT_37	[p4l544t268r705b327],
17	.	.	O	.	_	0	SENT_37	[p4l544t268r705b327],

1	For	IN	O	for	_	0	SENT_38	[p4l751t260r888b327],
2	determination	NN	O	determination	pobj	1	SENT_38	[p4l927t258r1479b327],
3	of	IN	O	of	_	0	SENT_38	[p4l1521t258r1606b327],
4	the	DT	O	the	det	5	SENT_38	[p4l1640t258r1758b327],
5	CYPZD6	NN	O	cypzd6	prep_of	2	SENT_38	[p4l1805t258r2153b327],

1	0920-9964/01	NN	DURATION	0920-9964/01	_	0	SENT_39	[p4l509t378r719b406],
2	/	:	O	/	punct	1	SENT_39	[p4l509t378r719b406],
3	$	$	MONEY	$	nsubj	5	SENT_39	[p4l509t378r719b406],
4	—	CD	MONEY	—	num	3	SENT_39	[p4l731t394r740b396],
5	see	VBP	O	see	dep	1	SENT_39	[p4l753t387r793b403],
6	front	JJ	O	front	amod	7	SENT_39	[p4l804t380r868b403],
7	matter	NN	O	matter	nsubj	15	SENT_39	[p4l879t383r964b403],
8	©	CD	NUMBER	©	num	14	SENT_39	[p4l976t380r999b403],
9	2001	CD	DATE	2001	num	14	SENT_39	[p4l1013t380r1075b403],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	14	SENT_39	[p4l1089t380r1198b403],
11	Science	NNP	ORGANIZATION	Science	nn	14	SENT_39	[p4l1209t380r1310b403],
12	B.V.	NNP	ORGANIZATION	B.V.	nn	14	SENT_39	[p4l1321t380r1381b403],
13	All	NNP	O	All	nn	14	SENT_39	[p4l1394t380r1435b403],
14	rights	NNS	O	rights	dep	7	SENT_39	[p4l1446t380r1521b410],
15	reserved	VBD	O	reserve	ccomp	5	SENT_39	[p4l1531t380r1650b403],
16	.	.	O	.	_	0	SENT_39	[p4l1531t380r1650b403],

1	PII	NN	O	pius	_	0	SENT_40	[p4l509t422r556b445],
2	:	:	O	:	_	0	SENT_40	[p4l509t422r556b445],
3	S0920-9964	NN	O	s0920-9964	dep	1	SENT_40	[p4l576t421r913b450],
4	(	CD	NUMBER	(	num	3	SENT_40	[p4l576t421r913b450],
5	00	CD	NUMBER	00	number	6	SENT_40	[p4l576t421r913b450],
6	)	CD	NUMBER	)	dep	3	SENT_40	[p4l576t421r913b450],
7	0017	CD	DATE	0017	num	8	SENT_40	[p4l576t421r913b450],
8	8-X	NN	O	8-x	dep	6	SENT_40	[p4l920t421r976b445],

1	140	CD	NUMBER	140	num	3	SENT_41	[p4l137t525r182b549],
2	N.	NNP	PERSON	N.	nn	3	SENT_41	[p4l606t526r633b549],
3	Yasui-Furukori	NNP	PERSON	Yasui-Furukori	_	0	SENT_41	[p4l649t525r850b549],
4	et	FW	O	et	nn	5	SENT_41	[p4l862t530r886b549],
5	al.	FW	O	al.	dep	3	SENT_41	[p4l895t525r926b549],
6	/	:	O	/	punct	26	SENT_41	[p4l937t525r952b549],
7	Schizophrenia	NNP	O	Schizophrenia	nn	16	SENT_41	[p4l959t525r1147b555],
8	Research	NNP	O	Research	nn	16	SENT_41	[p4l1158t525r1281b549],
9	52	CD	NUMBER	52	num	16	SENT_41	[p4l1292t525r1323b549],
10	(	CD	NUMBER	(	num	16	SENT_41	[p4l1336t525r1422b554],
11	2001	CD	DATE	2001	num	16	SENT_41	[p4l1336t525r1422b554],
12	)	CD	NUMBER	)	num	16	SENT_41	[p4l1336t525r1422b554],
13	139-142	CD	NUMBER	139-142	num	16	SENT_41	[p4l1435t525r1551b549],
14	Table	NNP	O	Table	nn	16	SENT_41	[p4l134t600r209b624],
15	1	CD	NUMBER	1	num	16	SENT_41	[p4l222t600r232b624],
16	Effect	NN	O	effect	nsubj	26	SENT_41	[p4l133t641r213b664],
17	of	IN	O	of	_	0	SENT_41	[p4l222t641r251b664],
18	CYPZD6	NN	O	cypzd6	nn	19	SENT_41	[p4l260t641r377b664],
19	genotype	NN	O	genotype	prep_of	26	SENT_41	[p4l385t645r506b671],
20	on	IN	O	on	_	0	SENT_41	[p4l516t648r548b664],
21	plasma	NN	O	plasma	nn	22	SENT_41	[p4l557t641r651b671],
22	concentrations	NNS	O	concentration	prep_on	19	SENT_41	[p4l660t641r853b664],
23	of	IN	O	of	_	0	SENT_41	[p4l863t641r892b664],
24	haloperidol	NN	O	haloperidol	prep_of	22	SENT_41	[p4l899t641r1057b671],
25	,	,	O	,	_	0	SENT_41	[p4l899t641r1057b671],
26	reduced	VBD	O	reduce	dep	3	SENT_41	[p4l1067t641r1172b664],
27	haloperidol	NN	O	haloperidol	dobj	26	SENT_41	[p4l1181t641r1332b671],
28	and	CC	O	and	_	0	SENT_41	[p4l1342t641r1389b664],
29	lactin	NN	O	lactin	dobj	26	SENT_41	[p4l1443t641r1516b664],
30	(	CD	NUMBER	(	num	31	SENT_41	[p4l1527t641r1592b669],
31	data	NNS	O	datum	nsubjpass	33	SENT_41	[p4l1527t641r1592b669],
32	are	VBP	O	be	auxpass	33	SENT_41	[p4l1602t648r1641b664],
33	shown	VBN	O	show	rcmod	27	SENT_41	[p4l1652t641r1736b664],
34	as	IN	O	as	_	0	SENT_41	[p4l1746t648r1772b664],
35	mean	NN	O	mean	prep_as	33	SENT_41	[p4l1782t648r1853b664],
36	:	:	O	:	_	0	SENT_41	[p4l1865t643r1885b663],
37	SD	NN	O	sd	dobj	26	SENT_41	[p4l1897t641r1945b668],
38	;	:	O	;	_	0	SENT_41	[p4l1897t641r1945b668],
39	*	CD	NUMBER	*	num	40	SENT_41	[p4l1960t641r1988b671],
40	p	NN	O	p	dep	41	SENT_41	[p4l1960t641r1988b671],
41	<	JJR	O	<	dep	37	SENT_41	[p4l2001t643r2024b662],
42	0.05	CD	NUMBER	0.05	dep	41	SENT_41	[p4l134t682r198b709],
43	,	,	O	,	_	0	SENT_41	[p4l134t682r198b709],
44	**	CD	NUMBER	**	num	45	SENT_41	[p4l213t682r258b712],
45	p	NN	O	p	dep	26	SENT_41	[p4l213t682r258b712],
46	<	JJR	O	<	dep	45	SENT_41	[p4l271t685r293b704],
47	0.01	CD	NUMBER	0.01	dep	46	SENT_41	[p4l305t682r370b709],
48	,	,	O	,	_	0	SENT_41	[p4l305t682r370b709],
49	***	CD	NUMBER	***	num	50	SENT_41	[p4l385t682r447b712],
50	p	NN	O	p	dep	51	SENT_41	[p4l385t682r447b712],
51	<	JJR	O	<	appos	47	SENT_41	[p4l459t685r482b704],
52	0.001	CD	NUMBER	0.001	dep	51	SENT_41	[p4l494t682r575b709],
53	,	,	O	,	_	0	SENT_41	[p4l494t682r575b709],
54	compared	VBN	O	compare	_	0	SENT_41	[p4l587t682r717b712],
55	with	IN	O	with	prepc_compared_with	3	SENT_41	[p4l728t682r786b705],
56	wt/wt	NN	O	wt/wt	pobj	3	SENT_41	[p4l797t682r879b709],
57	;	:	O	;	_	0	SENT_41	[p4l797t682r879b709],
58	wt	JJ	O	wt	dep	56	SENT_41	[p4l892t686r931b705],
59	:	:	O	:	_	0	SENT_41	[p4l892t686r931b705],
60	wild-type	JJ	O	wild-type	amod	61	SENT_41	[p4l944t682r1070b712],
61	allele	NN	O	allele	dep	56	SENT_41	[p4l1082t682r1160b709],
62	,	,	O	,	_	0	SENT_41	[p4l1082t682r1160b709],
63	m	NN	O	m	appos	61	SENT_41	[p4l1172t689r1204b705],
64	:	:	O	:	_	0	SENT_41	[p4l1172t689r1204b705],
65	mutated-type	JJ	O	mutated-type	amod	67	SENT_41	[p4l1217t682r1391b712],
66	le	DT	O	le	det	67	SENT_41	[p4l1451t682r1484b711],
67	)	NN	O	)	dep	56	SENT_41	[p4l1451t682r1484b711],

1	CYPZD6	NN	O	cypzd6	nn	2	SENT_42	[p4l376t764r493b788],
2	genotype	NN	O	genotype	_	0	SENT_42	[p4l502t768r623b795],
3	Haloperidol	NNP	O	Haloperidol	dep	2	SENT_42	[p4l840t764r997b795],
4	(	CD	NUMBER	(	num	3	SENT_42	[p4l1009t764r1106b795],
5	ng/ml	NN	O	ng/ml	dep	2	SENT_42	[p4l1009t764r1106b795],
6	)	CD	NUMBER	)	num	5	SENT_42	[p4l1009t764r1106b795],
7	Reduced	VBN	O	reduce	partmod	2	SENT_42	[p4l1255t764r1371b788],
8	haloperidol	NN	O	haloperidol	nn	10	SENT_42	[p4l1381t764r1532b795],
9	(	CD	NUMBER	(	num	10	SENT_42	[p4l1544t764r1641b795],
10	ng/ml	NN	O	ng/ml	dobj	7	SENT_42	[p4l1544t764r1641b795],
11	)	CD	NUMBER	)	num	12	SENT_42	[p4l1544t764r1641b795],
12	Prolactin	NN	O	prolactin	tmod	7	SENT_42	[p4l1786t764r1906b788],
13	(	CD	NUMBER	(	num	15	SENT_42	[p4l1918t764r2015b795],
14	ng/ml	NN	O	ng/ml	nn	15	SENT_42	[p4l1918t764r2015b795],
15	)	NN	O	)	dep	12	SENT_42	[p4l1918t764r2015b795],

1	Male	JJ	O	male	amod	4	SENT_43	[p4l133t846r201b869],
2	wt/wt	JJ	O	wt/wt	amod	4	SENT_43	[p4l375t846r450b870],
3	(	NN	O	(	nn	4	SENT_43	[p4l461t846r487b875],
4	:1	NN	O	:1	dep	9	SENT_43	[p4l461t846r487b875],
5	=	JJ	O	=	amod	6	SENT_43	[p4l496t846r571b875],
6	11	CD	NUMBER	11	dep	4	SENT_43	[p4l496t846r571b875],
7	)	NN	O	)	dep	9	SENT_43	[p4l496t846r571b875],
8	7.4	CD	NUMBER	7.4	num	7	SENT_43	[p4l856t846r897b869],
9	i	FW	O	i	dep	14	SENT_43	[p4l908t848r928b868],
10	3.5	CD	NUMBER	3.5	number	11	SENT_43	[p4l941t846r979b870],
11	2.0	CD	NUMBER	2.0	dep	9	SENT_43	[p4l1255t846r1295b870],
12	i	FW	O	i	dep	11	SENT_43	[p4l1307t848r1327b868],
13	0.8	CD	NUMBER	0.8	num	14	SENT_43	[p4l1339t846r1378b870],
14	20.5	CD	NUMBER	20.5	dep	24	SENT_43	[p4l1787t846r1842b870],
15	:	:	O	:	_	0	SENT_43	[p4l1855t848r1875b868],
16	7.8	CD	NUMBER	7.8	num	17	SENT_43	[p4l1887t846r1926b870],
17	In/wt	NN	O	in/wt	dep	14	SENT_43	[p4l375t887r442b911],
18	and	CC	O	and	_	0	SENT_43	[p4l453t887r500b911],
19	m/m	NN	O	m/m	nn	21	SENT_43	[p4l511t887r571b911],
20	(	CD	NUMBER	(	num	21	SENT_43	[p4l583t888r608b916],
21	n	NN	O	n	conj_and	14	SENT_43	[p4l583t888r608b916],
22	=	JJ	O	=	amod	21	SENT_43	[p4l618t896r640b905],
23	17	CD	NUMBER	17	tmod	22	SENT_43	[p4l653t887r692b916],
24	)	NN	O	)	dep	26	SENT_43	[p4l653t887r692b916],
25	10.6	CD	NUMBER	10.6	num	24	SENT_43	[p4l843t887r896b911],
26	i	FW	O	i	_	0	SENT_43	[p4l908t889r928b909],
27	4.5	CD	NUMBER	4.5	nsubj	31	SENT_43	[p4l940t887r995b911],
28	*	CD	NUMBER	*	number	29	SENT_43	[p4l940t887r995b911],
29	3.7	CD	NUMBER	3.7	dep	27	SENT_43	[p4l1256t887r1295b911],
30	:	:	O	:	_	0	SENT_43	[p4l1307t889r1327b909],
31	l.	VB	O	l.	rcmod	26	SENT_43	[p4l1342t887r1427b911],
32	5	CD	NUMBER	5	dep	46	SENT_43	[p4l1342t887r1427b911],
33	***	CD	NUMBER	***	number	34	SENT_43	[p4l1342t887r1427b911],
34	32.4	CD	NUMBER	32.4	dep	32	SENT_43	[p4l1787t887r1843b911],
35	:	:	O	:	_	0	SENT_43	[p4l1855t889r1875b909],
36	164	CD	NUMBER	164	number	37	SENT_43	[p4l1890t887r1959b911],
37	*	CD	NUMBER	*	num	41	SENT_43	[p4l1890t887r1959b911],
38	Female	JJ	O	female	amod	41	SENT_43	[p4l134t928r231b952],
39	wt/wt	JJ	O	wt/wt	amod	41	SENT_43	[p4l375t928r450b952],
40	(	NN	O	(	nn	41	SENT_43	[p4l461t928r486b957],
41	n	NN	O	n	dep	34	SENT_43	[p4l461t928r486b957],
42	=	JJ	O	=	amod	41	SENT_43	[p4l496t937r519b946],
43	20	CD	NUMBER	20	tmod	42	SENT_43	[p4l529t928r571b957],
44	)	NN	O	)	dep	46	SENT_43	[p4l529t928r571b957],
45	8.5	CD	NUMBER	8.5	num	44	SENT_43	[p4l857t928r895b952],
46	i	FW	O	i	dep	51	SENT_43	[p4l908t930r928b950],
47	3.6	CD	NUMBER	3.6	number	48	SENT_43	[p4l941t928r980b952],
48	2.4	CD	NUMBER	2.4	dep	46	SENT_43	[p4l1255t928r1295b952],
49	i	FW	O	i	dep	48	SENT_43	[p4l1307t930r1327b950],
50	1.2	CD	NUMBER	1.2	number	51	SENT_43	[p4l1342t928r1379b952],
51	71.2	CD	NUMBER	71.2	dep	68	SENT_43	[p4l1787t928r1843b952],
52	i	FW	O	i	dep	51	SENT_43	[p4l1855t930r1875b950],
53	46.5	CD	NUMBER	46.5	num	54	SENT_43	[p4l1886t928r1942b952],
54	In/wt	NN	O	in/wt	dep	51	SENT_43	[p4l375t969r442b993],
55	and	CC	O	and	_	0	SENT_43	[p4l453t969r500b993],
56	m/m	NN	O	m/m	nn	58	SENT_43	[p4l511t969r571b993],
57	(	CD	NUMBER	(	num	58	SENT_43	[p4l583t970r608b998],
58	n	NN	O	n	conj_and	51	SENT_43	[p4l583t970r608b998],
59	=	JJ	O	=	amod	58	SENT_43	[p4l618t978r640b987],
60	28	CD	NUMBER	28	tmod	59	SENT_43	[p4l650t969r692b998],
61	)	CD	NUMBER	)	number	62	SENT_43	[p4l650t969r692b998],
62	10.9	CD	NUMBER	10.9	dep	58	SENT_43	[p4l843t969r896b993],
63	i	FW	O	i	dep	62	SENT_43	[p4l908t971r928b991],
64	3.8	CD	NUMBER	3.8	nsubj	68	SENT_43	[p4l941t969r995b993],
65	*	CD	NUMBER	*	number	66	SENT_43	[p4l941t969r995b993],
66	3.6	CD	NUMBER	3.6	dep	64	SENT_43	[p4l1256t969r1295b993],
67	:	:	O	:	_	0	SENT_43	[p4l1307t971r1327b991],
68	l.	VB	O	l.	dep	31	SENT_43	[p4l1342t969r1411b993],
69	8	CD	NUMBER	8	number	70	SENT_43	[p4l1342t969r1411b993],
70	**	CD	NUMBER	**	num	71	SENT_43	[p4l1342t969r1411b993],
71	72.1	CD	NUMBER	72.1	dobj	68	SENT_43	[p4l1787t969r1840b993],
72	i	FW	O	i	dep	71	SENT_43	[p4l1855t971r1875b991],
73	50.8	CD	NUMBER	50.8	dep	72	SENT_43	[p4l1887t969r1943b993],

1	genotypes	NNS	O	genotype	nsubjpass	5	SENT_44	[p4l10t1187r430b1266],
2	,	,	O	,	_	0	SENT_44	[p4l10t1187r430b1266],
3	DNA	NN	O	dna	appos	1	SENT_44	[p4l467t1177r678b1246],
4	was	VBD	O	be	auxpass	5	SENT_44	[p4l712t1198r860b1246],
5	isolated	VBN	O	isolate	_	0	SENT_44	[p4l896t1176r1203b1246],
6	from	IN	O	from	_	0	SENT_44	[p4l1236t1176r1428b1246],
7	peripheral	JJ	O	peripheral	amod	8	SENT_44	[p4l1458t1176r1860b1266],
8	leukocytes	NNS	O	leukocyte	prep_from	5	SENT_44	[p4l1894t1176r2143b1246, p4l9t1306r208b1385],
9	by	IN	O	by	_	0	SENT_44	[p4l238t1295r335b1385],
10	the	DT	O	the	det	13	SENT_44	[p4l364t1295r483b1365],
11	guanidinium	NN	O	guanidinium	nn	13	SENT_44	[p4l513t1295r1014b1385],
12	isothiocyanate	NN	O	isothiocyanate	nn	13	SENT_44	[p4l1043t1295r1614b1385],
13	method	NN	O	method	agent	5	SENT_44	[p4l1644t1295r1959b1365],
14	.	.	O	.	_	0	SENT_44	[p4l1644t1295r1959b1365],

1	The	DT	O	the	det	8	SENT_45	[p4l1994t1295r2145b1365],
2	wild	JJ	O	wild	amod	3	SENT_45	[p4l9t1414r212b1483],
3	—	NN	O	—	nn	8	SENT_45	[p4l9t1414r212b1483],
4	and	CC	O	and	_	0	SENT_45	[p4l251t1414r390b1483],
5	mutated	VBN	O	mutate	amod	7	SENT_45	[p4l422t1414r945b1504],
6	—	CD	NUMBER	—	num	7	SENT_45	[p4l422t1414r945b1504],
7	type	NN	O	type	conj_and	8	SENT_45	[p4l422t1414r945b1504],
8	alleles	NNS	O	allele	_	0	SENT_45	[p4l982t1414r1229b1483],
9	of	IN	O	of	_	0	SENT_45	[p4l1267t1414r1352b1483],
10	CYPZD6	NN	O	cypzd6	dep	11	SENT_45	[p4l1383t1413r1731b1484],
11	>	JJR	O	>	prep_of	8	SENT_45	[p4l1757t1428r1795b1471],
12	I	PRP	O	I	npadvmod	13	SENT_45	[p4l1757t1428r1795b1471],
13	<	JJR	O	<	amod	11	SENT_45	[p4l1757t1428r1795b1471],
14	I	CD	NUMBER	i	tmod	8	SENT_45	[p4l1827t1414r1886b1495],
15	,	,	O	,	_	0	SENT_45	[p4l1827t1414r1886b1495],
16	>	JJR	O	>	amod	8	SENT_45	[p4l1955t1429r1993b1471],
17	I	PRP	O	I	npadvmod	18	SENT_45	[p4l1955t1429r1993b1471],
18	<	JJR	O	<	dep	16	SENT_45	[p4l1955t1429r1993b1471],
19	3	CD	NUMBER	3	dep	18	SENT_45	[p4l2022t1414r2084b1495],
20	,	,	O	,	_	0	SENT_45	[p4l2022t1414r2084b1495],
21	>	JJR	O	>	dep	16	SENT_45	[p4l13t1548r51b1590],
22	I	PRP	O	I	npadvmod	23	SENT_45	[p4l13t1548r51b1590],
23	<	JJR	O	<	dep	21	SENT_45	[p4l13t1548r51b1590],
24	4	CD	NUMBER	4	dep	16	SENT_45	[p4l79t1533r142b1614],
25	,	,	O	,	_	0	SENT_45	[p4l79t1533r142b1614],
26	>	JJR	O	>	dobj	8	SENT_45	[p4l225t1548r264b1590],
27	I	PRP	O	I	npadvmod	28	SENT_45	[p4l225t1548r264b1590],
28	<	JJR	O	<	amod	26	SENT_45	[p4l225t1548r264b1590],
29	5	CD	NUMBER	5	amod	26	SENT_45	[p4l292t1534r340b1602],
30	and	CC	O	and	_	0	SENT_45	[p4l389t1533r529b1602],
31	>	JJR	O	>	amod	26	SENT_45	[p4l601t1548r640b1590],
32	!	.	O	!	_	0	SENT_45	[p4l601t1548r640b1590],

1	<	JJR	O	<	nsubjpass	4	SENT_46	[p4l601t1548r640b1590],
2	10	CD	NUMBER	10	dep	1	SENT_46	[p4l672t1533r766b1602],
3	were	VBD	O	be	auxpass	4	SENT_46	[p4l813t1555r1002b1603],
4	identiﬁed	VBN	O	identiﬁed	_	0	SENT_46	[p4l1051t1533r1425b1602],
5	using	VBG	O	use	xcomp	4	SENT_46	[p4l1471t1533r1683b1623],
6	the	DT	O	the	det	9	SENT_46	[p4l1732t1533r1850b1602],
7	allelespeciﬁc	JJ	O	allelespeciﬁc	amod	9	SENT_46	[p4l1900t1533r2143b1602, p4l12t1652r307b1742],
8	PCR	NN	O	pcr	nn	9	SENT_46	[p4l357t1653r542b1722],
9	analysis	NN	O	analysis	dobj	5	SENT_46	[p4l591t1652r905b1742],
10	as	IN	O	as	dep	11	SENT_46	[p4l956t1675r1031b1722],
11	described	VBN	O	describe	advcl	5	SENT_46	[p4l1082t1652r1461b1722],
12	in	IN	O	in	_	0	SENT_46	[p4l1507t1652r1583b1721],
13	our	PRP$	O	we	poss	15	SENT_46	[p4l1630t1675r1762b1722],
14	previous	JJ	O	previous	amod	15	SENT_46	[p4l1805t1652r2143b1742],
15	reports	NNS	O	report	prep_in	11	SENT_46	[p4l8t1782r279b1861],
16	(	VBP	O	(	dep	11	SENT_46	[p4l337t1771r640b1857],
17	Suzuki	NNP	PERSON	Suzuki	nsubj	19	SENT_46	[p4l337t1771r640b1857],
18	et	FW	O	et	nn	19	SENT_46	[p4l693t1782r764b1841],
19	al.	FW	O	al.	xcomp	16	SENT_46	[p4l816t1771r930b1854],
20	,	,	O	,	_	0	SENT_46	[p4l816t1771r930b1854],
21	1997	CD	DATE	1997	appos	19	SENT_46	[p4l995t1772r1206b1853],
22	;	:	O	;	_	0	SENT_46	[p4l995t1772r1206b1853],
23	Mihara	NNP	PERSON	Mihara	dep	21	SENT_46	[p4l1262t1771r1547b1841],
24	et	FW	O	et	nn	25	SENT_46	[p4l1600t1782r1670b1841],
25	al.	FW	O	al.	dep	23	SENT_46	[p4l1723t1771r1836b1853],
26	,	,	O	,	_	0	SENT_46	[p4l1723t1771r1836b1853],
27	1999	CD	DATE	1999	num	28	SENT_46	[p4l1902t1772r2141b1857],
28	)	NN	O	)	nsubj	11	SENT_46	[p4l1902t1772r2141b1857],
29	.	.	O	.	_	0	SENT_46	[p4l1902t1772r2141b1857],

1	Plasma	NN	O	plasma	nn	2	SENT_47	[p4l9t1890r294b1959],
2	concentrations	NNS	O	concentration	_	0	SENT_47	[p4l352t1890r927b1959],
3	of	IN	O	of	_	0	SENT_47	[p4l989t1890r1074b1959],
4	haloperidol	NN	O	haloperidol	prep_of	2	SENT_47	[p4l1124t1890r1576b1980],
5	and	CC	O	and	_	0	SENT_47	[p4l1636t1890r1776b1959],
6	reduced	VBD	O	reduce	conj_and	2	SENT_47	[p4l1832t1890r2147b1959],
7	haloperidol	NN	O	haloperidol	nsubj	17	SENT_47	[p4l8t2009r458b2099],
8	were	VBD	O	be	aux	9	SENT_47	[p4l518t2031r707b2078],
9	measured	VBN	O	measure	ccomp	6	SENT_47	[p4l766t2009r1146b2078],
10	in	IN	O	in	_	0	SENT_47	[p4l1203t2009r1278b2077],
11	duplicate	VB	O	duplicate	prepc_in	9	SENT_47	[p4l1336t2008r1698b2099],
12	using	VBG	O	use	xcomp	11	SENT_47	[p4l1756t2009r1967b2099],
13	the	DT	O	the	det	15	SENT_47	[p4l2027t2009r2145b2078],
14	HPLC	NN	O	hplc	nn	15	SENT_47	[p4l9t2129r257b2198],
15	method	NN	O	method	dobj	12	SENT_47	[p4l298t2128r595b2198],
16	as	IN	O	as	_	0	SENT_47	[p4l637t2150r712b2198],
17	described	VBN	O	describe	conj_as	9	SENT_47	[p4l755t2128r1133b2198],
18	by	IN	O	by	_	0	SENT_47	[p4l1171t2128r1269b2218],
19	Hikida	NNP	PERSON	Hikida	prep_by	17	SENT_47	[p4l1309t2128r1578b2198],
20	et	FW	O	et	nn	22	SENT_47	[p4l1617t2139r1687b2198],
21	al.	FW	O	al.	nn	22	SENT_47	[p4l1727t2128r1814b2198],
22	(	FW	O	(	dobj	17	SENT_47	[p4l1863t2129r2140b2214],
23	1989	CD	DATE	1989	num	24	SENT_47	[p4l1863t2129r2140b2214],
24	)	CD	NUMBER	)	dobj	9	SENT_47	[p4l1863t2129r2140b2214],
25	.	.	O	.	_	0	SENT_47	[p4l1863t2129r2140b2214],

1	The	DT	O	the	det	3	SENT_48	[p4l9t2247r160b2317],
2	lowest	JJS	O	lowest	amod	3	SENT_48	[p4l185t2247r442b2317],
3	limit	NN	O	limit	nsubj	8	SENT_48	[p4l465t2247r652b2317],
4	of	IN	O	of	_	0	SENT_48	[p4l676t2247r762b2317],
5	detection	NN	O	detection	prep_of	3	SENT_48	[p4l780t2247r1141b2317],
6	was	VBD	O	be	cop	8	SENT_48	[p4l1166t2269r1315b2317],
7	0.3	CD	NUMBER	0.3	num	8	SENT_48	[p4l1341t2247r1457b2317],
8	ng/ml	NN	O	ng/ml	_	0	SENT_48	[p4l1489t2247r1741b2337],
9	,	,	O	,	_	0	SENT_48	[p4l1489t2247r1741b2337],
10	and	CC	O	and	_	0	SENT_48	[p4l1770t2247r1910b2317],
11	interassay	JJ	O	interassay	amod	12	SENT_48	[p4l1933t2247r2142b2317, p4l11t2388r220b2456],
12	coefficient	NN	O	coefficient	nsubj	19	SENT_48	[p4l255t2365r667b2435],
13	of	IN	O	of	_	0	SENT_48	[p4l701t2366r786b2435],
14	variation	NN	O	variation	prep_of	12	SENT_48	[p4l812t2365r1165b2435],
15	was	VBD	O	be	cop	19	SENT_48	[p4l1198t2388r1346b2435],
16	less	JJR	O	less	mwe	17	SENT_48	[p4l1382t2366r1525b2435],
17	than	IN	O	than	quantmod	18	SENT_48	[p4l1561t2366r1729b2435],
18	5	CD	PERCENT	5	num	19	SENT_48	[p4l1764t2365r1887b2436],
19	%	NN	PERCENT	%	conj_and	8	SENT_48	[p4l1764t2365r1887b2436],
20	at	IN	O	at	_	0	SENT_48	[p4l1926t2376r1995b2435],
21	the	DT	O	the	det	22	SENT_48	[p4l2027t2366r2145b2435],
22	concentration	NN	O	concentration	prep_at	19	SENT_48	[p4l9t2485r549b2554],
23	of	IN	O	of	_	0	SENT_48	[p4l624t2485r709b2554],
24	2.1	CD	NUMBER	2.1	num	25	SENT_48	[p4l779t2485r889b2554],
25	ng/ml	NN	O	ng/ml	prep_of	22	SENT_48	[p4l926t2485r1155b2575],
26	for	IN	O	for	_	0	SENT_48	[p4l1230t2485r1345b2554],
27	both	DT	O	both	det	28	SENT_48	[p4l1416t2485r1592b2554],
28	compounds	NNS	O	compound	prep_for	25	SENT_48	[p4l1667t2485r2141b2575],
29	.	.	O	.	_	0	SENT_48	[p4l1667t2485r2141b2575],

1	Plasma	NN	O	plasma	nn	3	SENT_49	[p4l9t2604r294b2674],
2	prolactin	NN	O	prolactin	nn	3	SENT_49	[p4l383t2604r736b2694],
3	concentration	NN	O	concentration	nsubjpass	5	SENT_49	[p4l828t2604r1367b2674],
4	was	VBD	O	be	auxpass	5	SENT_49	[p4l1458t2627r1607b2674],
5	determined	VBN	O	determine	_	0	SENT_49	[p4l1701t2604r2146b2674],
6	using	VBG	O	use	xcomp	5	SENT_49	[p4l8t2723r220b2813],
7	enzyme	NN	O	enzyme	nn	8	SENT_49	[p4l267t2745r573b2813],
8	immunoassay	NN	O	immunoassay	dobj	6	SENT_49	[p4l618t2723r1163b2813],
9	(	CD	NUMBER	(	num	12	SENT_49	[p4l1211t2724r1431b2809],
10	IMX	NNP	O	IMX	nn	12	SENT_49	[p4l1211t2724r1431b2809],
11	Prolactin	NN	O	prolactin	nn	12	SENT_49	[p4l1476t2723r1832b2793],
12	Dainapack	NN	O	dainapack	dep	8	SENT_49	[p4l1878t2723r2142b2793, p4l8t2842r215b2932],
13	,	,	O	,	_	0	SENT_49	[p4l1878t2723r2142b2793, p4l8t2842r215b2932],
14	Dainabot	NN	O	dainabot	nn	15	SENT_49	[p4l264t2842r679b2927],
15	)	NN	O	)	appos	12	SENT_49	[p4l264t2842r679b2927],
16	.	.	O	.	_	0	SENT_49	[p4l264t2842r679b2927],

1	The	DT	O	the	det	3	SENT_50	[p4l729t2842r881b2911],
2	lowest	JJS	O	lowest	amod	3	SENT_50	[p4l927t2842r1184b2912],
3	limit	NN	O	limit	nsubj	8	SENT_50	[p4l1229t2842r1417b2911],
4	of	IN	O	of	_	0	SENT_50	[p4l1462t2842r1547b2911],
5	detection	NN	O	detection	prep_of	3	SENT_50	[p4l1587t2842r1949b2911],
6	was	VBD	O	be	cop	8	SENT_50	[p4l1995t2864r2144b2912],
7	0.6	CD	NUMBER	0.6	num	8	SENT_50	[p4l9t2960r129b3031],
8	ng/ml	NN	O	ng/ml	_	0	SENT_50	[p4l157t2961r408b3051],
9	,	,	O	,	_	0	SENT_50	[p4l157t2961r408b3051],
10	and	CC	O	and	_	0	SENT_50	[p4l477t2961r617b3030],
11	interassay	JJ	O	interassay	amod	12	SENT_50	[p4l679t2961r1073b3051],
12	coefﬁcients	NNS	O	coefﬁcients	nsubj	31	SENT_50	[p4l1138t2960r1586b3030],
13	of	IN	O	of	_	0	SENT_50	[p4l1653t2960r1738b3030],
14	variation	NN	O	variation	prep_of	12	SENT_50	[p4l1794t2961r2146b3030],
15	were	VBD	O	be	cop	31	SENT_50	[p4l9t3101r198b3148],
16	3.7	CD	NUMBER	3.7	nn	31	SENT_50	[p4l248t3080r388b3161],
17	,	,	O	,	_	0	SENT_50	[p4l248t3080r388b3161],
18	3.5	CD	NUMBER	3.5	conj_and	16	SENT_50	[p4l440t3079r555b3148],
19	and	CC	O	and	_	0	SENT_50	[p4l607t3079r747b3148],
20	3.5	CD	PERCENT	3.5	number	21	SENT_50	[p4l795t3079r992b3148],
21	%	NN	PERCENT	%	nn	31	SENT_50	[p4l795t3079r992b3148],
22	at	IN	O	at	_	0	SENT_50	[p4l1044t3089r1113b3148],
23	the	DT	O	the	det	24	SENT_50	[p4l1158t3079r1277b3148],
24	concentrations	NNS	O	concentration	prep_at	21	SENT_50	[p4l1325t3079r1899b3148],
25	of	IN	O	of	_	0	SENT_50	[p4l1950t3079r2035b3148],
26	8	CD	NUMBER	8	prep_of	24	SENT_50	[p4l2078t3080r2142b3161],
27	,	,	O	,	_	0	SENT_50	[p4l2078t3080r2142b3161],
28	20	CD	NUMBER	20	num	26	SENT_50	[p4l10t3198r104b3268],
29	and	CC	O	and	_	0	SENT_50	[p4l134t3198r273b3268],
30	40	CD	NUMBER	40	conj_and	26	SENT_50	[p4l299t3198r395b3268],
31	ng/ml	NN	O	ng/ml	conj_and	8	SENT_50	[p4l424t3198r653b3288],
32	for	IN	O	for	_	0	SENT_50	[p4l681t3198r795b3268],
33	prolactin	NN	O	prolactin	prep_for	31	SENT_50	[p4l820t3198r1194b3288],
34	,	,	O	,	_	0	SENT_50	[p4l820t3198r1194b3288],
35	respectively	RB	O	respectively	advmod	31	SENT_50	[p4l1223t3198r1722b3288],
36	.	.	O	.	_	0	SENT_50	[p4l1223t3198r1722b3288],

1	Statistical	JJ	O	statistical	amod	2	SENT_51	[p4l1758t3198r2145b3268],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_51	[p4l11t3317r340b3407],
3	were	VBD	O	be	auxpass	4	SENT_51	[p4l404t3339r593b3386],
4	performed	VBN	O	perform	_	0	SENT_51	[p4l654t3317r1068b3407],
5	using	VBG	O	use	xcomp	4	SENT_51	[p4l1128t3316r1339b3407],
6	student	NN	O	student	nn	7	SENT_51	[p4l1405t3317r1688b3386],
7	t-test	NN	O	t-test	dobj	5	SENT_51	[p4l1749t3327r1945b3386],
8	and	CC	O	and	_	0	SENT_51	[p4l2007t3317r2146b3386],
9	linear	JJ	O	linear	amod	11	SENT_51	[p4l9t3436r235b3505],
10	regression	NN	O	regression	nn	11	SENT_51	[p4l272t3436r679b3526],
11	analysis	NN	O	analysis	dobj	5	SENT_51	[p4l721t3436r1056b3526],
12	,	,	O	,	_	0	SENT_51	[p4l721t3436r1056b3526],
13	with	IN	O	with	_	0	SENT_51	[p4l1101t3436r1275b3506],
14	a	DT	O	a	det	16	SENT_51	[p4l1317t3458r1358b3505],
15	p	NN	O	p	nn	16	SENT_51	[p4l1387t3460r1442b3525],
16	value	NN	O	value	prep_with	4	SENT_51	[p4l1483t3436r1695b3506],
17	of	IN	O	of	_	0	SENT_51	[p4l1737t3436r1823b3505],
18	0.05	CD	NUMBER	0.05	prep_of	16	SENT_51	[p4l1856t3436r2022b3506],
19	or	CC	O	or	_	0	SENT_51	[p4l2068t3458r2148b3505],
20	less	JJR	O	less	prep_with	4	SENT_51	[p4l9t3555r153b3625],
21	regarded	VBN	O	regard	partmod	20	SENT_51	[p4l183t3555r530b3645],
22	as	IN	O	as	_	0	SENT_51	[p4l562t3578r637b3625],
23	statistically	RB	O	statistically	advmod	24	SENT_51	[p4l673t3555r1120b3645],
24	signiﬁcant	JJ	O	signiﬁcant	prep_as	21	SENT_51	[p4l1155t3555r1583b3645],
25	.	.	O	.	_	0	SENT_51	[p4l1155t3555r1583b3645],

1	All	DT	O	all	det	3	SENT_52	[p4l1617t3555r1741b3624],
2	statistical	JJ	O	statistical	amod	3	SENT_52	[p4l1775t3555r2145b3625],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_52	[p4l11t3674r340b3764],
4	were	VBD	O	be	auxpass	5	SENT_52	[p4l434t3696r623b3744],
5	conducted	VBN	O	conduct	_	0	SENT_52	[p4l715t3674r1122b3744],
6	using	VBG	O	use	xcomp	5	SENT_52	[p4l1211t3674r1422b3764],
7	SPSS8	NN	O	spss8	nn	9	SENT_52	[p4l1517t3675r1943b3744],
8	.01	CD	NUMBER	.01	num	9	SENT_52	[p4l1517t3675r1943b3744],
9	J	NN	O	j	dobj	6	SENT_52	[p4l1517t3675r1943b3744],
10	for	IN	O	for	prep	6	SENT_52	[p4l2033t3674r2148b3744],

1	Windows	NNP	MISC	Windows	nn	5	SENT_53	[p5l8t21r384b91],
2	(	CD	NUMBER	(	num	5	SENT_53	[p5l422t21r664b106],
3	SPSS	NNP	ORGANIZATION	SPSS	nn	5	SENT_53	[p5l422t21r664b106],
4	Japan	NNP	ORGANIZATION	Japan	nn	5	SENT_53	[p5l701t22r925b111],
5	Inc.	NNP	ORGANIZATION	Inc.	_	0	SENT_53	[p5l957t22r1127b103],
6	,	,	O	,	_	0	SENT_53	[p5l957t22r1127b103],
7	Tokyo	NNP	LOCATION	Tokyo	nn	9	SENT_53	[p5l1164t21r1442b111],
8	,	,	O	,	_	0	SENT_53	[p5l1164t21r1442b111],
9	Japan	NNP	LOCATION	Japan	appos	5	SENT_53	[p5l1477t22r1754b111],
10	)	CD	NUMBER	)	num	9	SENT_53	[p5l1477t22r1754b111],
11	.	.	O	.	_	0	SENT_53	[p5l1477t22r1754b111],

1	The	DT	O	the	det	7	SENT_54	[p5l108t140r258b209],
2	mean	JJ	O	mean	amod	7	SENT_54	[p5l290t162r501b209],
3	(	NN	O	(	nn	7	SENT_54	[p5l534t140r797b225],
4	iSD	NN	O	isd	nn	7	SENT_54	[p5l534t140r797b225],
5	)	CD	NUMBER	)	num	7	SENT_54	[p5l534t140r797b225],
6	prolactin	NN	O	prolactin	nn	7	SENT_54	[p5l830t140r1176b230],
7	concentration	NN	O	concentration	nsubj	12	SENT_54	[p5l1207t140r1736b209],
8	in	IN	O	in	_	0	SENT_54	[p5l1766t140r1841b208],
9	plasma	NN	O	plasma	prep_in	7	SENT_54	[p5l1871t140r2148b230],
10	was	VBD	O	be	cop	12	SENT_54	[p5l9t281r156b329],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_54	[p5l222t259r697b349],
12	higher	JJR	O	higher	_	0	SENT_54	[p5l756t259r1006b349],
13	in	IN	O	in	_	0	SENT_54	[p5l1064t259r1139b328],
14	females	NNS	O	female	prep_in	12	SENT_54	[p5l1198t259r1498b329],
15	than	IN	O	than	mark	18	SENT_54	[p5l1560t259r1727b329],
16	in	IN	O	in	_	0	SENT_54	[p5l1786t259r1861b328],
17	males	NNS	O	male	prep_in	18	SENT_54	[p5l1920t259r2145b329],
18	(	VBP	O	(	ccomp	12	SENT_54	[p5l12t379r199b464],
19	71.1	CD	NUMBER	71.1	dobj	18	SENT_54	[p5l12t379r199b464],
20	i	FW	O	i	dep	19	SENT_54	[p5l242t384r302b443],
21	48.0	CD	NUMBER	48.0	dep	43	SENT_54	[p5l335t378r504b448],
22	versus	CC	O	versus	prep	21	SENT_54	[p5l593t400r837b448],
23	27.7	CD	NUMBER	27.7	dep	22	SENT_54	[p5l929t378r1093b448],
24	i	FW	O	i	dep	23	SENT_54	[p5l1129t384r1189b443],
25	14.5	CD	NUMBER	14.5	num	26	SENT_54	[p5l1231t378r1387b448],
26	ng/ml	NN	O	ng/ml	dep	23	SENT_54	[p5l1417t378r1664b468],
27	,	,	O	,	_	0	SENT_54	[p5l1417t378r1664b468],
28	p	NN	O	p	appos	23	SENT_54	[p5l1747t402r1801b467],
29	<	JJR	O	<	amod	28	SENT_54	[p5l1840t385r1906b443],
30	0.01	CD	NUMBER	0.01	num	31	SENT_54	[p5l1944t378r2144b463],
31	)	NN	O	)	advmod	28	SENT_54	[p5l1944t378r2144b463],
32	despite	IN	O	despite	_	0	SENT_54	[p5l10t496r282b587],
33	no	DT	O	no	det	34	SENT_54	[p5l312t519r408b566],
34	difference	NN	O	difference	prep_despite	31	SENT_54	[p5l439t496r825b566],
35	in	IN	O	in	_	0	SENT_54	[p5l856t497r931b565],
36	plasma	NN	O	plasma	nn	38	SENT_54	[p5l959t497r1237b587],
37	haloperidol	NN	O	haloperidol	nn	38	SENT_54	[p5l1265t497r1707b587],
38	concentration	NN	O	concentration	prep_in	34	SENT_54	[p5l1738t508r2144b566, p5l8t616r159b685],
39	(	CD	NUMBER	(	num	40	SENT_54	[p5l216t616r490b701],
40	males	NNS	O	male	dep	28	SENT_54	[p5l216t616r490b701],
41	:	:	O	:	_	0	SENT_54	[p5l216t616r490b701],
42	9.4	CD	NUMBER	9.4	dep	43	SENT_54	[p5l553t616r671b686],
43	i	FW	O	i	dep	52	SENT_54	[p5l705t621r765b681],
44	4.3	CD	NUMBER	4.3	num	45	SENT_54	[p5l798t616r913b686],
45	ng/ml	NN	O	ng/ml	dep	43	SENT_54	[p5l944t616r1191b706],
46	,	,	O	,	_	0	SENT_54	[p5l944t616r1191b706],
47	females	NNS	O	female	appos	45	SENT_54	[p5l1248t616r1571b685],
48	:	:	O	:	_	0	SENT_54	[p5l1248t616r1571b685],
49	9.9	CD	NUMBER	9.9	dep	45	SENT_54	[p5l1632t616r1748b686],
50	i	FW	O	i	dep	49	SENT_54	[p5l1784t621r1844b681],
51	3.8	CD	NUMBER	3.8	num	52	SENT_54	[p5l1881t616r1993b686],
52	ng	NN	O	ng	dep	55	SENT_54	[p5l2024t616r2148b706],
53	/	:	O	/	punct	55	SENT_54	[p5l2024t616r2148b706],
54	ml	NN	O	ml	nn	55	SENT_54	[p5l9t735r162b821],
55	)	NN	O	)	dep	18	SENT_54	[p5l9t735r162b821],
56	.	.	O	.	_	0	SENT_54	[p5l9t735r162b821],

1	Accordingly	RB	O	accordingly	advmod	8	SENT_55	[p5l201t735r707b825],
2	,	,	O	,	_	0	SENT_55	[p5l201t735r707b825],
3	plasma	NN	O	plasma	nn	5	SENT_55	[p5l743t735r1022b825],
4	prolactin	NN	O	prolactin	nn	5	SENT_55	[p5l1054t735r1399b825],
5	concentration	NN	O	concentration	nsubjpass	8	SENT_55	[p5l1434t735r1962b805],
6	was	VBD	O	be	auxpass	8	SENT_55	[p5l1998t758r2145b805],
7	independently	RB	O	independently	advmod	8	SENT_55	[p5l9t854r559b944],
8	analyzed	VBN	O	analyze	_	0	SENT_55	[p5l603t854r948b944],
9	in	IN	O	in	_	0	SENT_55	[p5l988t854r1063b923],
10	males	NNS	O	male	prep_in	8	SENT_55	[p5l1104t854r1328b924],
11	and	CC	O	and	_	0	SENT_55	[p5l1374t854r1511b924],
12	females	NNS	O	female	prep_in	8	SENT_55	[p5l1553t854r1874b924],
13	.	.	O	.	_	0	SENT_55	[p5l1553t854r1874b924],

1	There	EX	O	there	expl	2	SENT_56	[p5l1920t854r2145b924],
2	were	VBD	O	be	_	0	SENT_56	[p5l9t995r196b1043],
3	no	DT	O	no	det	10	SENT_56	[p5l233t995r328b1042],
4	differences	NNS	O	difference	nn	10	SENT_56	[p5l366t973r788b1042],
5	in	IN	O	in	_	0	SENT_56	[p5l826t973r901b1041],
6	clinical	JJ	O	clinical	amod	7	SENT_56	[p5l937t973r1221b1042],
7	proﬁles	NNS	O	proﬁles	prep_in	4	SENT_56	[p5l1256t973r1567b1063],
8	,	,	O	,	_	0	SENT_56	[p5l1256t973r1567b1063],
9	i.e.	FW	O	i.e.	dep	4	SENT_56	[p5l1606t973r1718b1042],
10	age	NN	O	age	nsubj	2	SENT_56	[p5l1761t995r1914b1063],
11	,	,	O	,	_	0	SENT_56	[p5l1761t995r1914b1063],
12	body	NN	O	body	nn	13	SENT_56	[p5l1952t973r2146b1063],
13	weight	NN	O	weight	appos	10	SENT_56	[p5l9t1092r293b1182],
14	,	,	O	,	_	0	SENT_56	[p5l9t1092r293b1182],
15	habitual	JJ	O	habitual	amod	17	SENT_56	[p5l321t1092r634b1161],
16	smoking	NN	O	smoking	nn	17	SENT_56	[p5l663t1091r993b1182],
17	status	NN	O	status	appos	10	SENT_56	[p5l1024t1102r1259b1174],
18	,	,	O	,	_	0	SENT_56	[p5l1024t1102r1259b1174],
19	coadministered	VBN	O	coadminister	partmod	10	SENT_56	[p5l1290t1092r1884b1161],
20	drugs	NNS	O	drug	dobj	19	SENT_56	[p5l1910t1092r2143b1182],
21	,	,	O	,	_	0	SENT_56	[p5l1910t1092r2143b1182],
22	between	IN	O	between	_	0	SENT_56	[p5l7t1211r332b1281],
23	both	DT	O	both	det	24	SENT_56	[p5l378t1211r551b1281],
24	genders	NNS	O	gender	prep_between	19	SENT_56	[p5l598t1211r895b1301],
25	or	CC	O	or	_	0	SENT_56	[p5l946t1233r1026b1281],
26	between	IN	O	between	_	0	SENT_56	[p5l1069t1211r1394b1281],
27	patients	NNS	O	patient	prep_between	19	SENT_56	[p5l1440t1211r1739b1301],
28	with	IN	O	with	prep	27	SENT_56	[p5l1789t1211r1961b1281],
29	and	CC	O	and	_	0	SENT_56	[p5l2009t1211r2147b1281],
30	without	IN	O	without	prep	27	SENT_56	[p5l9t1329r305b1398],
31	mutated	VBN	O	mutate	amod	32	SENT_56	[p5l350t1329r664b1398],
32	alleles	NNS	O	allele	pobj	30	SENT_56	[p5l711t1329r954b1398],
33	for	IN	O	for	_	0	SENT_56	[p5l1001t1329r1114b1398],
34	CYPZD6	NN	O	cypzd6	prep_for	32	SENT_56	[p5l1163t1329r1522b1398],
35	.	.	O	.	_	0	SENT_56	[p5l1163t1329r1522b1398],

1	The	DT	O	the	det	2	SENT_57	[p5l1573t1329r1722b1398],
2	eﬁects	NNS	O	eﬁects	nsubj	13	SENT_57	[p5l1770t1329r2019b1398],
3	of	IN	O	of	_	0	SENT_57	[p5l2068t1329r2153b1398],
4	the	DT	O	the	det	6	SENT_57	[p5l9t1448r126b1517],
5	CYPZD6	NN	O	cypzd6	nn	6	SENT_57	[p5l182t1447r526b1518],
6	genotype	NN	O	genotype	prep_of	2	SENT_57	[p5l574t1458r928b1538],
7	on	IN	O	on	_	0	SENT_57	[p5l980t1470r1075b1517],
8	plasma	NN	O	plasma	nn	9	SENT_57	[p5l1124t1448r1402b1538],
9	concentrations	NNS	O	concentration	prep_on	13	SENT_57	[p5l1451t1448r2015b1517],
10	of	IN	O	of	_	0	SENT_57	[p5l2068t1447r2153b1517],
11	haloperidol	NN	O	haloperidol	prep_of	9	SENT_57	[p5l8t1567r470b1657],
12	,	,	O	,	_	0	SENT_57	[p5l8t1567r470b1657],
13	reduced	VBD	O	reduce	_	0	SENT_57	[p5l538t1567r847b1636],
14	haloperidol	NN	O	haloperidol	dobj	13	SENT_57	[p5l909t1567r1350b1657],
15	and	CC	O	and	_	0	SENT_57	[p5l1418t1567r1556b1636],
16	prolactin	NN	O	prolactin	conj_and	14	SENT_57	[p5l1618t1567r1964b1657],
17	are	VBP	O	be	auxpass	18	SENT_57	[p5l2031t1589r2145b1636],
18	summarized	VBN	O	summarize	rcmod	14	SENT_57	[p5l12t1686r486b1756],
19	in	IN	O	in	_	0	SENT_57	[p5l516t1686r591b1755],
20	Table	NNP	O	Table	nn	24	SENT_57	[p5l623t1686r844b1756],
21	l.	NNP	O	l.	nn	24	SENT_57	[p5l885t1687r943b1756],
22	The	NNP	O	The	nn	24	SENT_57	[p5l979t1686r1129b1756],
23	plasma	NN	O	plasma	nn	24	SENT_57	[p5l1161t1686r1438b1776],
24	concentrations	NNS	O	concentration	prep_in	18	SENT_57	[p5l1470t1686r2033b1756],
25	of	IN	O	of	_	0	SENT_57	[p5l2068t1686r2153b1756],
26	haloperidol	NN	O	haloperidol	prep_of	24	SENT_57	[p5l8t1805r451b1895],
27	and	CC	O	and	_	0	SENT_57	[p5l470t1805r607b1875],
28	reduced	VBD	O	reduce	conj_and	13	SENT_57	[p5l624t1805r932b1875],
29	haloperidol	NN	O	haloperidol	nsubj	42	SENT_57	[p5l949t1805r1390b1895],
30	in	IN	O	in	_	0	SENT_57	[p5l1408t1805r1484b1874],
31	patients	NNS	O	patient	prep_in	29	SENT_57	[p5l1499t1805r1798b1895],
32	with	IN	O	with	_	0	SENT_57	[p5l1819t1805r1990b1875],
33	one	CD	NUMBER	one	prep_with	31	SENT_57	[p5l2008t1827r2146b1875],
34	or	CC	O	or	_	0	SENT_57	[p5l8t1946r89b1994],
35	two	CD	NUMBER	two	conj_or	33	SENT_57	[p5l119t1935r263b1994],
36	mutated	VBN	O	mutate	partmod	29	SENT_57	[p5l298t1924r613b1994],
37	alleles	NNS	O	allele	dobj	36	SENT_57	[p5l647t1924r889b1994],
38	for	IN	O	for	_	0	SENT_57	[p5l925t1924r1038b1994],
39	CYPZD6	NN	O	cypzd6	prep_for	37	SENT_57	[p5l1075t1924r1420b1995],
40	were	VBD	O	be	cop	42	SENT_57	[p5l1449t1946r1636b1994],
41	signiﬁcantly	RB	O	signiﬁcantly	advmod	42	SENT_57	[p5l1674t1924r2150b2014],
42	higher	JJR	O	higher	ccomp	28	SENT_57	[p5l6t2043r257b2133],
43	than	IN	O	than	_	0	SENT_57	[p5l277t2043r444b2112],
44	those	DT	O	those	prep_than	42	SENT_57	[p5l466t2043r669b2112],
45	in	IN	O	in	_	0	SENT_57	[p5l693t2043r768b2112],
46	patients	NNS	O	patient	prep_in	44	SENT_57	[p5l788t2043r1089b2133],
47	without	IN	O	without	_	0	SENT_57	[p5l1114t2043r1411b2113],
48	mutated	VBN	O	mutate	amod	49	SENT_57	[p5l1432t2043r1747b2112],
49	alleles	NNS	O	allele	prep_without	42	SENT_57	[p5l1771t2043r2014b2112],
50	for	IN	O	for	_	0	SENT_57	[p5l2039t2043r2152b2112],
51	C	NN	O	c	nn	52	SENT_57	[p5l12t2163r74b2232],
52	YPZD6	NN	O	ypzd6	prep_for	49	SENT_57	[p5l79t2161r358b2231],
53	in	IN	O	in	prep	49	SENT_57	[p5l410t2162r484b2230],
54	both	CC	O	both	dep	53	SENT_57	[p5l539t2162r712b2231],
55	genders	NNS	O	gender	conj	53	SENT_57	[p5l770t2162r1090b2252],
56	.	.	O	.	_	0	SENT_57	[p5l770t2162r1090b2252],

1	Males	NNS	O	male	nsubj	11	SENT_58	[p5l1151t2162r1386b2231],
2	with	IN	O	with	_	0	SENT_58	[p5l1446t2161r1617b2231],
3	one	CD	NUMBER	one	prep_with	1	SENT_58	[p5l1675t2184r1812b2231],
4	or	CC	O	or	_	0	SENT_58	[p5l1871t2184r1952b2231],
5	two	CD	NUMBER	two	conj_or	3	SENT_58	[p5l2006t2172r2149b2232],
6	mutated	VBN	O	mutate	partmod	1	SENT_58	[p5l7t2281r322b2350],
7	alleles	NNS	O	allele	dobj	6	SENT_58	[p5l362t2281r606b2350],
8	for	IN	O	for	_	0	SENT_58	[p5l647t2281r760b2350],
9	C	NN	O	c	nn	10	SENT_58	[p5l803t2282r865b2351],
10	YPZD6	NN	O	ypzd6	prep_for	7	SENT_58	[p5l869t2281r1147b2350],
11	showed	VBD	O	show	_	0	SENT_58	[p5l1186t2281r1481b2351],
12	higher	JJR	O	higher	amod	14	SENT_58	[p5l1518t2281r1768b2371],
13	prolactin	NN	O	prolactin	nn	14	SENT_58	[p5l1804t2281r2151b2371],
14	concentration	NN	O	concentration	dobj	11	SENT_58	[p5l8t2400r537b2470],
15	than	IN	O	than	_	0	SENT_58	[p5l609t2400r777b2470],
16	those	DT	O	those	prep_than	11	SENT_58	[p5l848t2400r1052b2470],
17	without	IN	O	without	_	0	SENT_58	[p5l1125t2400r1422b2470],
18	mutated	VBN	O	mutate	amod	19	SENT_58	[p5l1493t2400r1807b2470],
19	alleles	NNS	O	allele	prep_without	11	SENT_58	[p5l1881t2400r2147b2483],
20	,	,	O	,	_	0	SENT_58	[p5l1881t2400r2147b2483],
21	whereas	IN	O	whereas	mark	23	SENT_58	[p5l7t2519r323b2589],
22	there	EX	O	there	expl	23	SENT_58	[p5l368t2519r560b2589],
23	was	VBD	O	be	dep	19	SENT_58	[p5l605t2541r753b2589],
24	no	DT	O	no	det	25	SENT_58	[p5l798t2541r893b2589],
25	diﬁerence	NN	O	diﬁerence	nn	36	SENT_58	[p5l939t2519r1325b2589],
26	in	IN	O	in	_	0	SENT_58	[p5l1369t2519r1443b2588],
27	plasma	NN	O	plasma	nn	29	SENT_58	[p5l1485t2519r1764b2609],
28	prolactin	NN	O	prolactin	nn	29	SENT_58	[p5l1804t2519r2151b2609],
29	concentration	NN	O	concentration	prep_in	25	SENT_58	[p5l8t2638r537b2707],
30	between	IN	O	between	_	0	SENT_58	[p5l600t2638r927b2708],
31	the	DT	O	the	det	35	SENT_58	[p5l991t2638r1107b2707],
32	two	CD	NUMBER	two	num	35	SENT_58	[p5l1173t2648r1317b2707],
33	C	NN	O	c	nn	35	SENT_58	[p5l1388t2639r1451b2708],
34	YPZD6	NN	O	ypzd6	nn	35	SENT_58	[p5l1455t2637r1733b2707],
35	genotype	NN	O	genotype	prep_between	29	SENT_58	[p5l1795t2649r2151b2728],
36	groups	NNS	O	group	nsubj	23	SENT_58	[p5l8t2779r268b2847],
37	in	IN	O	in	_	0	SENT_58	[p5l332t2757r408b2825],
38	females	NNS	O	female	prep_in	23	SENT_58	[p5l470t2757r791b2826],
39	.	.	O	.	_	0	SENT_58	[p5l470t2757r791b2826],

1	Signiﬁcant	NN	O	signiﬁcant	nn	2	SENT_59	[p5l862t2756r1281b2847],
2	correlation	NN	O	correlation	nsubjpass	11	SENT_59	[p5l1343t2757r1763b2826],
3	between	IN	O	between	_	0	SENT_59	[p5l1825t2757r2151b2826],
4	plasma	NN	O	plasma	nn	5	SENT_59	[p5l6t2876r284b2966],
5	concentrations	NNS	O	concentration	prep_between	2	SENT_59	[p5l342t2876r906b2946],
6	of	IN	O	of	_	0	SENT_59	[p5l969t2876r1054b2946],
7	haloperidol	NN	O	haloperidol	prep_of	5	SENT_59	[p5l1104t2876r1547b2966],
8	and	CC	O	and	_	0	SENT_59	[p5l1609t2876r1747b2946],
9	prolactin	NN	O	prolactin	prep_of	5	SENT_59	[p5l1804t2876r2151b2966],
10	was	VBD	O	be	auxpass	11	SENT_59	[p5l7t3017r155b3065],
11	observed	VBN	O	observe	_	0	SENT_59	[p5l190t2995r541b3065],
12	in	IN	O	in	_	0	SENT_59	[p5l572t2995r647b3064],
13	males	NNS	O	male	prep_in	11	SENT_59	[p5l678t2995r903b3064],
14	(	VBP	O	(	rcmod	13	SENT_59	[p5l941t2996r1010b3081],
15	r	NN	O	r	dobj	14	SENT_59	[p5l941t2996r1010b3081],
16	=	JJ	O	=	amod	17	SENT_59	[p5l1042t3022r1110b3047],
17	0.479	CD	NUMBER	0.479	nsubj	44	SENT_59	[p5l1146t2995r1385b3077],
18	,	,	O	,	_	0	SENT_59	[p5l1146t2995r1385b3077],
19	p	NN	O	p	appos	17	SENT_59	[p5l1413t3019r1468b3084],
20	<	JJR	O	<	amod	19	SENT_59	[p5l1506t3002r1573b3059],
21	0.01	CD	NUMBER	0.01	num	22	SENT_59	[p5l1611t2995r1835b3081],
22	)	NN	O	)	nsubj	34	SENT_59	[p5l1611t2995r1835b3081],
23	,	,	O	,	_	0	SENT_59	[p5l1611t2995r1835b3081],
24	but	CC	O	but	_	0	SENT_59	[p5l1871t2995r1996b3064],
25	not	RB	O	not	advmod	29	SENT_59	[p5l2027t3005r2151b3064],
26	in	IN	O	in	_	0	SENT_59	[p5l7t3114r82b3182],
27	females	NNS	O	female	prep_in	25	SENT_59	[p5l109t3114r409b3183],
28	(	CD	NUMBER	(	num	29	SENT_59	[p5l442t3115r512b3199],
29	r	NN	O	r	conj_but	22	SENT_59	[p5l442t3115r512b3199],
30	=	JJ	O	=	amod	29	SENT_59	[p5l544t3141r612b3166],
31	0.1	CD	NUMBER	0.1	number	32	SENT_59	[p5l647t3114r759b3184],
32	14	CD	NUMBER	14	dep	30	SENT_59	[p5l780t3114r887b3196],
33	,	,	O	,	_	0	SENT_59	[p5l780t3114r887b3196],
34	ns	VBZ	O	n	ccomp	20	SENT_59	[p5l919t3114r1033b3199],
35	)	CD	NUMBER	)	dobj	34	SENT_59	[p5l919t3114r1033b3199],
36	or	CC	O	or	_	0	SENT_59	[p5l1065t3136r1146b3183],
37	total	JJ	O	total	amod	38	SENT_59	[p5l1170t3114r1343b3183],
38	patients	NNS	O	patient	dobj	34	SENT_59	[p5l1368t3114r1669b3204],
39	(	IN	O	(	_	0	SENT_59	[p5l1702t3114r1772b3199],
40	r	NN	O	r	prep_(	20	SENT_59	[p5l1702t3114r1772b3199],
41	=	JJ	O	=	amod	40	SENT_59	[p5l1804t3141r1872b3166],
42	0.167	CD	NUMBER	0.167	tmod	41	SENT_59	[p5l1907t3113r2147b3196],
43	,	,	O	,	_	0	SENT_59	[p5l1907t3113r2147b3196],
44	ns	VBZ	O	n	rcmod	15	SENT_59	[p5l7t3233r144b3318],
45	)	NN	O	)	dobj	44	SENT_59	[p5l7t3233r144b3318],
46	.	.	O	.	_	0	SENT_59	[p5l7t3233r144b3318],

1	A	DT	O	a	det	3	SENT_60	[p5l190t3233r260b3301],
2	similar	JJ	O	similar	amod	3	SENT_60	[p5l306t3233r574b3302],
3	tendency	NN	O	tendency	nsubjpass	8	SENT_60	[p5l615t3233r966b3323],
4	for	IN	O	for	_	0	SENT_60	[p5l1010t3233r1123b3302],
5	reduced	VBN	O	reduce	amod	6	SENT_60	[p5l1163t3233r1472b3302],
6	haloperidol	NN	O	haloperidol	prep_for	3	SENT_60	[p5l1514t3233r1957b3323],
7	was	VBD	O	be	auxpass	8	SENT_60	[p5l2001t3255r2148b3303],
8	found	VBN	O	find	dep	11	SENT_60	[p5l7t3352r234b3422],
9	between	IN	O	between	_	0	SENT_60	[p5l307t3352r633b3422],
10	males	NNS	O	male	prep_between	8	SENT_60	[p5l710t3352r935b3422],
11	(	VBP	O	(	_	0	SENT_60	[p5l1016t3353r1086b3439],
12	r	NN	O	r	dobj	11	SENT_60	[p5l1016t3353r1086b3439],
13	=	JJ	O	=	amod	12	SENT_60	[p5l1118t3380r1185b3404],
14	0.443	CD	NUMBER	0.443	tmod	13	SENT_60	[p5l1221t3353r1461b3435],
15	,	,	O	,	_	0	SENT_60	[p5l1221t3353r1461b3435],
16	p	NN	O	p	dep	17	SENT_60	[p5l1533t3376r1587b3441],
17	<	JJR	O	<	conj_and	12	SENT_60	[p5l1626t3360r1693b3417],
18	0.05	CD	NUMBER	0.05	num	19	SENT_60	[p5l1730t3352r1931b3439],
19	)	NN	O	)	dep	17	SENT_60	[p5l1730t3352r1931b3439],
20	and	CC	O	and	_	0	SENT_60	[p5l2013t3352r2151b3422],
21	females	NNS	O	female	conj_and	12	SENT_60	[p5l7t3470r307b3539],
22	(	CD	NUMBER	(	num	23	SENT_60	[p5l339t3471r409b3556],
23	r	NN	O	r	nsubj	11	SENT_60	[p5l339t3471r409b3556],
24	=	JJ	O	=	amod	23	SENT_60	[p5l441t3497r509b3522],
25	0.006	CD	NUMBER	0.006	tmod	24	SENT_60	[p5l544t3470r784b3552],
26	,	,	O	,	_	0	SENT_60	[p5l544t3470r784b3552],
27	ns	VBZ	O	n	ccomp	11	SENT_60	[p5l815t3471r952b3556],
28	)	NN	O	)	dobj	27	SENT_60	[p5l815t3471r952b3556],
29	.	.	O	.	_	0	SENT_60	[p5l815t3471r952b3556],

1	The	DT	O	the	det	3	SENT_61	[p5l106t3589r259b3658],
2	CYPZD6	NN	O	cypzd6	nn	3	SENT_61	[p5l319t3589r678b3659],
3	enzyme	NN	O	enzyme	nsubjpass	6	SENT_61	[p5l738t3611r1044b3679],
4	has	VBZ	O	have	aux	6	SENT_61	[p5l1103t3589r1232b3658],
5	been	VBN	O	be	auxpass	6	SENT_61	[p5l1291t3589r1478b3658],
6	reported	VBN	O	report	_	0	SENT_61	[p5l1535t3589r1868b3679],
7	to	TO	O	to	aux	9	SENT_61	[p5l1925t3599r1999b3658],
8	be	VB	O	be	auxpass	9	SENT_61	[p5l2057t3589r2149b3658],
9	involved	VBN	O	involve	xcomp	6	SENT_61	[p5l7t3708r353b3777],
10	in	IN	O	in	_	0	SENT_61	[p5l395t3708r470b3776],
11	the	DT	O	the	det	12	SENT_61	[p5l511t3708r630b3777],
12	metabolism	NN	O	metabolism	prep_in	9	SENT_61	[p5l671t3708r1137b3777],
13	of	IN	O	of	_	0	SENT_61	[p5l1179t3707r1264b3777],
14	several	JJ	O	several	amod	16	SENT_61	[p5l1302t3708r1578b3778],
15	antipsychotic	JJ	O	antipsychotic	amod	16	SENT_61	[p5l1622t3708r2148b3798],
16	agents	NNS	O	agent	prep_of	12	SENT_61	[p6l9t32r257b111],
17	such	JJ	O	such	_	0	SENT_61	[p6l287t21r464b91],
18	as	IN	O	as	_	0	SENT_61	[p6l491t43r566b91],
19	haloperidol	NN	O	haloperidol	prep_such_as	16	SENT_61	[p6l592t21r1066b111],
20	,	,	O	,	_	0	SENT_61	[p6l592t21r1066b111],
21	perphenazine	NN	O	perphenazine	conj_and	19	SENT_61	[p6l1094t21r1646b111],
22	,	,	O	,	_	0	SENT_61	[p6l1094t21r1646b111],
23	thioridazine	NN	O	thioridazine	conj_and	19	SENT_61	[p6l1675t21r2150b91],
24	and	CC	O	and	_	0	SENT_61	[p6l9t140r149b209],
25	risperidone	NN	O	risperidone	prep_such_as	16	SENT_61	[p6l183t140r651b230],
26	,	,	O	,	_	0	SENT_61	[p6l183t140r651b230],
27	suggesting	VBG	O	suggest	xcomp	6	SENT_61	[p6l694t140r1112b230],
28	that	IN	O	that	complm	35	SENT_61	[p6l1149t140r1297b209],
29	this	DT	O	this	det	31	SENT_61	[p6l1332t140r1471b209],
30	enzyme	NN	O	enzyme	nn	31	SENT_61	[p6l1509t162r1816b230],
31	activity	NN	O	activity	nsubj	35	SENT_61	[p6l1855t140r2150b230],
32	could	MD	O	could	aux	35	SENT_61	[p6l8t259r227b328],
33	be	VB	O	be	cop	35	SENT_61	[p6l261t259r353b328],
34	a	DT	O	a	det	35	SENT_61	[p6l393t281r433b328],
35	determinant	NN	O	determinant	ccomp	27	SENT_61	[p6l470t259r945b328],
36	of	IN	O	of	_	0	SENT_61	[p6l982t258r1068b328],
37	the	DT	O	the	det	38	SENT_61	[p6l1097t259r1216b328],
38	plasma	NN	O	plasma	prep_of	35	SENT_61	[p6l1253t259r1534b349],
39	concentrations	NNS	O	concentration	nsubj	43	SENT_61	[p6l1571t259r2147b328],
40	of	IN	O	of	_	0	SENT_61	[p6l8t378r94b447],
41	these	DT	O	these	det	42	SENT_61	[p6l126t378r327b447],
42	drugs	NNS	O	drug	prep_of	39	SENT_61	[p6l369t378r583b468],
43	(	VBP	O	(	rcmod	38	SENT_61	[p6l627t378r1059b463],
44	Bertilsson	NN	PERSON	bertilsson	dobj	43	SENT_61	[p6l627t378r1059b463],
45	and	CC	O	and	_	0	SENT_61	[p6l1100t378r1240b447],
46	Dahl	NNP	PERSON	Dahl	conj_and	44	SENT_61	[p6l1278t378r1490b460],
47	,	,	O	,	_	0	SENT_61	[p6l1278t378r1490b460],
48	1996	CD	DATE	1996	num	49	SENT_61	[p6l1543t378r1782b463],
49	)	NN	O	)	appos	46	SENT_61	[p6l1543t378r1782b463],
50	.	.	O	.	_	0	SENT_61	[p6l1543t378r1782b463],

1	Furthermore	RB	O	furthermore	advmod	18	SENT_62	[p6l1826t378r2147b447, p6l7t520r231b580],
2	,	,	O	,	_	0	SENT_62	[p6l1826t378r2147b447, p6l7t520r231b580],
3	a	DT	O	a	det	5	SENT_62	[p6l298t520r340b567],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_62	[p6l403t497r814b587],
5	relationship	NN	O	relationship	nsubjpass	18	SENT_62	[p6l873t497r1343b587],
6	between	IN	O	between	_	0	SENT_62	[p6l1404t497r1735b567],
7	prolactin	NN	O	prolactin	nn	8	SENT_62	[p6l1796t497r2150b587],
8	response	NN	O	response	prep_between	5	SENT_62	[p6l6t638r352b706],
9	to	TO	O	to	_	0	SENT_62	[p6l398t627r472b686],
10	several	JJ	O	several	amod	11	SENT_62	[p6l522t616r797b686],
11	antipsychotics	NNS	O	antipsychotic	prep_to	8	SENT_62	[p6l846t616r1410b706],
12	and	CC	O	and	_	0	SENT_62	[p6l1460t616r1600b686],
13	plasma	NN	O	plasma	nn	15	SENT_62	[p6l1644t616r1926b706],
14	drug	NN	O	drug	nn	15	SENT_62	[p6l1971t616r2148b706],
15	concentrations	NNS	O	concentration	prep_to	8	SENT_62	[p6l8t735r584b804],
16	has	VBZ	O	have	aux	18	SENT_62	[p6l627t735r756b804],
17	been	VBN	O	be	auxpass	18	SENT_62	[p6l798t735r985b804],
18	demonstrated	VBN	O	demonstrate	_	0	SENT_62	[p6l1028t735r1563b804],
19	(	IN	O	(	_	0	SENT_62	[p6l1607t735r1878b820],
20	Rubin	NNP	PERSON	Rubin	prep_(	18	SENT_62	[p6l1607t735r1878b820],
21	et	FW	O	et	nn	22	SENT_62	[p6l1921t745r1990b804],
22	al.	FW	O	al.	dep	20	SENT_62	[p6l2033t735r2147b817],
23	,	,	O	,	_	0	SENT_62	[p6l2033t735r2147b817],
24	1980	CD	DATE	1980	appos	22	SENT_62	[p6l16t853r226b935],
25	;	:	O	;	_	0	SENT_62	[p6l16t853r226b935],
26	van	NN	PERSON	van	nn	27	SENT_62	[p6l256t875r397b923],
27	Putten	NNP	PERSON	Putten	dep	22	SENT_62	[p6l422t854r674b922],
28	et	FW	O	et	nn	29	SENT_62	[p6l701t863r771b922],
29	al.	FW	O	al.	dep	27	SENT_62	[p6l797t853r910b935],
30	,	,	O	,	_	0	SENT_62	[p6l797t853r910b935],
31	1991	CD	DATE	1991	appos	29	SENT_62	[p6l949t853r1159b935],
32	;	:	O	;	_	0	SENT_62	[p6l949t853r1159b935],
33	Otani	NNP	ORGANIZATION	Otani	dep	22	SENT_62	[p6l1190t853r1406b923],
34	et	FW	O	et	nn	35	SENT_62	[p6l1433t863r1503b922],
35	al.	FW	O	al.	dep	33	SENT_62	[p6l1529t853r1643b935],
36	,	,	O	,	_	0	SENT_62	[p6l1529t853r1643b935],
37	1993	CD	DATE	1993	appos	35	SENT_62	[p6l1681t853r1891b935],
38	;	:	O	;	_	0	SENT_62	[p6l1681t853r1891b935],
39	Yasui	NNP	PERSON	Yasui	dep	22	SENT_62	[p6l1921t852r2148b922],
40	et	FW	O	et	nn	41	SENT_62	[p6l8t983r78b1041],
41	al.	FW	O	al.	dep	39	SENT_62	[p6l111t972r224b1054],
42	,	,	O	,	_	0	SENT_62	[p6l111t972r224b1054],
43	1998	CD	DATE	1998	num	44	SENT_62	[p6l270t973r509b1058],
44	)	NN	O	)	appos	20	SENT_62	[p6l270t973r509b1058],
45	.	.	O	.	_	0	SENT_62	[p6l270t973r509b1058],

1	However	RB	O	however	advmod	5	SENT_63	[p6l547t974r930b1054],
2	,	,	O	,	_	0	SENT_63	[p6l547t974r930b1054],
3	no	DT	O	no	det	4	SENT_63	[p6l965t994r1061b1041],
4	studies	NNS	O	study	nsubj	5	SENT_63	[p6l1097t972r1365b1041],
5	referred	VBD	O	refer	_	0	SENT_63	[p6l1398t972r1713b1041],
6	to	TO	O	to	_	0	SENT_63	[p6l1745t983r1818b1041],
7	a	DT	O	a	det	9	SENT_63	[p6l1854t994r1894b1041],
8	direct	JJ	O	direct	amod	9	SENT_63	[p6l1926t972r2152b1041],
9	association	NN	O	association	prep_to	5	SENT_63	[p6l9t1091r448b1160],
10	between	IN	O	between	_	0	SENT_63	[p6l526t1091r857b1160],
11	the	DT	O	the	det	13	SENT_63	[p6l937t1091r1055b1160],
12	CYPZD6	NN	O	cypzd6	nn	13	SENT_63	[p6l1141t1091r1490b1161],
13	genotype	NN	O	genotype	prep_between	9	SENT_63	[p6l1568t1101r1929b1181],
14	and	CC	O	and	_	0	SENT_63	[p6l2011t1091r2151b1160],
15	prolactin	NN	O	prolactin	nn	16	SENT_63	[p6l6t1210r360b1300],
16	response	NN	O	response	prep_between	9	SENT_63	[p6l425t1232r771b1300],
17	to	TO	O	to	_	0	SENT_63	[p6l838t1220r912b1279],
18	antipsychotic	JJ	O	antipsychotic	amod	19	SENT_63	[p6l981t1210r1507b1300],
19	drugs	NNS	O	drug	prep_to	5	SENT_63	[p6l1576t1210r1813b1300],
20	.	.	O	.	_	0	SENT_63	[p6l1576t1210r1813b1300],

1	In	IN	O	in	_	0	SENT_64	[p6l1885t1211r1965b1278],
2	the	DT	O	the	det	4	SENT_64	[p6l2031t1210r2149b1279],
3	present	JJ	DATE	present	amod	4	SENT_64	[p6l6t1339r294b1419],
4	study	NN	O	study	prep_in	13	SENT_64	[p6l384t1329r614b1419],
5	,	,	O	,	_	0	SENT_64	[p6l384t1329r614b1419],
6	males	NNS	O	male	nsubj	13	SENT_64	[p6l706t1329r934b1398],
7	with	IN	O	with	_	0	SENT_64	[p6l1026t1329r1200b1398],
8	mutated	VBN	O	mutate	amod	9	SENT_64	[p6l1288t1329r1608b1398],
9	alleles	NNS	O	allele	prep_with	6	SENT_64	[p6l1698t1329r1946b1398],
10	for	IN	O	for	_	0	SENT_64	[p6l2038t1329r2152b1398],
11	C	NN	O	c	nn	12	SENT_64	[p6l12t1450r74b1519],
12	YPZD6	NN	O	ypzd6	prep_for	9	SENT_64	[p6l79t1448r362b1518],
13	showed	VBD	O	show	_	0	SENT_64	[p6l402t1448r699b1518],
14	greater	JJR	O	greater	amod	16	SENT_64	[p6l740t1459r1015b1538],
15	prolactin	NN	O	prolactin	nn	16	SENT_64	[p6l1053t1448r1407b1538],
16	response	NN	O	response	dobj	13	SENT_64	[p6l1446t1471r1792b1538],
17	to	TO	O	to	_	0	SENT_64	[p6l1832t1459r1906b1518],
18	haloperidol	NN	O	haloperidol	prep_to	13	SENT_64	[p6l1947t1448r2147b1518, p6l6t1567r286b1657],
19	via	IN	O	via	_	0	SENT_64	[p6l349t1567r469b1637],
20	alteration	NN	O	alteration	prep_via	18	SENT_64	[p6l532t1567r906b1637],
21	than	IN	O	than	_	0	SENT_64	[p6l967t1567r1136b1637],
22	those	DT	O	those	prep_than	13	SENT_64	[p6l1198t1567r1405b1637],
23	without	IN	O	without	_	0	SENT_64	[p6l1468t1567r1770b1637],
24	mutated	VBN	O	mutate	amod	25	SENT_64	[p6l1831t1567r2151b1637],
25	alleles	NNS	O	allele	prep_without	13	SENT_64	[p6l9t1686r259b1755],
26	in	IN	O	in	_	0	SENT_64	[p6l296t1686r371b1754],
27	plasma	NN	O	plasma	nn	29	SENT_64	[p6l405t1686r688b1776],
28	drug	NN	O	drug	nn	29	SENT_64	[p6l724t1686r901b1776],
29	concentrations	NNS	O	concentration	prep_in	25	SENT_64	[p6l939t1686r1538b1755],
30	.	.	O	.	_	0	SENT_64	[p6l939t1686r1538b1755],

1	Therefore	RB	O	therefore	advmod	16	SENT_65	[p6l1579t1686r1990b1768],
2	,	,	O	,	_	0	SENT_65	[p6l1579t1686r1990b1768],
3	the	DT	O	the	det	4	SENT_65	[p6l2031t1686r2150b1755],
4	risk	NN	O	risk	nsubjpass	16	SENT_65	[p6l6t1805r156b1874],
5	of	IN	O	of	_	0	SENT_65	[p6l190t1805r275b1874],
6	hyperprolactinemia	NN	O	hyperprolactinemia	prep_of	4	SENT_65	[p6l303t1805r1080b1895],
7	in	IN	O	in	_	0	SENT_65	[p6l1114t1804r1189b1873],
8	male	JJ	O	male	amod	9	SENT_65	[p6l1224t1805r1415b1874],
9	patients	NNS	O	patient	prep_in	6	SENT_65	[p6l1449t1805r1757b1895],
10	with	IN	O	with	_	0	SENT_65	[p6l1794t1805r1969b1874],
11	low	JJ	O	low	amod	13	SENT_65	[p6l2004t1805r2150b1875],
12	CYPZD6	NN	O	cypzd6	nn	13	SENT_65	[p6l8t1924r367b1994],
13	activity	NN	O	activity	prep_with	9	SENT_65	[p6l403t1924r699b2014],
14	should	MD	O	should	aux	16	SENT_65	[p6l736t1924r997b1994],
15	be	VB	O	be	auxpass	16	SENT_65	[p6l1028t1924r1120b1994],
16	noted	VBN	O	note	_	0	SENT_65	[p6l1154t1924r1374b1994],
17	during	IN	O	during	_	0	SENT_65	[p6l1408t1924r1664b2014],
18	haloperidol	NN	O	haloperidol	nn	19	SENT_65	[p6l1697t1924r2149b2014],
19	treatment	NN	O	treatment	prep_during	16	SENT_65	[p6l7t2053r402b2112],
20	.	.	O	.	_	0	SENT_65	[p6l7t2053r402b2112],

1	In	IN	O	in	_	0	SENT_66	[p6l106t2163r187b2230],
2	females	NNS	O	female	prep_in	5	SENT_66	[p6l238t2162r566b2244],
3	,	,	O	,	_	0	SENT_66	[p6l238t2162r566b2244],
4	there	EX	O	there	expl	5	SENT_66	[p6l622t2162r819b2231],
5	was	VBD	O	be	_	0	SENT_66	[p6l872t2184r1021b2232],
6	no	DT	O	no	det	7	SENT_66	[p6l1074t2184r1170b2231],
7	difference	NN	O	difference	nsubj	5	SENT_66	[p6l1223t2161r1618b2231],
8	in	IN	O	in	_	0	SENT_66	[p6l1671t2162r1746b2230],
9	prolactin	NN	O	prolactin	nn	10	SENT_66	[p6l1796t2162r2150b2252],
10	response	NN	O	response	prep_in	7	SENT_66	[p6l6t2303r352b2371],
11	to	TO	O	to	_	0	SENT_66	[p6l407t2292r480b2350],
12	haloperidol	NN	O	haloperidol	prep_to	10	SENT_66	[p6l535t2281r986b2371],
13	between	IN	O	between	_	0	SENT_66	[p6l1040t2281r1372b2351],
14	the	DT	O	the	det	18	SENT_66	[p6l1425t2281r1544b2350],
15	two	CD	NUMBER	two	num	18	SENT_66	[p6l1599t2291r1744b2351],
16	CYPZD6	NN	O	cypzd6	nn	18	SENT_66	[p6l1805t2280r2153b2351],
17	genotype	NN	O	genotype	nn	18	SENT_66	[p6l8t2411r370b2490],
18	groups	NNS	O	group	prep_between	12	SENT_66	[p6l432t2423r696b2490],
19	despite	IN	O	despite	_	0	SENT_66	[p6l760t2400r1039b2490],
20	the	DT	O	the	det	21	SENT_66	[p6l1101t2400r1220b2470],
21	fact	NN	O	fact	prep_despite	5	SENT_66	[p6l1282t2400r1429b2470],
22	that	IN	O	that	complm	27	SENT_66	[p6l1489t2400r1638b2470],
23	haloperidol	NN	O	haloperidol	nn	24	SENT_66	[p6l1697t2400r2149b2490],
24	concentrations	NNS	O	concentration	nsubjpass	27	SENT_66	[p6l8t2519r584b2589],
25	were	VBD	O	be	auxpass	27	SENT_66	[p6l638t2541r827b2589],
26	signiﬁcantly	RB	O	signiﬁcantly	advmod	27	SENT_66	[p6l882t2519r1368b2609],
27	inﬂuenced	VBN	O	inﬂuenced	ccomp	5	SENT_66	[p6l1420t2519r1833b2589],
28	by	IN	O	by	_	0	SENT_66	[p6l1882t2519r1980b2609],
29	the	DT	O	the	agent	27	SENT_66	[p6l2031t2519r2150b2589],

1	N.	NNP	PERSON	N.	nn	2	SENT_67	[p6l371t2685r399b2708],
2	Yasui-Furukori	NNP	PERSON	Yasui-Furukori	_	0	SENT_67	[p6l415t2684r616b2708],
3	et	FW	O	et	nn	4	SENT_67	[p6l627t2689r651b2708],
4	al.	FW	O	al.	dep	2	SENT_67	[p6l661t2684r691b2708],
5	/	:	O	/	punct	2	SENT_67	[p6l702t2684r717b2708],
6	Schizophrenia	NNP	O	Schizophrenia	nn	7	SENT_67	[p6l724t2684r913b2714],
7	Research	NNP	O	Research	dep	2	SENT_67	[p6l923t2684r1046b2708],
8	52	CD	NUMBER	52	number	9	SENT_67	[p6l1057t2684r1089b2708],
9	(	CD	NUMBER	(	num	10	SENT_67	[p6l1101t2684r1187b2713],
10	2001	CD	DATE	2001	dep	7	SENT_67	[p6l1101t2684r1187b2713],
11	)	CD	NUMBER	)	number	12	SENT_67	[p6l1101t2684r1187b2713],
12	139-142 141	CD	NUMBER	139-142 141	num	10	SENT_67	[p6l1745t2684r1788b2708],[p6l1200t2684r1317b2708],

1	C	NN	O	c	_	0	SENT_68	[p6l12t2823r74b2892],
2	YPZD6	NN	O	ypzd6	nn	3	SENT_68	[p6l80t2822r361b2891],
3	genotypes	NNS	O	genotype	dep	1	SENT_68	[p6l393t2832r812b2912],
4	.	.	O	.	_	0	SENT_68	[p6l393t2832r812b2912],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_69	[p6l854t2822r1281b2912],
2	variability	NN	O	variability	nsubjpass	23	SENT_69	[p6l1314t2822r1721b2912],
3	in	IN	O	in	_	0	SENT_69	[p6l1757t2822r1831b2890],
4	prolactin	NN	O	prolactin	nn	5	SENT_69	[p6l1864t2822r2141b2912, p6l7t2941r110b3010],
5	response	NN	O	response	prep_in	2	SENT_69	[p6l146t2963r491b3031],
6	to	TO	O	to	_	0	SENT_69	[p6l530t2951r603b3010],
7	haloperidol	NN	O	haloperidol	prep_to	5	SENT_69	[p6l641t2941r1092b3031],
8	and	CC	O	and	_	0	SENT_69	[p6l1131t2941r1271b3010],
9	a	DT	O	a	det	10	SENT_69	[p6l1310t2963r1351b3010],
10	lack	NN	O	lack	prep_in	2	SENT_69	[p6l1388t2941r1553b3010],
11	of	IN	O	of	_	0	SENT_69	[p6l1589t2941r1675b3010],
12	association	NN	O	association	prep_of	10	SENT_69	[p6l1708t2941r2145b3010],
13	between	IN	O	between	_	0	SENT_69	[p6l6t3060r337b3130],
14	plasma	NN	O	plasma	nn	15	SENT_69	[p6l391t3060r673b3150],
15	concentrations	NNS	O	concentration	prep_between	12	SENT_69	[p6l728t3060r1303b3130],
16	of	IN	O	of	_	0	SENT_69	[p6l1363t3060r1448b3130],
17	haloperidol	NN	O	haloperidol	prep_of	15	SENT_69	[p6l1496t3060r1947b3150],
18	and	CC	O	and	_	0	SENT_69	[p6l2006t3060r2146b3130],
19	prolactin	NN	O	prolactin	conj_and	17	SENT_69	[p6l6t3179r360b3269],
20	were	VBD	O	be	auxpass	23	SENT_69	[p6l397t3201r586b3249],
21	both	DT	O	both	dep	23	SENT_69	[p6l624t3179r800b3249],
22	also	RB	O	also	advmod	23	SENT_69	[p6l839t3179r994b3249],
23	observed	VBN	O	observe	_	0	SENT_69	[p6l1035t3179r1389b3249],
24	in	IN	O	in	_	0	SENT_69	[p6l1427t3179r1502b3248],
25	females	NNS	O	female	prep_in	23	SENT_69	[p6l1540t3179r1867b3249],
26	.	.	O	.	_	0	SENT_69	[p6l1540t3179r1867b3249],

1	These	DT	O	these	det	2	SENT_70	[p6l1910t3179r2144b3249],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_70	[p6l9t3297r322b3388],
3	suggest	VBP	O	suggest	_	0	SENT_70	[p6l367t3308r660b3388],
4	that	IN	O	that	complm	12	SENT_70	[p6l699t3298r847b3367],
5	factors	NNS	O	factor	nsubj	12	SENT_70	[p6l886t3297r1152b3367],
6	other	JJ	O	other	dep	5	SENT_70	[p6l1195t3298r1397b3367],
7	than	IN	O	than	_	0	SENT_70	[p6l1436t3298r1604b3367],
8	pharmacoki	JJ	O	pharmacoki	amod	9	SENT_70	[p6l1643t3298r2142b3388],
9	—	NN	O	—	prep_than	5	SENT_70	[p6l1643t3298r2142b3388],
10	netic	JJ	O	netic	amod	11	SENT_70	[p6l7t3417r197b3486],
11	conditions	NNS	O	condition	dep	9	SENT_70	[p6l264t3417r671b3486],
12	have	VBP	O	have	ccomp	3	SENT_70	[p6l736t3417r921b3487],
13	greater	JJR	O	greater	amod	14	SENT_70	[p6l987t3427r1262b3507],
14	impact	NN	O	impact	dobj	12	SENT_70	[p6l1323t3417r1592b3507],
15	in	IN	O	in	_	0	SENT_70	[p6l1655t3417r1730b3486],
16	prolactin	NN	O	prolactin	nn	17	SENT_70	[p6l1792t3417r2145b3507],
17	response	NN	O	response	prep_in	14	SENT_70	[p6l6t3559r351b3626],
18	to	TO	O	to	_	0	SENT_70	[p6l386t3547r460b3606],
19	haloperidol	NN	O	haloperidol	prep_to	12	SENT_70	[p6l494t3536r944b3626],
20	in	IN	O	in	_	0	SENT_70	[p6l978t3536r1053b3605],
21	females	NNS	O	female	prep_in	19	SENT_70	[p6l1087t3536r1414b3606],
22	.	.	O	.	_	0	SENT_70	[p6l1087t3536r1414b3606],

1	It	PRP	O	it	nsubj	3	SENT_71	[p6l1452t3538r1512b3606],
2	is	VBZ	O	be	cop	3	SENT_71	[p6l1544t3536r1606b3606],
3	possible	JJ	O	possible	_	0	SENT_71	[p6l1641t3536r1963b3626],
4	that	IN	O	that	complm	9	SENT_71	[p6l1998t3536r2146b3606],
5	variability	NN	O	variability	nsubj	9	SENT_71	[p6l8t3655r414b3745],
6	in	IN	O	in	_	0	SENT_71	[p6l450t3655r524b3724],
7	estrogen	NN	O	estrogen	nn	8	SENT_71	[p6l559t3666r893b3745],
8	concentrations	NNS	O	concentration	prep_in	5	SENT_71	[p6l927t3655r1502b3725],
9	affect	VBP	O	affect	ccomp	3	SENT_71	[p6l1542t3655r1759b3725],
10	prolactin	NN	O	prolactin	nn	11	SENT_71	[p6l1792t3655r2145b3745],
11	concentrations	NNS	O	concentration	dobj	9	SENT_71	[p7l8t21r584b90],
12	in	IN	O	in	_	0	SENT_71	[p7l627t21r702b89],
13	female	JJ	O	female	amod	14	SENT_71	[p7l743t21r1011b90],
14	patients	NNS	O	patient	prep_in	11	SENT_71	[p7l1052t21r1380b111],
15	.	.	O	.	_	0	SENT_71	[p7l1052t21r1380b111],

1	In	IN	O	in	_	0	SENT_72	[p7l1427t22r1507b90],
2	addition	NN	O	addition	prep_in	15	SENT_72	[p7l1550t21r1892b103],
3	,	,	O	,	_	0	SENT_72	[p7l1550t21r1892b103],
4	some	DT	O	some	det	7	SENT_72	[p7l1941t43r2144b90],
5	other	JJ	O	other	amod	7	SENT_72	[p7l9t140r211b209],
6	endogenous	JJ	O	endogenous	amod	7	SENT_72	[p7l242t140r710b230],
7	factors	NNS	O	factor	nsubj	15	SENT_72	[p7l745t140r1010b209],
8	such	JJ	O	such	_	0	SENT_72	[p7l1048t140r1223b209],
9	as	IN	O	as	_	0	SENT_72	[p7l1257t162r1332b209],
10	genetics	NNS	O	genetics	prep_such_as	7	SENT_72	[p7l1368t140r1688b230],
11	(	RB	O	(	advmod	15	SENT_72	[p7l1725t140r2144b230],
12	dopamine	NN	O	dopamine	nn	14	SENT_72	[p7l1725t140r2144b230],
13	receptor	NN	O	receptor	nn	14	SENT_72	[p7l6t270r333b349],
14	polymorphisms	NNS	O	polymorphism	nsubj	15	SENT_72	[p7l394t259r1065b349],
15	)	VBP	O	)	ccomp	19	SENT_72	[p7l394t259r1065b349],
16	,	,	O	,	_	0	SENT_72	[p7l394t259r1065b349],
17	can	MD	O	can	aux	19	SENT_72	[p7l1134t281r1269b329],
18	also	RB	O	also	advmod	19	SENT_72	[p7l1334t259r1488b329],
19	alter	VB	O	alter	_	0	SENT_72	[p7l1556t259r1731b329],
20	prolactin	NN	O	prolactin	nn	21	SENT_72	[p7l1792t259r2145b349],
21	response	NN	O	response	dobj	19	SENT_72	[p7l6t400r351b468],
22	in	IN	O	in	_	0	SENT_72	[p7l386t378r461b447],
23	females	NNS	O	female	prep_in	21	SENT_72	[p7l495t378r800b448],
24	by	IN	O	by	_	0	SENT_72	[p7l834t378r931b468],
25	modifying	VBG	O	modify	prepc_by	19	SENT_72	[p7l966t378r1376b468],
26	pharmacodynamic	JJ	O	pharmacodynamic	amod	27	SENT_72	[p7l1410t378r2143b468],
27	responsiveness	NN	O	responsiveness	dobj	25	SENT_72	[p7l6t497r598b587],
28	to	TO	O	to	_	0	SENT_72	[p7l647t507r720b566],
29	antipsychotic	JJ	O	antipsychotic	amod	30	SENT_72	[p7l771t497r1294b587],
30	agents	NNS	O	agent	prep_to	25	SENT_72	[p7l1345t507r1593b587],
31	as	IN	O	as	mark	32	SENT_72	[p7l1643t519r1719b566],
32	shown	VBN	O	show	advcl	25	SENT_72	[p7l1771t497r2024b566],
33	in	IN	O	in	_	0	SENT_72	[p7l2070t497r2145b565],
34	our	PRP$	O	we	poss	36	SENT_72	[p7l9t638r139b685],
35	previous	JJ	O	previous	amod	36	SENT_72	[p7l176t616r514b706],
36	study	NN	O	study	prep_in	32	SENT_72	[p7l560t616r769b706],
37	(	CD	NUMBER	(	num	38	SENT_72	[p7l813t616r1128b701],
38	Mihara	NNP	PERSON	Mihara	dep	36	SENT_72	[p7l813t616r1128b701],
39	et	FW	O	et	nn	40	SENT_72	[p7l1168t626r1238b685],
40	al.	FW	O	al.	nsubj	19	SENT_72	[p7l1279t616r1392b698],
41	,	,	O	,	_	0	SENT_72	[p7l1279t616r1392b698],
42	2000	CD	DATE	2000	num	43	SENT_72	[p7l1438t616r1684b701],
43	)	NN	O	)	appos	40	SENT_72	[p7l1438t616r1684b701],
44	.	.	O	.	_	0	SENT_72	[p7l1438t616r1684b701],

1	Therefore	RB	O	therefore	advmod	9	SENT_73	[p7l1730t616r2141b698],
2	,	,	O	,	_	0	SENT_73	[p7l1730t616r2141b698],
3	plasma	NN	O	plasma	nn	5	SENT_73	[p7l6t735r288b825],
4	drug	NN	O	drug	nn	5	SENT_73	[p7l325t735r502b825],
5	monitoring	NN	O	monitoring	nsubj	9	SENT_73	[p7l539t735r979b825],
6	is	VBZ	O	be	cop	9	SENT_73	[p7l1016t735r1078b805],
7	not	RB	O	not	neg	9	SENT_73	[p7l1116t746r1242b805],
8	necessarily	RB	O	necessarily	advmod	9	SENT_73	[p7l1277t735r1716b825],
9	helpful	JJ	O	helpful	_	0	SENT_73	[p7l1753t735r2033b825],
10	in	IN	O	in	_	0	SENT_73	[p7l2070t735r2145b804],
11	predicting	VBG	O	predict	prepc_in	9	SENT_73	[p7l6t854r408b944],
12	prolactin	NN	O	prolactin	nn	13	SENT_73	[p7l440t854r793b944],
13	response	NN	O	response	dobj	11	SENT_73	[p7l825t876r1169b944],
14	in	IN	O	in	_	0	SENT_73	[p7l1203t854r1278b923],
15	female	JJ	O	female	amod	16	SENT_73	[p7l1311t854r1578b924],
16	patients	NNS	O	patient	prep_in	11	SENT_73	[p7l1611t854r1938b944],
17	.	.	O	.	_	0	SENT_73	[p7l1611t854r1938b944],

1	As	IN	O	as	prep	5	SENT_74	[p7l106t973r211b1042],
2	with	IN	O	with	pcomp	1	SENT_74	[p7l255t973r429b1043],
3	haloperidol	NN	O	haloperidol	pobj	2	SENT_74	[p7l469t973r942b1063],
4	,	,	O	,	_	0	SENT_74	[p7l469t973r942b1063],
5	reduced	VBD	O	reduce	_	0	SENT_74	[p7l985t973r1300b1042],
6	haloperidol	NN	O	haloperidol	nn	7	SENT_74	[p7l1340t973r1790b1063],
7	concentrations	NNS	O	concentration	nsubj	9	SENT_74	[p7l1833t995r2142b1042, p7l7t1092r301b1161],
8	also	RB	O	also	advmod	9	SENT_74	[p7l333t1092r487b1161],
9	correlated	VBD	O	correlate	ccomp	5	SENT_74	[p7l517t1092r912b1161],
10	positively	RB	O	positively	advmod	9	SENT_74	[p7l938t1092r1329b1182],
11	with	IN	O	with	_	0	SENT_74	[p7l1358t1092r1531b1161],
12	plasma	NN	O	plasma	nn	16	SENT_74	[p7l1557t1092r1838b1182],
13	prolac	NN	O	prolac	nn	16	SENT_74	[p7l1864t1092r2141b1182],
14	—	CD	NUMBER	—	num	16	SENT_74	[p7l1864t1092r2141b1182],
15	tin	NN	O	tin	nn	16	SENT_74	[p7l7t1210r110b1279],
16	concentrations	NNS	O	concentration	prep_with	9	SENT_74	[p7l145t1210r720b1279],
17	in	IN	O	in	_	0	SENT_74	[p7l756t1210r831b1278],
18	males	NNS	O	male	prep_in	9	SENT_74	[p7l865t1210r1092b1279],
19	but	CC	O	but	_	0	SENT_74	[p7l1128t1210r1255b1279],
20	not	RB	O	not	_	0	SENT_74	[p7l1287t1220r1412b1279],
21	in	IN	O	in	_	0	SENT_74	[p7l1445t1210r1520b1278],
22	females	NNS	O	female	prep_in	9	SENT_74	[p7l1555t1210r1858b1279],
23	in	IN	O	in	_	0	SENT_74	[p7l1895t1210r1970b1278],
24	this	DT	O	this	det	25	SENT_74	[p7l2004t1210r2142b1279],
25	study	NN	O	study	prep_in	22	SENT_74	[p7l11t1329r239b1419],
26	.	.	O	.	_	0	SENT_74	[p7l11t1329r239b1419],

1	It	PRP	O	it	nsubjpass	4	SENT_75	[p7l282t1331r341b1399],
2	has	VBZ	O	have	aux	4	SENT_75	[p7l376t1329r504b1399],
3	been	VBN	O	be	auxpass	4	SENT_75	[p7l542t1329r728b1399],
4	reported	VBN	O	report	_	0	SENT_75	[p7l765t1329r1096b1419],
5	that	IN	O	that	complm	22	SENT_75	[p7l1131t1329r1280b1399],
6	despite	IN	O	despite	_	0	SENT_75	[p7l1317t1329r1594b1419],
7	having	VBG	O	have	prepc_despite	22	SENT_75	[p7l1631t1329r1900b1419],
8	some	DT	O	some	det	10	SENT_75	[p7l1941t1351r2144b1399],
9	pharmacological	JJ	O	pharmacological	amod	10	SENT_75	[p7l6t1448r669b1538],
10	activity	NN	O	activity	dobj	7	SENT_75	[p7l703t1448r997b1538],
11	at	IN	O	at	_	0	SENT_75	[p7l1031t1458r1100b1517],
12	sigma	NN	O	sigma	nn	13	SENT_75	[p7l1134t1448r1366b1538],
13	receptors	NNS	O	receptor	prep_at	7	SENT_75	[p7l1395t1458r1780b1538],
14	,	,	O	,	_	0	SENT_75	[p7l1395t1458r1780b1538],
15	the	DT	O	the	det	17	SENT_75	[p7l1814t1448r1932b1517],
16	antidopaminergic	JJ	O	antidopaminergic	amod	17	SENT_75	[p7l1967t1447r2141b1517, p7l8t1567r550b1657],
17	property	NN	O	property	nsubj	22	SENT_75	[p7l622t1577r956b1657],
18	of	IN	O	of	_	0	SENT_75	[p7l1029t1567r1114b1636],
19	reduced	VBN	O	reduce	amod	20	SENT_75	[p7l1177t1567r1490b1636],
20	haloperidol	NN	O	haloperidol	prep_of	17	SENT_75	[p7l1560t1567r2010b1657],
21	is	VBZ	O	be	cop	22	SENT_75	[p7l2081t1567r2142b1636],
22	much	JJ	O	much	ccomp	4	SENT_75	[p7l7t1686r226b1756],
23	weaker	JJR	O	weaker	dep	22	SENT_75	[p7l291t1686r577b1756],
24	than	IN	O	than	_	0	SENT_75	[p7l641t1686r809b1756],
25	that	DT	O	that	prep_than	22	SENT_75	[p7l875t1686r1023b1756],
26	of	IN	O	of	_	0	SENT_75	[p7l1088t1686r1174b1756],
27	the	DT	O	the	det	31	SENT_75	[p7l1232t1686r1350b1756],
28	parent	NN	O	parent	nn	31	SENT_75	[p7l1415t1697r1664b1776],
29	compound	NN	O	compound	nn	31	SENT_75	[p7l1729t1686r2146b1776],
30	(	NN	O	(	nn	31	SENT_75	[p7l11t1806r319b1891],
31	Bowen	NNP	PERSON	Bowen	prep_of	25	SENT_75	[p7l11t1806r319b1891],
32	et	FW	O	et	nn	33	SENT_75	[p7l347t1816r417b1875],
33	al.	FW	O	al.	tmod	22	SENT_75	[p7l445t1805r558b1888],
34	,	,	O	,	_	0	SENT_75	[p7l445t1805r558b1888],
35	1990	CD	DATE	1990	num	36	SENT_75	[p7l599t1806r838b1891],
36	)	NN	O	)	appos	33	SENT_75	[p7l599t1806r838b1891],
37	.	.	O	.	_	0	SENT_75	[p7l599t1806r838b1891],

1	In	IN	O	in	_	0	SENT_76	[p7l870t1807r950b1874],
2	addition	NN	O	addition	prep_in	13	SENT_76	[p7l980t1805r1322b1887],
3	,	,	O	,	_	0	SENT_76	[p7l980t1805r1322b1887],
4	clinical	JJ	O	clinical	amod	5	SENT_76	[p7l1353t1805r1644b1875],
5	signiﬁcance	NN	O	signiﬁcance	nsubj	13	SENT_76	[p7l1675t1805r2144b1895],
6	of	IN	O	of	_	0	SENT_76	[p7l9t1924r94b1993],
7	reduced	VBN	O	reduce	amod	8	SENT_76	[p7l115t1924r429b1993],
8	haloperidol	NN	O	haloperidol	prep_of	5	SENT_76	[p7l456t1924r906b2014],
9	is	VBZ	O	be	cop	13	SENT_76	[p7l936t1924r997b1993],
10	still	RB	O	still	advmod	13	SENT_76	[p7l1030t1924r1173b1993],
11	equivocal	JJ	O	equivocal	amod	13	SENT_76	[p7l1203t1924r1586b2014],
12	(	NNP	O	(	nn	13	SENT_76	[p7l1618t1924r1900b2009],
13	Ulrich	NNP	PERSON	Ulrich	_	0	SENT_76	[p7l1618t1924r1900b2009],
14	et	FW	O	et	nn	15	SENT_76	[p7l1929t1934r1998b1993],
15	al.	FW	O	al.	dep	13	SENT_76	[p7l2028t1924r2141b2006],
16	,	,	O	,	_	0	SENT_76	[p7l2028t1924r2141b2006],
17	1999	CD	DATE	1999	num	18	SENT_76	[p7l17t2043r256b2128],
18	)	NN	O	)	appos	15	SENT_76	[p7l17t2043r256b2128],
19	.	.	O	.	_	0	SENT_76	[p7l17t2043r256b2128],

1	Therefore	RB	O	therefore	advmod	10	SENT_77	[p7l298t2043r709b2125],
2	,	,	O	,	_	0	SENT_77	[p7l298t2043r709b2125],
3	the	DT	O	the	det	5	SENT_77	[p7l750t2043r868b2112],
4	prolactin	NN	O	prolactin	nn	5	SENT_77	[p7l904t2043r1258b2133],
5	response	NN	O	response	nsubj	10	SENT_77	[p7l1294t2065r1638b2133],
6	to	TO	O	to	_	0	SENT_77	[p7l1677t2053r1750b2112],
7	haloperidol	NN	O	haloperidol	nn	8	SENT_77	[p7l1787t2042r2141b2133, p7l8t2162r131b2232],
8	treatment	NN	O	treatment	prep_to	5	SENT_77	[p7l165t2173r541b2232],
9	is	VBZ	O	be	cop	10	SENT_77	[p7l573t2162r634b2232],
10	unlikely	JJ	O	unlikely	_	0	SENT_77	[p7l668t2162r992b2252],
11	to	TO	O	to	aux	13	SENT_77	[p7l1025t2173r1099b2232],
12	be	VB	O	be	auxpass	13	SENT_77	[p7l1132t2162r1224b2232],
13	inﬂuenced	VBN	O	inﬂuenced	xcomp	10	SENT_77	[p7l1258t2162r1670b2232],
14	by	IN	O	by	_	0	SENT_77	[p7l1702t2162r1799b2252],
15	reduced	VBN	O	reduce	amod	16	SENT_77	[p7l1831t2162r2146b2232],
16	haloperidol	NN	O	haloperidol	agent	13	SENT_77	[p7l7t2281r479b2371],
17	.	.	O	.	_	0	SENT_77	[p7l7t2281r479b2371],

1	Thus	RB	O	thus	advmod	18	SENT_78	[p7l533t2281r750b2363],
2	,	,	O	,	_	0	SENT_78	[p7l533t2281r750b2363],
3	the	DT	O	the	det	5	SENT_78	[p7l804t2281r923b2351],
4	positive	JJ	O	positive	amod	5	SENT_78	[p7l973t2281r1285b2371],
5	correlation	NN	O	correlation	nsubj	18	SENT_78	[p7l1337t2281r1765b2351],
6	between	IN	O	between	_	0	SENT_78	[p7l1814t2281r2145b2351],
7	plasma	NN	O	plasma	nn	8	SENT_78	[p7l6t2400r288b2490],
8	concentrations	NNS	O	concentration	prep_between	5	SENT_78	[p7l347t2400r922b2469],
9	of	IN	O	of	_	0	SENT_78	[p7l985t2400r1070b2469],
10	reduced	VBN	O	reduce	amod	11	SENT_78	[p7l1121t2400r1435b2469],
11	haloperidol	NN	O	haloperidol	prep_of	8	SENT_78	[p7l1493t2400r1944b2490],
12	and	CC	O	and	_	0	SENT_78	[p7l2006t2400r2146b2469],
13	prolactin	NN	O	prolactin	conj_and	11	SENT_78	[p7l6t2519r360b2609],
14	in	IN	O	in	_	0	SENT_78	[p7l418t2519r492b2587],
15	males	NNS	O	male	prep_in	11	SENT_78	[p7l550t2519r777b2588],
16	may	MD	O	may	aux	18	SENT_78	[p7l838t2541r1005b2609],
17	secondarily	RB	O	secondarily	advmod	18	SENT_78	[p7l1068t2519r1519b2609],
18	result	VB	O	result	_	0	SENT_78	[p7l1577t2519r1798b2588],
19	from	IN	O	from	_	0	SENT_78	[p7l1855t2519r2046b2588],
20	a	DT	O	a	det	22	SENT_78	[p7l2105t2541r2146b2588],
21	strong	JJ	O	strong	amod	22	SENT_78	[p7l11t2649r251b2728],
22	correlation	NN	O	correlation	prep_from	18	SENT_78	[p7l299t2638r728b2708],
23	between	IN	O	between	_	0	SENT_78	[p7l772t2638r1103b2708],
24	haloperidol	NN	O	haloperidol	prep_between	22	SENT_78	[p7l1148t2638r1599b2728],
25	and	CC	O	and	_	0	SENT_78	[p7l1647t2638r1787b2708],
26	reduced	VBD	O	reduce	conj_and	18	SENT_78	[p7l1831t2638r2146b2708],
27	haloperidol	NN	O	haloperidol	nn	28	SENT_78	[p7l7t2757r458b2847],
28	concentrations	NNS	O	concentration	nsubj	29	SENT_78	[p7l492t2757r1067b2827],
29	(	VBP	O	(	ccomp	26	SENT_78	[p7l1105t2758r1175b2843],
30	r	NN	O	r	npadvmod	35	SENT_78	[p7l1105t2758r1175b2843],
31	=	JJ	O	=	amod	30	SENT_78	[p7l1207t2784r1274b2809],
32	0.837	CD	NUMBER	0.837	tmod	31	SENT_78	[p7l1309t2758r1551b2839],
33	,	,	O	,	_	0	SENT_78	[p7l1309t2758r1551b2839],
34	p	NN	O	p	appos	32	SENT_78	[p7l1578t2781r1633b2846],
35	<	JJR	O	<	acomp	29	SENT_78	[p7l1671t2765r1737b2822],
36	0.001	CD	NUMBER	0.001	num	37	SENT_78	[p7l1775t2758r2048b2843],
37	)	NN	O	)	dep	29	SENT_78	[p7l1775t2758r2048b2843],
38	.	.	O	.	_	0	SENT_78	[p7l1775t2758r2048b2843],

1	Earlier	JJR	O	earlier	amod	2	SENT_79	[p7l106t2876r371b2945],
2	reports	NNS	O	report	nsubj	3	SENT_79	[p7l446t2886r714b2966],
3	indicated	VBD	O	indicate	_	0	SENT_79	[p7l791t2876r1148b2945],
4	a	DT	O	a	det	6	SENT_79	[p7l1226t2898r1266b2945],
5	positive	JJ	O	positive	amod	6	SENT_79	[p7l1341t2876r1648b2966],
6	correlation	NN	O	correlation	dobj	3	SENT_79	[p7l1727t2876r2146b2945],
7	between	IN	O	between	_	0	SENT_79	[p7l6t2995r331b3064],
8	prolactin	NN	O	prolactin	nn	9	SENT_79	[p7l364t2995r709b3085],
9	response	NN	O	response	prep_between	6	SENT_79	[p7l741t3017r1080b3085],
10	to	TO	O	to	_	0	SENT_79	[p7l1114t3005r1188b3064],
11	haloperidol	NN	O	haloperidol	nn	15	SENT_79	[p7l1221t2995r1664b3085],
12	and	CC	O	and	_	0	SENT_79	[p7l1699t2995r1837b3064],
13	plasma	NN	O	plasma	nn	15	SENT_79	[p7l1869t2995r2147b3085],
14	drug	NN	O	drug	nn	15	SENT_79	[p7l8t3114r183b3204],
15	concentration	NN	O	concentration	prep_to	3	SENT_79	[p7l224t3114r752b3184],
16	with	IN	O	with	prep	3	SENT_79	[p7l792t3114r962b3184],
17	both	CC	O	both	dep	16	SENT_79	[p7l1000t3114r1174b3184],
18	genders	NNS	O	gender	conj	16	SENT_79	[p7l1213t3114r1510b3204],
19	comprising	VBG	O	comprise	partmod	18	SENT_79	[p7l1553t3114r1987b3204],
20	the	DT	O	the	det	22	SENT_79	[p7l2028t3114r2145b3184],
21	total	JJ	O	total	amod	22	SENT_79	[p7l7t3233r178b3303],
22	subjects	NNS	O	subject	dobj	19	SENT_79	[p7l228t3233r534b3323],
23	(	JJ	O	(	amod	24	SENT_79	[p7l584t3233r850b3318],
24	Rubin	NNP	PERSON	Rubin	dep	22	SENT_79	[p7l584t3233r850b3318],
25	et	FW	O	et	nn	26	SENT_79	[p7l896t3244r966b3303],
26	al.	FW	O	al.	dep	22	SENT_79	[p7l1012t3233r1123b3315],
27	,	,	O	,	_	0	SENT_79	[p7l1012t3233r1123b3315],
28	1980	CD	DATE	1980	appos	22	SENT_79	[p7l1181t3233r1387b3315],
29	;	:	O	;	_	0	SENT_79	[p7l1181t3233r1387b3315],
30	van	NN	PERSON	van	nn	31	SENT_79	[p7l1437t3255r1577b3303],
31	Putten	NNP	PERSON	Putten	dep	22	SENT_79	[p7l1622t3235r1868b3303],
32	et	FW	O	et	nn	33	SENT_79	[p7l1915t3244r1985b3303],
33	al.	FW	O	al.	dep	31	SENT_79	[p7l2030t3233r2142b3315],
34	,	,	O	,	_	0	SENT_79	[p7l2030t3233r2142b3315],
35	1991	CD	DATE	1991	num	36	SENT_79	[p7l17t3352r252b3437],
36	)	NN	O	)	appos	33	SENT_79	[p7l17t3352r252b3437],
37	.	.	O	.	_	0	SENT_79	[p7l17t3352r252b3437],

1	In	IN	O	in	_	0	SENT_80	[p7l275t3353r355b3420],
2	the	DT	O	the	det	4	SENT_80	[p7l372t3352r489b3421],
3	present	JJ	DATE	present	amod	4	SENT_80	[p7l507t3362r788b3442],
4	study	NN	O	study	prep_in	12	SENT_80	[p7l809t3352r1035b3442],
5	,	,	O	,	_	0	SENT_80	[p7l809t3352r1035b3442],
6	however	RB	O	however	advmod	12	SENT_80	[p7l1056t3352r1412b3434],
7	,	,	O	,	_	0	SENT_80	[p7l1056t3352r1412b3434],
8	a	DT	O	a	det	10	SENT_80	[p7l1435t3374r1476b3421],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_80	[p7l1497t3351r1898b3442],
10	correlation	NN	O	correlation	nsubjpass	12	SENT_80	[p7l1916t3374r2143b3421, p7l8t3471r228b3540],
11	was	VBD	O	be	auxpass	12	SENT_80	[p7l248t3493r395b3541],
12	found	VBN	O	find	_	0	SENT_80	[p7l417t3471r643b3540],
13	only	RB	O	only	acomp	12	SENT_80	[p7l663t3471r833b3561],
14	in	IN	O	in	prep	13	SENT_80	[p7l854t3471r927b3539],
15	male	JJ	O	male	amod	16	SENT_80	[p7l947t3471r1136b3540],
16	patients	NNS	O	patient	pobj	14	SENT_80	[p7l1155t3471r1477b3561],
17	,	,	O	,	_	0	SENT_80	[p7l1155t3471r1477b3561],
18	but	CC	O	but	_	0	SENT_80	[p7l1500t3471r1625b3540],
19	not	RB	O	not	conj_but	14	SENT_80	[p7l1644t3481r1768b3540],
20	in	IN	O	in	dep	14	SENT_80	[p7l1786t3471r1862b3539],
21	female	JJ	O	female	amod	22	SENT_80	[p7l1881t3471r2145b3540],
22	patients	NNS	O	patient	pobj	20	SENT_80	[p7l6t3590r307b3680],
23	nor	CC	O	nor	_	0	SENT_80	[p7l368t3613r497b3660],
24	in	IN	O	in	acomp	12	SENT_80	[p7l555t3590r629b3659],
25	total	JJ	O	total	amod	26	SENT_80	[p7l688t3590r860b3660],
26	patients	NNS	O	patient	pobj	24	SENT_80	[p7l918t3590r1238b3680],
27	.	.	O	.	_	0	SENT_80	[p7l918t3590r1238b3680],

1	Similar	JJ	O	similar	amod	2	SENT_81	[p7l1305t3590r1589b3660],
2	results	NNS	O	result	nsubjpass	4	SENT_81	[p7l1646t3590r1895b3660],
3	were	VBD	O	be	auxpass	4	SENT_81	[p7l1958t3613r2145b3660],
4	reported	VBN	O	report	dep	9	SENT_81	[p7l6t3709r331b3799],
5	in	IN	O	in	_	0	SENT_81	[p7l353t3709r428b3778],
6	previous	JJ	O	previous	amod	8	SENT_81	[p7l449t3709r782b3799],
7	preliminary	JJ	O	preliminary	amod	8	SENT_81	[p7l805t3709r1258b3799],
8	studies	NNS	O	study	prep_in	4	SENT_81	[p7l1286t3709r1548b3779],
9	(	VBP	O	(	_	0	SENT_81	[p7l1576t3709r2145b3795],
10	Ravichandran	NNP	O	Ravichandran	nsubj	12	SENT_81	[p7l1576t3709r2145b3795],
11	et	FW	O	et	nn	12	SENT_81	[p8l8t31r78b90],
12	al.	FW	O	al.	xcomp	9	SENT_81	[p8l103t21r214b103],
13	,	,	O	,	_	0	SENT_81	[p8l103t21r214b103],
14	1984	CD	DATE	1984	appos	12	SENT_81	[p8l251t21r457b103],
15	;	:	O	;	_	0	SENT_81	[p8l251t21r457b103],
16	Swigar	NNP	O	Swigar	dep	14	SENT_81	[p8l489t21r762b111],
17	et	FW	O	et	nn	18	SENT_81	[p8l785t32r855b90],
18	al.	FW	O	al.	nsubj	9	SENT_81	[p8l879t21r991b103],
19	,	,	O	,	_	0	SENT_81	[p8l879t21r991b103],
20	1984	CD	DATE	1984	num	21	SENT_81	[p8l1028t21r1264b106],
21	)	NN	O	)	appos	18	SENT_81	[p8l1028t21r1264b106],
22	,	,	O	,	_	0	SENT_81	[p8l1028t21r1264b106],
23	although	IN	O	although	mark	27	SENT_81	[p8l1294t21r1632b111],
24	these	DT	O	these	det	25	SENT_81	[p8l1655t21r1852b90],
25	studies	NNS	O	study	nsubjpass	27	SENT_81	[p8l1881t21r2143b90],
26	were	VBD	O	be	auxpass	27	SENT_81	[p8l8t162r196b210],
27	conducted	VBN	O	conduct	dep	21	SENT_81	[p8l252t140r650b209],
28	with	IN	O	with	_	0	SENT_81	[p8l705t140r876b209],
29	a	DT	O	a	det	32	SENT_81	[p8l933t162r974b209],
30	relatively	RB	O	relatively	advmod	31	SENT_81	[p8l1027t140r1394b230],
31	small	JJ	O	small	amod	32	SENT_81	[p8l1452t140r1658b209],
32	number	NN	O	number	prep_with	27	SENT_81	[p8l1715t140r2012b209],
33	of	IN	O	of	_	0	SENT_81	[p8l2067t140r2153b209],
34	subjects	NNS	O	subject	prep_of	32	SENT_81	[p8l11t259r316b349],
35	(	JJ	O	(	dep	36	SENT_81	[p8l353t259r591b345],
36	male	NN	O	male	amod	34	SENT_81	[p8l353t259r591b345],
37	:	:	O	:	_	0	SENT_81	[p8l353t259r591b345],
38	n	NN	O	n	dep	21	SENT_81	[p8l628t283r674b329],
39	=	JJ	O	=	amod	38	SENT_81	[p8l709t286r776b311],
40	12-14	CD	NUMBER	12-14	tmod	39	SENT_81	[p8l820t260r1075b341],
41	,	,	O	,	_	0	SENT_81	[p8l820t260r1075b341],
42	female	NN	O	female	appos	38	SENT_81	[p8l1112t259r1396b329],
43	:	:	O	:	_	0	SENT_81	[p8l1112t259r1396b329],
44	n	NN	O	n	dep	21	SENT_81	[p8l1433t283r1479b329],
45	=	JJ	O	=	amod	47	SENT_81	[p8l1514t286r1581b311],
46	17	CD	NUMBER	17	tmod	45	SENT_81	[p8l1626t260r1764b345],
47	)	NN	O	)	dep	44	SENT_81	[p8l1626t260r1764b345],
48	.	.	O	.	_	0	SENT_81	[p8l1626t260r1764b345],

1	Thus	RB	O	thus	advmod	28	SENT_82	[p8l1802t259r2016b342],
2	,	,	O	,	_	0	SENT_82	[p8l1802t259r2016b342],
3	by	IN	O	by	_	0	SENT_82	[p8l2048t259r2145b349],
4	increasing	VBG	O	increase	prepc_by	28	SENT_82	[p8l7t378r405b468],
5	the	DT	O	the	det	6	SENT_82	[p8l441t378r558b448],
6	number	NN	O	number	dobj	4	SENT_82	[p8l595t378r894b448],
7	of	IN	O	of	_	0	SENT_82	[p8l929t378r1014b448],
8	both	DT	O	both	det	23	SENT_82	[p8l1042t378r1215b448],
9	gender	NN	O	gender	nn	10	SENT_82	[p8l1252t378r1516b468],
10	subjects	NNS	O	subject	nn	23	SENT_82	[p8l1554t378r1860b468],
11	(	JJ	O	(	dep	12	SENT_82	[p8l1901t378r2138b464],
12	male	NN	O	male	amod	10	SENT_82	[p8l1901t378r2138b464],
13	:	:	O	:	_	0	SENT_82	[p8l1901t378r2138b464],
14	n	NN	O	n	dep	10	SENT_82	[p8l7t521r53b566],
15	=	JJ	O	=	amod	14	SENT_82	[p8l88t524r155b549],
16	28	CD	NUMBER	28	tmod	15	SENT_82	[p8l191t497r307b579],
17	,	,	O	,	_	0	SENT_82	[p8l191t497r307b579],
18	female	NN	O	female	appos	14	SENT_82	[p8l346t497r630b566],
19	:	:	O	:	_	0	SENT_82	[p8l346t497r630b566],
20	n	NN	O	n	dep	10	SENT_82	[p8l672t521r717b566],
21	=	JJ	O	=	amod	20	SENT_82	[p8l752t524r819b549],
22	48	CD	NUMBER	48	tmod	21	SENT_82	[p8l853t497r1004b582],
23	)	NN	O	)	prep_of	6	SENT_82	[p8l853t497r1004b582],
24	,	,	O	,	_	0	SENT_82	[p8l853t497r1004b582],
25	the	DT	O	the	det	27	SENT_82	[p8l1043t497r1159b566],
26	present	JJ	DATE	present	amod	27	SENT_82	[p8l1194t507r1475b587],
27	study	NN	O	study	nsubj	28	SENT_82	[p8l1512t497r1716b587],
28	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_82	[p8l1752t496r2147b566],
29	that	IN	O	that	complm	37	SENT_82	[p8l7t616r154b685],
30	the	DT	O	the	det	32	SENT_82	[p8l185t616r302b685],
31	prolactin	NN	O	prolactin	nn	32	SENT_82	[p8l335t616r681b706],
32	response	NN	O	response	nsubj	37	SENT_82	[p8l713t638r1052b706],
33	to	TO	O	to	_	0	SENT_82	[p8l1085t626r1159b685],
34	haloperidol	NN	O	haloperidol	prep_to	32	SENT_82	[p8l1192t616r1633b706],
35	is	VBZ	O	be	cop	37	SENT_82	[p8l1667t616r1729b685],
36	obviously	RB	O	obviously	advmod	37	SENT_82	[p8l1765t616r2145b706],
37	heterogeneous	JJ	O	heterogeneous	ccomp	28	SENT_82	[p8l7t735r566b825],
38	with	IN	O	with	mark	39	SENT_82	[p8l595t735r766b805],
39	regards	VBZ	O	regard	advcl	37	SENT_82	[p8l791t735r1074b825],
40	to	TO	O	to	aux	41	SENT_82	[p8l1102t746r1176b805],
41	gender	VB	O	gender	xcomp	39	SENT_82	[p8l1204t735r1469b825],
42	difference	NN	O	difference	dobj	41	SENT_82	[p8l1494t735r1900b805],
43	.	.	O	.	_	0	SENT_82	[p8l1494t735r1900b805],

1	In	IN	O	in	_	0	SENT_83	[p8l107t856r187b923],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_83	[p8l227t854r676b936],
3	,	,	O	,	_	0	SENT_83	[p8l227t854r676b936],
4	this	DT	O	this	det	5	SENT_83	[p8l719t854r858b924],
5	study	NN	O	study	nsubj	6	SENT_83	[p8l903t854r1111b944],
6	suggests	VBZ	O	suggest	_	0	SENT_83	[p8l1155t865r1483b944],
7	that	IN	O	that	complm	13	SENT_83	[p8l1525t854r1673b924],
8	the	DT	O	the	det	12	SENT_83	[p8l1711t854r1830b924],
9	genetically	RB	O	genetically	advmod	10	SENT_83	[p8l1871t854r2142b944, p8l9t973r199b1063],
10	determined	VBN	O	determine	amod	12	SENT_83	[p8l237t973r683b1042],
11	CYP2D6	NN	O	cyp2d6	nn	12	SENT_83	[p8l720t973r1079b1043],
12	activity	NN	O	activity	nsubj	13	SENT_83	[p8l1119t973r1414b1063],
13	has	VBZ	O	have	ccomp	6	SENT_83	[p8l1450t973r1578b1042],
14	an	DT	O	a	det	15	SENT_83	[p8l1619t995r1709b1042],
15	impact	NN	O	impact	dobj	13	SENT_83	[p8l1745t973r2016b1063],
16	on	IN	O	on	_	0	SENT_83	[p8l2053t995r2148b1042],
17	prolactin	NN	O	prolactin	nn	18	SENT_83	[p8l7t1092r360b1182],
18	response	NN	O	response	prep_on	15	SENT_83	[p8l387t1114r732b1182],
19	to	TO	O	to	_	0	SENT_83	[p8l761t1102r835b1161],
20	haloperidol	NN	O	haloperidol	nn	21	SENT_83	[p8l864t1092r1315b1182],
21	treatment	NN	O	treatment	prep_to	18	SENT_83	[p8l1344t1102r1721b1161],
22	via	IN	O	via	_	0	SENT_83	[p8l1748t1092r1868b1161],
23	alteration	NN	O	alteration	prep_via	21	SENT_83	[p8l1897t1092r2145b1161, p8l8t1211r161b1281],
24	in	IN	O	in	_	0	SENT_83	[p8l213t1211r288b1280],
25	plasma	NN	O	plasma	nn	27	SENT_83	[p8l340t1211r621b1301],
26	drug	NN	O	drug	nn	27	SENT_83	[p8l675t1211r852b1301],
27	concentrations	NNS	O	concentration	prep_in	21	SENT_83	[p8l907t1211r1483b1281],
28	only	RB	O	only	advmod	21	SENT_83	[p8l1539t1211r1711b1301],
29	in	IN	O	in	_	0	SENT_83	[p8l1765t1211r1840b1280],
30	males	NNS	O	male	prep_in	28	SENT_83	[p8l1892t1211r2144b1293],
31	,	,	O	,	_	0	SENT_83	[p8l1892t1211r2144b1293],
32	Whereas	IN	O	whereas	mark	37	SENT_83	[p8l9t1330r329b1400],
33	pharmacodynamic	JJ	O	pharmacodynamic	amod	34	SENT_83	[p8l359t1330r1093b1420],
34	factors	NNS	O	factor	nsubj	37	SENT_83	[p8l1125t1330r1390b1399],
35	are	VBP	O	be	cop	37	SENT_83	[p8l1424t1352r1540b1399],
36	more	RBR	O	more	advmod	37	SENT_83	[p8l1570t1352r1772b1399],
37	involved	VBN	O	involve	dep	28	SENT_83	[p8l1802t1330r2148b1400],
38	in	IN	O	in	_	0	SENT_83	[p8l8t1448r83b1517],
39	prolactin	NN	O	prolactin	nn	40	SENT_83	[p8l114t1449r467b1539],
40	response	NN	O	response	prep_in	37	SENT_83	[p8l499t1471r844b1539],
41	in	IN	O	in	_	0	SENT_83	[p8l878t1448r953b1517],
42	females	NNS	O	female	prep_in	37	SENT_83	[p8l986t1449r1312b1518],
43	.	.	O	.	_	0	SENT_83	[p8l986t1449r1312b1518],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_84	[p8l8t1718r790b1808],

1	This	DT	O	this	det	2	SENT_85	[p8l108t1957r280b2027],
2	study	NN	O	study	nsubjpass	4	SENT_85	[p8l313t1957r521b2047],
3	was	VBD	O	be	auxpass	4	SENT_85	[p8l550t1980r699b2027],
4	supported	VBN	O	support	_	0	SENT_85	[p8l732t1957r1119b2047],
5	by	IN	O	by	_	0	SENT_85	[p8l1145t1957r1243b2047],
6	a	DT	O	a	det	7	SENT_85	[p8l1272t1980r1313b2027],
7	grant	NN	O	grant	agent	4	SENT_85	[p8l1341t1968r1543b2047],
8	from	IN	O	from	_	0	SENT_85	[p8l1570t1957r1761b2027],
9	the	DT	O	the	det	12	SENT_85	[p8l1788t1957r1907b2027],
10	Hirosaki	NNP	ORGANIZATION	Hirosaki	nn	12	SENT_85	[p8l1935t1957r2145b2027, p8l12t2075r165b2144],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_85	[p8l198t2075r560b2144],
12	Institute	NNP	ORGANIZATION	Institute	prep_from	7	SENT_85	[p8l594t2075r916b2144],
13	for	IN	ORGANIZATION	for	_	0	SENT_85	[p8l951t2075r1065b2144],
14	Neurosciences	NNP	ORGANIZATION	Neurosciences	prep_for	4	SENT_85	[p8l1096t2075r1693b2144],
15	.	.	O	.	_	0	SENT_85	[p8l1096t2075r1693b2144],

1	References	NNS	O	reference	_	0	SENT_86	[p8l9t2323r468b2393],

1	American	JJ	ORGANIZATION	american	amod	3	SENT_87	[p8l8t2560r319b2615],
2	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	3	SENT_87	[p8l343t2560r693b2632],
3	Association	NNP	ORGANIZATION	Association	_	0	SENT_87	[p8l717t2559r1107b2625],
4	,	,	O	,	_	0	SENT_87	[p8l717t2559r1107b2625],
5	1994	CD	DATE	1994	appos	3	SENT_87	[p8l1142t2560r1307b2616],
6	.	.	O	.	_	0	SENT_87	[p8l1142t2560r1307b2616],

1	Diagnostic	JJ	MISC	diagnostic	amod	4	SENT_88	[p8l1334t2560r1675b2632],
2	and	CC	O	and	_	0	SENT_88	[p8l1701t2560r1813b2615],
3	Statistical	JJ	O	statistical	conj_and	1	SENT_88	[p8l1839t2559r2148b2615],
4	Manual	NN	O	manual	_	0	SENT_88	[p8l126t2659r367b2714],
5	of	IN	O	of	_	0	SENT_88	[p8l410t2659r479b2714],
6	Mental	JJ	O	mental	amod	7	SENT_88	[p8l515t2659r738b2714],
7	Disorders	NNS	O	disorder	prep_of	4	SENT_88	[p8l780t2659r1102b2714],
8	.	.	O	.	_	0	SENT_88	[p8l780t2659r1102b2714],

1	.	.	O	.	_	0	SENT_89	[p8l1152t2705r1161b2714],

1	4th	JJ	ORDINAL	4th	_	0	SENT_90	[p8l1207t2659r1307b2714],
2	ed	VBN	O	ed	dep	1	SENT_90	[p8l1350t2659r1756b2714],
3	.	.	O	.	_	0	SENT_90	[p8l1350t2659r1756b2714],

1	American	JJ	ORGANIZATION	american	amod	3	SENT_91	[p8l1350t2659r1756b2714],
2	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	3	SENT_91	[p8l1797t2659r2147b2731],
3	Association	NNP	ORGANIZATION	Association	_	0	SENT_91	[p8l126t2758r516b2823],
4	,	,	O	,	_	0	SENT_91	[p8l126t2758r516b2823],
5	Washington	NNP	LOCATION	Washington	nn	7	SENT_91	[p8l544t2758r943b2830],
6	,	,	O	,	_	0	SENT_91	[p8l544t2758r943b2830],
7	DC	NNP	ORGANIZATION	DC	appos	3	SENT_91	[p8l971t2758r1095b2813],
8	.	.	O	.	_	0	SENT_91	[p8l971t2758r1095b2813],

1	Bertilsson	NNP	PERSON	Bertilsson	nn	7	SENT_92	[p8l8t2856r344b2922],
2	,	,	O	,	_	0	SENT_92	[p8l8t2856r344b2922],
3	L.	NNP	O	L.	appos	7	SENT_92	[p8l369t2857r453b2922],
4	,	,	O	,	_	0	SENT_92	[p8l369t2857r453b2922],
5	Dahl	NNP	PERSON	Dahl	appos	7	SENT_92	[p8l477t2856r646b2922],
6	,	,	O	,	_	0	SENT_92	[p8l477t2856r646b2922],
7	M.L.	NNP	LOCATION	M.L.	_	0	SENT_92	[p8l671t2857r845b2922],
8	,	,	O	,	_	0	SENT_92	[p8l671t2857r845b2922],
9	1996	CD	DATE	1996	appos	7	SENT_92	[p8l877t2856r1042b2913],
10	.	.	O	.	_	0	SENT_92	[p8l877t2856r1042b2913],

1	Polymorphic	JJ	MISC	polymorphic	amod	3	SENT_93	[p8l1068t2856r1473b2928],
2	drug	NN	O	drug	nn	3	SENT_93	[p8l1498t2856r1639b2928],
3	oxidation	NN	O	oxidation	_	0	SENT_93	[p8l1663t2856r1977b2911],
4	:	:	O	:	_	0	SENT_93	[p8l1663t2856r1977b2911],
5	relevance	NN	O	relevance	dep	3	SENT_93	[p8l2004t2856r2146b2911, p8l127t2973r310b3011],
6	to	TO	O	to	_	0	SENT_93	[p8l351t2964r410b3011],
7	the	DT	O	the	det	10	SENT_93	[p8l452t2956r547b3011],
8	treatment	NN	O	treatment	nn	10	SENT_93	[p8l589t2964r889b3011],
9	psychiatric	JJ	O	psychiatric	amod	10	SENT_93	[p8l928t2956r1275b3028],
10	disorders	NNS	O	disorder	prep_to	5	SENT_93	[p8l1318t2956r1621b3011],
11	.	.	O	.	_	0	SENT_93	[p8l1318t2956r1621b3011],

1	CNS	NNS	O	cn	nn	2	SENT_94	[p8l1668t2956r1815b3011],
2	Drugs	NNS	O	drug	_	0	SENT_94	[p8l1859t2957r2048b3028],
3	5	CD	NUMBER	5	dep	2	SENT_94	[p8l2092t2956r2145b3021],
4	,	,	O	,	_	0	SENT_94	[p8l2092t2956r2145b3021],
5	200-223	CD	NUMBER	200-223	appos	3	SENT_94	[p8l128t3054r428b3109],
6	.	.	O	.	_	0	SENT_94	[p8l128t3054r428b3109],

1	Bowen	NNP	PERSON	Bowen	nn	15	SENT_95	[p8l8t3153r247b3218],
2	,	,	O	,	_	0	SENT_95	[p8l8t3153r247b3218],
3	W.D.	NNP	LOCATION	W.D.	appos	15	SENT_95	[p8l285t3153r472b3218],
4	,	,	O	,	_	0	SENT_95	[p8l285t3153r472b3218],
5	Moses	NNP	PERSON	Moses	appos	15	SENT_95	[p8l510t3153r731b3218],
6	,	,	O	,	_	0	SENT_95	[p8l510t3153r731b3218],
7	E.L.	NNP	LOCATION	E.L.	appos	15	SENT_95	[p8l769t3153r922b3218],
8	,	,	O	,	_	0	SENT_95	[p8l769t3153r922b3218],
9	Tolentino	NNP	PERSON	Tolentino	appos	15	SENT_95	[p8l961t3152r1284b3218],
10	,	,	O	,	_	0	SENT_95	[p8l961t3152r1284b3218],
11	P.J.	NNP	PERSON	P.J.	appos	15	SENT_95	[p8l1323t3153r1452b3218],
12	,	,	O	,	_	0	SENT_95	[p8l1323t3153r1452b3218],
13	Walker	NNP	PERSON	Walker	appos	15	SENT_95	[p8l1490t3152r1740b3218],
14	,	,	O	,	_	0	SENT_95	[p8l1490t3152r1740b3218],
15	J.M.	NNP	O	J.M.	_	0	SENT_95	[p8l1778t3153r1933b3218],
16	,	,	O	,	_	0	SENT_95	[p8l1778t3153r1933b3218],
17	1990	CD	DATE	1990	appos	15	SENT_95	[p8l1980t3152r2145b3209],
18	.	.	O	.	_	0	SENT_95	[p8l1980t3152r2145b3209],

1	Metabolite	NN	O	metabolite	nsubj	4	SENT_96	[p8l126t3251r469b3307],
2	of	IN	O	of	_	0	SENT_96	[p8l517t3251r585b3307],
3	haloperidol	NN	O	haloperidol	prep_of	1	SENT_96	[p8l625t3251r986b3323],
4	display	NN	O	display	_	0	SENT_96	[p8l1033t3251r1259b3323],
5	preferential	JJ	O	preferential	amod	6	SENT_96	[p8l1304t3251r1670b3323],
6	activity	NN	O	activity	dobj	4	SENT_96	[p8l1718t3251r1954b3323],
7	at	IN	O	at	_	0	SENT_96	[p8l2001t3260r2056b3307],
8	o	NN	O	o	prep_at	6	SENT_96	[p8l2103t3271r2147b3307],
9	'	''	O	'	_	0	SENT_96	[p8l2103t3271r2147b3307],
10	receptors	NNS	O	receptor	dep	4	SENT_96	[p8l125t3359r415b3423],
11	compared	VBN	O	compare	_	0	SENT_96	[p8l448t3351r760b3423],
12	to	TO	O	to	prepc_compared_to	10	SENT_96	[p8l792t3359r851b3406],
13	D-2	NN	O	d-2	nn	14	SENT_96	[p8l884t3351r1004b3405],
14	receptors	NNS	O	receptor	pobj	10	SENT_96	[p8l1036t3359r1342b3423],
15	.	.	O	.	_	0	SENT_96	[p8l1036t3359r1342b3423],

1	Eur	NNP	O	Eur	_	0	SENT_97	[p8l1377t3352r1506b3406],
2	.	.	O	.	_	0	SENT_97	[p8l1377t3352r1506b3406],

1	J	NN	O	j	_	0	SENT_98	[p8l1541t3352r1570b3406],
2	.	.	O	.	_	0	SENT_98	[p8l1577t3397r1586b3406],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_99	[p8l1622t3351r1975b3406],
2	.	.	O	.	_	0	SENT_99	[p8l1622t3351r1975b3406],

1	177	CD	NUMBER	177	_	0	SENT_100	[p8l2019t3351r2146b3416],
2	,	,	O	,	_	0	SENT_100	[p8l2019t3351r2146b3416],
3	111-118	CD	NUMBER	111-118	appos	1	SENT_100	[p8l134t3448r428b3503],
4	.	.	O	.	_	0	SENT_100	[p8l134t3448r428b3503],

1	Heim	NNP	PERSON	Heim	nn	7	SENT_101	[p8l8t3547r199b3613],
2	,	,	O	,	_	0	SENT_101	[p8l8t3547r199b3613],
3	M.	NNP	O	M.	appos	7	SENT_101	[p8l226t3548r331b3613],
4	,	,	O	,	_	0	SENT_101	[p8l226t3548r331b3613],
5	Meyer	NNP	PERSON	Meyer	appos	7	SENT_101	[p8l358t3548r581b3619],
6	,	,	O	,	_	0	SENT_101	[p8l358t3548r581b3619],
7	U.A.	NNP	LOCATION	U.A.	_	0	SENT_101	[p8l608t3548r776b3613],
8	,	,	O	,	_	0	SENT_101	[p8l608t3548r776b3613],
9	1990	CD	DATE	1990	appos	7	SENT_101	[p8l811t3548r975b3604],
10	.	.	O	.	_	0	SENT_101	[p8l811t3548r975b3604],

1	Genotyping	NN	O	genotyping	_	0	SENT_102	[p8l1004t3547r1375b3619],
2	of	IN	O	of	_	0	SENT_102	[p8l1401t3547r1470b3603],
3	poor	JJ	O	poor	amod	4	SENT_102	[p8l1487t3565r1633b3619],
4	metabolizers	NNS	O	metabolizer	prep_of	1	SENT_102	[p8l1656t3547r2059b3603],
5	of	IN	O	of	_	0	SENT_102	[p8l2085t3547r2153b3603],
6	debrisoquine	NN	O	debrisoquine	prep_of	1	SENT_102	[p8l127t3647r534b3719],
7	by	IN	O	by	_	0	SENT_102	[p8l560t3647r638b3719],
8	allele-speciﬁc	JJ	O	allele-speciﬁc	amod	10	SENT_102	[p8l666t3647r1104b3719],
9	PCR	NN	O	pcr	nn	10	SENT_102	[p8l1131t3647r1280b3702],
10	ampliﬁcation	NN	O	ampliﬁcation	prep_by	1	SENT_102	[p8l1308t3647r1740b3719],
11	.	.	O	.	_	0	SENT_102	[p8l1308t3647r1740b3719],

1	Lancet	NNP	O	Lancet	_	0	SENT_103	[p8l1769t3648r1986b3702],
2	336	CD	NUMBER	336	num	1	SENT_103	[p8l2014t3647r2146b3712],
3	,	,	O	,	_	0	SENT_103	[p8l2014t3647r2146b3712],
4	529-532	CD	NUMBER	529-532	appos	1	SENT_103	[p8l128t3744r428b3800],
5	.	.	O	.	_	0	SENT_103	[p8l128t3744r428b3800],

1	Hikida	NNP	PERSON	Hikida	nn	19	SENT_104	[p9l8t33r239b99],
2	,	,	O	,	_	0	SENT_104	[p9l8t33r239b99],
3	K.	NNP	O	K.	appos	19	SENT_104	[p9l267t34r357b99],
4	,	,	O	,	_	0	SENT_104	[p9l267t34r357b99],
5	Inoue	NNP	PERSON	Inoue	appos	19	SENT_104	[p9l384t34r580b99],
6	,	,	O	,	_	0	SENT_104	[p9l384t34r580b99],
7	Y.	NNP	O	Y.	appos	19	SENT_104	[p9l607t34r698b99],
8	,	,	O	,	_	0	SENT_104	[p9l607t34r698b99],
9	Miyazaki	NNP	PERSON	Miyazaki	appos	19	SENT_104	[p9l724t33r1040b105],
10	,	,	O	,	_	0	SENT_104	[p9l724t33r1040b105],
11	T.	NNP	O	T.	appos	19	SENT_104	[p9l1067t34r1150b99],
12	,	,	O	,	_	0	SENT_104	[p9l1067t34r1150b99],
13	Kojima	NNP	PERSON	Kojima	appos	19	SENT_104	[p9l1178t33r1430b105],
14	,	,	O	,	_	0	SENT_104	[p9l1178t33r1430b105],
15	N.	NNP	O	N.	appos	19	SENT_104	[p9l1456t34r1548b99],
16	,	,	O	,	_	0	SENT_104	[p9l1456t34r1548b99],
17	Ohkura	NNP	LOCATION	Ohkura	appos	19	SENT_104	[p9l1576t33r1828b99],
18	,	,	O	,	_	0	SENT_104	[p9l1576t33r1828b99],
19	Y.	NNP	O	Y.	_	0	SENT_104	[p9l1854t34r1945b99],
20	,	,	O	,	_	0	SENT_104	[p9l1854t34r1945b99],
21	1989	CD	DATE	1989	appos	19	SENT_104	[p9l1980t34r2145b90],
22	.	.	O	.	_	0	SENT_104	[p9l1980t34r2145b90],

1	Determination	NN	O	determination	_	0	SENT_105	[p9l126t132r584b188],
2	of	IN	O	of	_	0	SENT_105	[p9l612t132r680b188],
3	bromperidol	NN	O	bromperidol	prep_of	1	SENT_105	[p9l701t132r1092b204],
4	in	IN	O	in	_	0	SENT_105	[p9l1119t132r1179b187],
5	serum	NN	O	serum	prep_in	1	SENT_105	[p9l1209t150r1399b188],
6	by	IN	O	by	_	0	SENT_105	[p9l1424t132r1502b204],
7	automated	VBN	O	automate	prep_by	1	SENT_105	[p9l1531t132r1860b188],
8	columnswitching	VBG	O	columnswitch	partmod	7	SENT_105	[p9l1887t132r2147b188, p9l129t231r433b303],
9	high-performance	JJ	O	high-performance	amod	11	SENT_105	[p9l452t231r1019b303],
10	liquid	JJ	O	liquid	amod	11	SENT_105	[p9l1039t231r1224b303],
11	chromatography	NN	O	chromatography	dobj	8	SENT_105	[p9l1243t231r1777b303],
12	.	.	O	.	_	0	SENT_105	[p9l1243t231r1777b303],

1	J.	NNP	PERSON	J.	nn	2	SENT_106	[p9l1800t232r1845b287],
2	Chromatogr	NNP	PERSON	Chromatogr	_	0	SENT_106	[p9l1870t231r2147b287, p9l126t338r268b402],
3	.	.	O	.	_	0	SENT_106	[p9l1870t231r2147b287, p9l126t338r268b402],

1	495	CD	NUMBER	495	_	0	SENT_107	[p9l297t330r432b396],
2	,	,	O	,	_	0	SENT_107	[p9l297t330r432b396],
3	227-234	CD	NUMBER	227-234	appos	1	SENT_107	[p9l461t330r761b386],
4	.	.	O	.	_	0	SENT_107	[p9l461t330r761b386],

1	Johansson	NNP	PERSON	Johansson	_	0	SENT_108	[p9l8t429r348b495],
2	,	,	O	,	_	0	SENT_108	[p9l8t429r348b495],
3	1.	CD	NUMBER	1.	appos	1	SENT_108	[p9l374t430r435b495],
4	,	,	O	,	_	0	SENT_108	[p9l374t430r435b495],
5	Oscarson	NNP	PERSON	Oscarson	nn	23	SENT_108	[p9l462t430r770b495],
6	,	,	O	,	_	0	SENT_108	[p9l462t430r770b495],
7	M.	NNP	O	M.	appos	23	SENT_108	[p9l795t430r901b495],
8	,	,	O	,	_	0	SENT_108	[p9l795t430r901b495],
9	Yue	NNP	O	Yue	appos	23	SENT_108	[p9l927t430r1074b495],
10	,	,	O	,	_	0	SENT_108	[p9l927t430r1074b495],
11	Q.Y.	NNP	O	Q.Y.	appos	23	SENT_108	[p9l1102t430r1269b498],
12	,	,	O	,	_	0	SENT_108	[p9l1102t430r1269b498],
13	Bertilsson	NNP	PERSON	Bertilsson	appos	23	SENT_108	[p9l1295t429r1630b495],
14	,	,	O	,	_	0	SENT_108	[p9l1295t429r1630b495],
15	L.	NNP	O	L.	appos	23	SENT_108	[p9l1657t430r1740b495],
16	,	,	O	,	_	0	SENT_108	[p9l1657t430r1740b495],
17	Sjoqvist	NNP	O	Sjoqvist	appos	23	SENT_108	[p9l1768t429r2041b501],
18	,	,	O	,	_	0	SENT_108	[p9l1768t429r2041b501],
19	F.	NNP	O	F.	appos	23	SENT_108	[p9l2067t430r2146b495],
20	,	,	O	,	_	0	SENT_108	[p9l2067t430r2146b495],
21	Ingelman-Sundberg	NNP	PERSON	Ingelman-Sundberg	appos	23	SENT_108	[p9l126t528r772b600],
22	,	,	O	,	_	0	SENT_108	[p9l126t528r772b600],
23	M.	NNP	O	M.	appos	1	SENT_108	[p9l799t530r905b594],
24	,	,	O	,	_	0	SENT_108	[p9l799t530r905b594],
25	1994	CD	DATE	1994	appos	1	SENT_108	[p9l941t529r1105b585],
26	.	.	O	.	_	0	SENT_108	[p9l941t529r1105b585],

1	Genetic	JJ	O	genetic	amod	2	SENT_109	[p9l1136t528r1379b584],
2	analysis	NN	O	analysis	_	0	SENT_109	[p9l1407t528r1658b600],
3	of	IN	O	of	_	0	SENT_109	[p9l1686t528r1754b584],
4	the	DT	O	the	det	8	SENT_109	[p9l1774t528r1869b584],
5	Chinese	JJ	MISC	chinese	amod	8	SENT_109	[p9l1896t528r2147b584],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_109	[p9l127t627r500b699],
7	P4502D	NN	O	p4502d	nn	8	SENT_109	[p9l521t627r778b683],
8	locus	NN	O	locus	prep_of	2	SENT_109	[p9l799t627r981b682],
9	:	:	O	:	_	0	SENT_109	[p9l799t627r981b682],
10	characterization	NN	O	characterization	dep	2	SENT_109	[p9l1008t627r1515b682],
11	of	IN	O	of	_	0	SENT_109	[p9l1536t627r1605b682],
12	Variant	JJ	O	variant	amod	14	SENT_109	[p9l1621t627r1841b682],
13	CYP2D6	NN	O	cyp2d6	nn	14	SENT_109	[p9l1862t627r2148b683],
14	genes	NNS	O	gene	prep_of	10	SENT_109	[p9l127t744r304b798],
15	present	JJ	DATE	present	amod	10	SENT_109	[p9l329t735r559b798],
16	in	IN	O	in	_	0	SENT_109	[p9l583t726r643b781],
17	subjects	NNS	O	subject	prep_in	15	SENT_109	[p9l670t726r920b798],
18	with	IN	O	with	_	0	SENT_109	[p9l947t726r1086b782],
19	diminished	VBN	O	diminish	amod	20	SENT_109	[p9l1111t726r1462b782],
20	capacity	NN	O	capacity	prep_with	17	SENT_109	[p9l1487t726r1749b798],
21	for	IN	O	for	_	0	SENT_109	[p9l1776t726r1867b782],
22	debrisoquine	NN	O	debrisoquine	nn	23	SENT_109	[p9l1891t726r2146b782, p9l127t825r301b897],
23	hydroxylation	NN	O	hydroxylation	prep_for	20	SENT_109	[p9l326t825r786b897],
24	.	.	O	.	_	0	SENT_109	[p9l326t825r786b897],

1	M01	NN	O	m01	_	0	SENT_110	[p9l816t825r962b881],
2	.	.	O	.	_	0	SENT_110	[p9l816t825r962b881],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_111	[p9l991t825r1344b881],
2	.	.	O	.	_	0	SENT_111	[p9l991t825r1344b881],

1	46	CD	NUMBER	46	_	0	SENT_112	[p9l1374t825r1468b891],
2	,	,	O	,	_	0	SENT_112	[p9l1374t825r1468b891],
3	452-458	CD	NUMBER	452-458	appos	1	SENT_112	[p9l1497t825r1798b881],
4	.	.	O	.	_	0	SENT_112	[p9l1497t825r1798b881],

1	LLerena	NNP	PERSON	LLerena	_	0	SENT_113	[p9l8t925r293b989],
2	,	,	O	,	_	0	SENT_113	[p9l8t925r293b989],
3	A.	NN	O	a.	appos	1	SENT_113	[p9l316t924r408b989],
4	,	,	O	,	_	0	SENT_113	[p9l316t924r408b989],
5	Alm	NNP	PERSON	Alm	nn	19	SENT_113	[p9l432t923r589b989],
6	,	,	O	,	_	0	SENT_113	[p9l432t923r589b989],
7	C.	NNP	O	C.	appos	19	SENT_113	[p9l614t924r700b989],
8	,	,	O	,	_	0	SENT_113	[p9l614t924r700b989],
9	Dahl	NNP	PERSON	Dahl	appos	19	SENT_113	[p9l724t924r894b989],
10	,	,	O	,	_	0	SENT_113	[p9l724t924r894b989],
11	M.L.	NNP	LOCATION	M.L.	appos	19	SENT_113	[p9l917t925r1091b989],
12	,	,	O	,	_	0	SENT_113	[p9l917t925r1091b989],
13	Eqvist	NNP	O	Eqvist	appos	19	SENT_113	[p9l1114t923r1333b996],
14	,	,	O	,	_	0	SENT_113	[p9l1114t923r1333b996],
15	B.	NNP	O	B.	appos	19	SENT_113	[p9l1357t925r1445b989],
16	,	,	O	,	_	0	SENT_113	[p9l1357t925r1445b989],
17	Bertilsson	NNP	PERSON	Bertilsson	appos	19	SENT_113	[p9l1469t924r1805b989],
18	,	,	O	,	_	0	SENT_113	[p9l1469t924r1805b989],
19	L.	NNP	O	L.	appos	1	SENT_113	[p9l1829t925r1912b989],
20	,	,	O	,	_	0	SENT_113	[p9l1829t925r1912b989],
21	1992a	CD	DATE	1992a	appos	1	SENT_113	[p9l1944t924r2145b980],
22	.	.	O	.	_	0	SENT_113	[p9l1944t924r2145b980],

1	Haloperidol	NNP	O	Haloperidol	nn	2	SENT_114	[p9l127t1022r504b1094],
2	disposition	NN	O	disposition	nsubj	4	SENT_114	[p9l530t1022r876b1094],
3	is	VBZ	O	be	cop	4	SENT_114	[p9l900t1022r949b1078],
4	dependent	JJ	O	dependent	_	0	SENT_114	[p9l976t1022r1301b1094],
5	on	IN	O	on	_	0	SENT_114	[p9l1326t1040r1403b1078],
6	debrisoquine	NN	O	debrisoquine	nn	8	SENT_114	[p9l1429t1022r1834b1094],
7	hydroXylation	NN	O	hydroxylation	nn	8	SENT_114	[p9l1859t1022r2147b1094, p9l127t1121r306b1177],
8	phenotype	NN	O	phenotype	prep_on	4	SENT_114	[p9l331t1121r676b1193],
9	.	.	O	.	_	0	SENT_114	[p9l331t1121r676b1193],

1	Ther	NNP	O	Ther	_	0	SENT_115	[p9l706t1121r870b1177],
2	.	.	O	.	_	0	SENT_115	[p9l706t1121r870b1177],

1	Drug	NN	O	drug	_	0	SENT_116	[p9l900t1123r1060b1193],
2	Monit	NN	O	monit	dep	1	SENT_116	[p9l1085t1121r1293b1177],
3	.	.	O	.	_	0	SENT_116	[p9l1085t1121r1293b1177],

1	14	CD	NUMBER	14	_	0	SENT_117	[p9l1331t1122r1417b1187],
2	,	,	O	,	_	0	SENT_117	[p9l1331t1122r1417b1187],
3	92-97	CD	NUMBER	92-97	appos	1	SENT_117	[p9l1447t1122r1667b1178],
4	.	.	O	.	_	0	SENT_117	[p9l1447t1122r1667b1178],

1	LLerena	NNP	PERSON	LLerena	_	0	SENT_118	[p9l8t1222r293b1286],
2	,	,	O	,	_	0	SENT_118	[p9l8t1222r293b1286],
3	A.	NN	O	a.	appos	1	SENT_118	[p9l315t1221r406b1286],
4	,	,	O	,	_	0	SENT_118	[p9l315t1221r406b1286],
5	Dahl	NNP	PERSON	Dahl	nn	15	SENT_118	[p9l429t1220r598b1286],
6	,	,	O	,	_	0	SENT_118	[p9l429t1220r598b1286],
7	M.L.	NNP	LOCATION	M.L.	appos	15	SENT_118	[p9l621t1222r795b1286],
8	,	,	O	,	_	0	SENT_118	[p9l621t1222r795b1286],
9	Eqvist	NNP	O	Eqvist	appos	15	SENT_118	[p9l817t1220r1035b1292],
10	,	,	O	,	_	0	SENT_118	[p9l817t1220r1035b1292],
11	B.	NNP	O	B.	appos	15	SENT_118	[p9l1057t1222r1145b1286],
12	,	,	O	,	_	0	SENT_118	[p9l1057t1222r1145b1286],
13	Bertilsson	NNP	PERSON	Bertilsson	appos	15	SENT_118	[p9l1167t1220r1504b1286],
14	,	,	O	,	_	0	SENT_118	[p9l1167t1220r1504b1286],
15	L.	NNP	O	L.	appos	1	SENT_118	[p9l1527t1222r1610b1286],
16	,	,	O	,	_	0	SENT_118	[p9l1527t1222r1610b1286],
17	1992b	CD	DATE	1992b	appos	1	SENT_118	[p9l1641t1220r1845b1277],
18	.	.	O	.	_	0	SENT_118	[p9l1641t1220r1845b1277],

1	Haloperidol	NNP	O	Haloperidol	nn	2	SENT_119	[p9l1869t1220r2147b1292, p9l126t1319r247b1375],
2	disposition	NN	O	disposition	nsubj	4	SENT_119	[p9l291t1319r637b1391],
3	is	VBZ	O	be	cop	4	SENT_119	[p9l678t1319r727b1375],
4	dependent	JJ	O	dependent	_	0	SENT_119	[p9l772t1319r1097b1391],
5	on	IN	O	on	_	0	SENT_119	[p9l1138t1337r1214b1375],
6	debrisoquine	NN	O	debrisoquine	nn	8	SENT_119	[p9l1257t1319r1663b1391],
7	hydroxylation	NN	O	hydroxylation	nn	8	SENT_119	[p9l1705t1319r2148b1391],
8	phenotype	NN	O	phenotype	prep_on	4	SENT_119	[p9l125t1418r472b1490],
9	:	:	O	:	_	0	SENT_119	[p9l125t1418r472b1490],
10	increased	VBN	O	increase	amod	12	SENT_119	[p9l509t1418r808b1474],
11	plasma	NN	O	plasma	nn	12	SENT_119	[p9l838t1418r1064b1490],
12	levels	NNS	O	level	dep	8	SENT_119	[p9l1094t1418r1276b1474],
13	of	IN	O	of	_	0	SENT_119	[p9l1311t1418r1379b1474],
14	the	DT	O	the	det	16	SENT_119	[p9l1406t1418r1501b1474],
15	reduced	VBN	O	reduce	amod	16	SENT_119	[p9l1532t1418r1783b1474],
16	metabolite	NN	O	metabolite	prep_of	12	SENT_119	[p9l1813t1418r2148b1474],
17	in	IN	O	in	_	0	SENT_119	[p9l126t1517r186b1572],
18	poor	JJ	O	poor	amod	19	SENT_119	[p9l211t1535r357b1589],
19	metabolizers	NNS	O	metabolizer	prep_in	16	SENT_119	[p9l381t1517r802b1573],
20	.	.	O	.	_	0	SENT_119	[p9l381t1517r802b1573],

1	Ther	NNP	O	Ther	_	0	SENT_120	[p9l831t1517r995b1573],
2	.	.	O	.	_	0	SENT_120	[p9l831t1517r995b1573],

1	Drug	NN	O	drug	_	0	SENT_121	[p9l1025t1519r1184b1589],
2	Monit	NN	O	monit	dep	1	SENT_121	[p9l1210t1517r1418b1573],
3	.	.	O	.	_	0	SENT_121	[p9l1210t1517r1418b1573],

1	14	CD	NUMBER	14	_	0	SENT_122	[p9l1456t1518r1543b1583],
2	,	,	O	,	_	0	SENT_122	[p9l1456t1518r1543b1583],
3	261-264	CD	NUMBER	261-264	appos	1	SENT_122	[p9l1572t1517r1872b1573],
4	.	.	O	.	_	0	SENT_122	[p9l1572t1517r1872b1573],

1	Mihara	NNP	PERSON	Mihara	_	0	SENT_123	[p9l8t1615r252b1681],
2	,	,	O	,	_	0	SENT_123	[p9l8t1615r252b1681],
3	K.	NNP	O	K.	appos	1	SENT_123	[p9l278t1617r369b1681],
4	,	,	O	,	_	0	SENT_123	[p9l278t1617r369b1681],
5	Suzuki	NNP	PERSON	Suzuki	appos	3	SENT_123	[p9l397t1615r630b1681],
6	,	,	O	,	_	0	SENT_123	[p9l397t1615r630b1681],
7	A.	NN	O	a.	appos	3	SENT_123	[p9l655t1616r747b1681],
8	,	,	O	,	_	0	SENT_123	[p9l655t1616r747b1681],
9	Kondo	NNP	PERSON	Kondo	nn	31	SENT_123	[p9l774t1616r1004b1681],
10	,	,	O	,	_	0	SENT_123	[p9l774t1616r1004b1681],
11	T.	NNP	O	T.	appos	31	SENT_123	[p9l1029t1617r1112b1681],
12	,	,	O	,	_	0	SENT_123	[p9l1029t1617r1112b1681],
13	Yasui	NNP	PERSON	Yasui	appos	31	SENT_123	[p9l1138t1616r1337b1681],
14	,	,	O	,	_	0	SENT_123	[p9l1138t1616r1337b1681],
15	N.	NNP	O	N.	appos	31	SENT_123	[p9l1362t1617r1454b1681],
16	,	,	O	,	_	0	SENT_123	[p9l1362t1617r1454b1681],
17	Nagashima	NNP	PERSON	Nagashima	appos	31	SENT_123	[p9l1479t1616r1852b1688],
18	,	,	O	,	_	0	SENT_123	[p9l1479t1616r1852b1688],
19	U.	NNP	O	U.	appos	31	SENT_123	[p9l1877t1617r1969b1681],
20	,	,	O	,	_	0	SENT_123	[p9l1877t1617r1969b1681],
21	Ono	NNP	PERSON	Ono	appos	31	SENT_123	[p9l1996t1616r2146b1681],
22	,	,	O	,	_	0	SENT_123	[p9l1996t1616r2146b1681],
23	S.	NNP	O	S.	appos	31	SENT_123	[p9l129t1714r205b1780],
24	,	,	O	,	_	0	SENT_123	[p9l129t1714r205b1780],
25	Otani	NNP	LOCATION	Otani	appos	31	SENT_123	[p9l244t1714r434b1780],
26	,	,	O	,	_	0	SENT_123	[p9l244t1714r434b1780],
27	K.	NNP	O	K.	appos	31	SENT_123	[p9l473t1715r563b1780],
28	,	,	O	,	_	0	SENT_123	[p9l473t1715r563b1780],
29	Kaneko	NNP	PERSON	Kaneko	appos	31	SENT_123	[p9l602t1714r862b1780],
30	,	,	O	,	_	0	SENT_123	[p9l602t1714r862b1780],
31	S.	NNP	O	S.	appos	3	SENT_123	[p9l902t1715r978b1780],
32	,	,	O	,	_	0	SENT_123	[p9l902t1715r978b1780],
33	1999	CD	DATE	1999	appos	3	SENT_123	[p9l1023t1715r1187b1771],
34	.	.	O	.	_	0	SENT_123	[p9l1023t1715r1187b1771],

1	Effects	NNS	O	effect	nsubj	16	SENT_124	[p9l1225t1714r1442b1770],
2	of	IN	O	of	_	0	SENT_124	[p9l1480t1714r1549b1770],
3	the	DT	O	the	det	4	SENT_124	[p9l1577t1714r1672b1770],
4	CYP2D6	NN	O	cyp2d6	prep_of	1	SENT_124	[p9l1708t1714r1994b1770],
5	*	CD	NUMBER	*	number	6	SENT_124	[p9l2018t1726r2048b1760],
6	10	CD	NUMBER	10	num	7	SENT_124	[p9l2079t1715r2148b1770],
7	allele	NN	O	allele	_	0	SENT_124	[p9l128t1813r297b1869],
8	on	IN	O	on	_	0	SENT_124	[p9l327t1831r404b1869],
9	the	DT	O	the	det	12	SENT_124	[p9l431t1813r526b1869],
10	steady-state	JJ	O	steady-state	amod	12	SENT_124	[p9l557t1813r927b1885],
11	plasma	NN	O	plasma	nn	12	SENT_124	[p9l954t1813r1180b1885],
12	concentrations	NNS	O	concentration	prep_on	7	SENT_124	[p9l1208t1813r1668b1869],
13	of	IN	O	of	_	0	SENT_124	[p9l1698t1813r1766b1869],
14	haloperidol	NN	O	haloperidol	prep_of	12	SENT_124	[p9l1788t1813r2148b1885],
15	and	CC	O	and	_	0	SENT_124	[p9l128t1911r240b1967],
16	reduced	VBD	O	reduce	conj_and	7	SENT_124	[p9l267t1911r519b1967],
17	haloperidol	NN	O	haloperidol	dobj	16	SENT_124	[p9l547t1912r908b1984],
18	in	IN	O	in	_	0	SENT_124	[p9l938t1911r998b1966],
19	Japanese	JJ	MISC	japanese	amod	20	SENT_124	[p9l1026t1913r1307b1984],
20	patients	NNS	O	patient	prep_in	16	SENT_124	[p9l1336t1912r1581b1984],
21	with	IN	O	with	_	0	SENT_124	[p9l1612t1912r1752b1967],
22	schizophrenia	NN	O	schizophrenia	prep_with	16	SENT_124	[p9l1783t1911r2147b1984, p9l126t2011r238b2067],
23	.	.	O	.	_	0	SENT_124	[p9l1783t1911r2147b1984, p9l126t2011r238b2067],

1	Clin	NNP	O	Clin	_	0	SENT_125	[p9l269t2011r418b2067],
2	.	.	O	.	_	0	SENT_125	[p9l269t2011r418b2067],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_126	[p9l448t2011r801b2067],
2	.	.	O	.	_	0	SENT_126	[p9l448t2011r801b2067],

1	Ther	NNP	O	Ther	_	0	SENT_127	[p9l831t2011r995b2067],
2	.	.	O	.	_	0	SENT_127	[p9l831t2011r995b2067],

1	65	CD	NUMBER	65	_	0	SENT_128	[p9l1026t2010r1119b2076],
2	,	,	O	,	_	0	SENT_128	[p9l1026t2010r1119b2076],
3	291-294	CD	NUMBER	291-294	appos	1	SENT_128	[p9l1149t2011r1448b2068],
4	.	.	O	.	_	0	SENT_128	[p9l1149t2011r1448b2068],

1	Mihara	NNP	PERSON	Mihara	nn	9	SENT_129	[p9l8t2109r252b2175],
2	,	,	O	,	_	0	SENT_129	[p9l8t2109r252b2175],
3	K.	NNP	O	K.	appos	9	SENT_129	[p9l278t2111r369b2175],
4	,	,	O	,	_	0	SENT_129	[p9l278t2111r369b2175],
5	Kondo	NNP	PERSON	Kondo	appos	9	SENT_129	[p9l396t2109r625b2175],
6	,	,	O	,	_	0	SENT_129	[p9l396t2109r625b2175],
7	T.	NNP	O	T.	appos	9	SENT_129	[p9l651t2111r734b2175],
8	,	,	O	,	_	0	SENT_129	[p9l651t2111r734b2175],
9	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_129	[p9l762t2109r995b2175],
10	,	,	O	,	_	0	SENT_129	[p9l762t2109r995b2175],
11	A.	NN	O	a.	appos	9	SENT_129	[p9l1020t2110r1112b2175],
12	,	,	O	,	_	0	SENT_129	[p9l1020t2110r1112b2175],
13	Yasui	NNP	PERSON	Yasui	nn	31	SENT_129	[p9l1138t2109r1337b2175],
14	,	,	O	,	_	0	SENT_129	[p9l1138t2109r1337b2175],
15	N.	NNP	O	N.	appos	31	SENT_129	[p9l1362t2111r1454b2175],
16	,	,	O	,	_	0	SENT_129	[p9l1362t2111r1454b2175],
17	Nagashima	NNP	PERSON	Nagashima	appos	31	SENT_129	[p9l1479t2109r1852b2181],
18	,	,	O	,	_	0	SENT_129	[p9l1479t2109r1852b2181],
19	U.	NNP	O	U.	appos	31	SENT_129	[p9l1877t2111r1969b2175],
20	,	,	O	,	_	0	SENT_129	[p9l1877t2111r1969b2175],
21	Ono	NNP	PERSON	Ono	appos	31	SENT_129	[p9l1996t2110r2146b2175],
22	,	,	O	,	_	0	SENT_129	[p9l1996t2110r2146b2175],
23	S.	NNP	O	S.	appos	31	SENT_129	[p9l129t2208r205b2273],
24	,	,	O	,	_	0	SENT_129	[p9l129t2208r205b2273],
25	Otani	NNP	LOCATION	Otani	appos	31	SENT_129	[p9l236t2208r426b2273],
26	,	,	O	,	_	0	SENT_129	[p9l236t2208r426b2273],
27	K.	NNP	O	K.	appos	31	SENT_129	[p9l456t2209r546b2273],
28	,	,	O	,	_	0	SENT_129	[p9l456t2209r546b2273],
29	Kaneko	NNP	PERSON	Kaneko	appos	31	SENT_129	[p9l576t2208r836b2273],
30	,	,	O	,	_	0	SENT_129	[p9l576t2208r836b2273],
31	S.	NNP	O	S.	appos	9	SENT_129	[p9l867t2208r944b2273],
32	,	,	O	,	_	0	SENT_129	[p9l867t2208r944b2273],
33	2000	CD	DATE	2000	appos	9	SENT_129	[p9l973t2208r1145b2263],
34	.	.	O	.	_	0	SENT_129	[p9l973t2208r1145b2263],

1	Prolactin	NN	O	prolactin	nn	2	SENT_130	[p9l1174t2208r1460b2263],
2	response	NN	O	response	_	0	SENT_130	[p9l1485t2225r1760b2280],
3	to	TO	O	to	_	0	SENT_130	[p9l1787t2216r1846b2263],
4	nemonapride	NN	O	nemonapride	prep_to	2	SENT_130	[p9l1872t2225r2147b2263, p9l126t2307r305b2379],
5	,	,	O	,	_	0	SENT_130	[p9l1872t2225r2147b2263, p9l126t2307r305b2379],
6	a	DT	O	a	det	8	SENT_130	[p9l334t2324r367b2362],
7	selective	JJ	O	selective	amod	8	SENT_130	[p9l394t2307r667b2362],
8	antagonist	NN	O	antagonist	appos	2	SENT_130	[p9l694t2307r1018b2379],
9	for	IN	O	for	_	0	SENT_130	[p9l1042t2307r1134b2362],
10	D2	NN	O	d2	prep_for	8	SENT_130	[p9l1157t2307r1251b2361],
11	like	IN	O	like	_	0	SENT_130	[p9l1277t2307r1393b2362],
12	dopamine	NN	O	dopamine	nn	13	SENT_130	[p9l1419t2307r1730b2379],
13	receptors	NNS	O	receptor	prep_like	10	SENT_130	[p9l1754t2315r2061b2379],
14	,	,	O	,	_	0	SENT_130	[p9l1754t2315r2061b2379],
15	in	IN	O	in	_	0	SENT_130	[p9l2088t2307r2149b2361],
16	schizophrenic	JJ	O	schizophrenic	amod	17	SENT_130	[p9l129t2405r565b2477],
17	patients	NNS	O	patient	prep_in	2	SENT_130	[p9l595t2405r840b2477],
18	in	IN	O	in	_	0	SENT_130	[p9l872t2405r932b2460],
19	relation	NN	O	relation	prep_in	17	SENT_130	[p9l962t2405r1204b2461],
20	to	TO	O	to	_	0	SENT_130	[p9l1235t2413r1294b2461],
21	T	NN	O	t	nn	24	SENT_130	[p9l1328t2407r1374b2460],
22	aq	NN	O	aq	nn	24	SENT_130	[p9l1369t2424r1446b2477],
23	IA	NN	O	ia	nn	24	SENT_130	[p9l1479t2406r1561b2460],
24	polymorphism	NN	O	polymorphism	prep_to	19	SENT_130	[p9l1592t2405r2055b2477],
25	of	IN	O	of	_	0	SENT_130	[p9l2085t2405r2153b2461],
26	DRD2	NN	O	drd2	nn	27	SENT_130	[p9l124t2504r325b2558],
27	gene	NN	O	gene	prep_of	24	SENT_130	[p9l353t2521r516b2576],
28	.	.	O	.	_	0	SENT_130	[p9l353t2521r516b2576],

1	Psychopharmacology	NN	O	psychopharmacology	_	0	SENT_131	[p9l546t2504r1227b2576],
2	149	CD	NUMBER	149	num	1	SENT_131	[p9l1260t2504r1387b2569],
3	,	,	O	,	_	0	SENT_131	[p9l1260t2504r1387b2569],
4	246-250	CD	NUMBER	246-250	appos	1	SENT_131	[p9l1416t2503r1716b2559],
5	.	.	O	.	_	0	SENT_131	[p9l1416t2503r1716b2559],

1	Nordstrom	NNP	ORGANIZATION	Nordstrom	nn	7	SENT_132	[p9l8t2602r365b2667],
2	,	,	O	,	_	0	SENT_132	[p9l8t2602r365b2667],
3	A.L.	NNP	O	A.L.	appos	7	SENT_132	[p9l393t2602r554b2667],
4	,	,	O	,	_	0	SENT_132	[p9l393t2602r554b2667],
5	Farde	NNP	PERSON	Farde	appos	7	SENT_132	[p9l581t2602r777b2667],
6	,	,	O	,	_	0	SENT_132	[p9l581t2602r777b2667],
7	L.	NNP	O	L.	_	0	SENT_132	[p9l805t2603r888b2667],
8	,	,	O	,	_	0	SENT_132	[p9l805t2603r888b2667],
9	1998	CD	DATE	1998	appos	7	SENT_132	[p9l924t2602r1089b2658],
10	.	.	O	.	_	0	SENT_132	[p9l924t2602r1089b2658],

1	Plasma	NN	O	plasma	nn	2	SENT_133	[p9l1118t2602r1346b2657],
2	prolactin	NN	O	prolactin	_	0	SENT_133	[p9l1369t2601r1651b2674],
3	and	CC	O	and	_	0	SENT_133	[p9l1677t2602r1790b2657],
4	central	JJ	O	central	amod	5	SENT_133	[p9l1815t2602r2029b2657],
5	D2	NN	O	d2	conj_and	2	SENT_133	[p9l2054t2602r2147b2656],

1	142	CD	NUMBER	142	num	3	SENT_134	[p9l372t2749r417b2773],
2	N.	NNP	PERSON	N.	nn	3	SENT_134	[p9l841t2750r868b2773],
3	Yasui-Furukori	NNP	PERSON	Yasui-Furukori	_	0	SENT_134	[p9l885t2749r1086b2773],
4	et	FW	O	et	nn	5	SENT_134	[p9l1097t2754r1121b2773],
5	al.	FW	O	al.	dep	3	SENT_134	[p9l1131t2749r1161b2773],
6	/	:	O	/	punct	3	SENT_134	[p9l1172t2749r1187b2773],
7	Schizophrenia	NNP	O	Schizophrenia	nn	8	SENT_134	[p9l1194t2749r1382b2779],
8	Research	NNP	O	Research	dep	3	SENT_134	[p9l1393t2749r1516b2773],
9	52	CD	NUMBER	52	number	10	SENT_134	[p9l1527t2749r1559b2773],
10	(	CD	NUMBER	(	num	11	SENT_134	[p9l1571t2749r1657b2778],
11	2001	CD	DATE	2001	dep	8	SENT_134	[p9l1571t2749r1657b2778],
12	)	CD	NUMBER	)	number	13	SENT_134	[p9l1571t2749r1657b2778],
13	139-142	CD	NUMBER	139-142	num	11	SENT_134	[p9l1670t2749r1787b2773],

1	receptor	NN	O	receptor	nn	2	SENT_135	[p9l125t2896r387b2959],
2	occupancy	NN	O	occupancy	nsubj	6	SENT_135	[p9l424t2905r761b2959],
3	in	IN	O	in	_	0	SENT_135	[p9l800t2887r860b2942],
4	antipsychotic	JJ	O	antipsychotic	amod	5	SENT_135	[p9l901t2887r1319b2959],
5	drug	NN	O	drug	prep_in	2	SENT_135	[p9l1361t2887r1502b2959],
6	treated	VBN	O	treat	_	0	SENT_135	[p9l1541t2887r1757b2943],
7	patients	NNS	O	patient	dobj	6	SENT_135	[p9l1794t2887r2057b2959],
8	.	.	O	.	_	0	SENT_135	[p9l1794t2887r2057b2959],

1	J.	NNP	PERSON	J.	nn	2	SENT_136	[p9l2099t2889r2144b2943],
2	Clin	NNP	PERSON	Clin	_	0	SENT_136	[p9l127t2986r277b3042],
3	.	.	O	.	_	0	SENT_136	[p9l127t2986r277b3042],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_137	[p9l307t2986r884b3058],
2	.	.	O	.	_	0	SENT_137	[p9l307t2986r884b3058],

1	18	CD	NUMBER	18	_	0	SENT_138	[p9l922t2986r1008b3052],
2	,	,	O	,	_	0	SENT_138	[p9l922t2986r1008b3052],
3	305-310	CD	NUMBER	305-310	appos	1	SENT_138	[p9l1039t2986r1337b3042],
4	.	.	O	.	_	0	SENT_138	[p9l1039t2986r1337b3042],

1	Otani	NNP	LOCATION	Otani	nn	27	SENT_139	[p9l9t3085r198b3151],
2	,	,	O	,	_	0	SENT_139	[p9l9t3085r198b3151],
3	K.	NNP	O	K.	appos	27	SENT_139	[p9l225t3086r315b3151],
4	,	,	O	,	_	0	SENT_139	[p9l225t3086r315b3151],
5	Kondo	NNP	PERSON	Kondo	appos	27	SENT_139	[p9l341t3085r570b3151],
6	,	,	O	,	_	0	SENT_139	[p9l341t3085r570b3151],
7	T.	NNP	O	T.	appos	27	SENT_139	[p9l595t3086r678b3151],
8	,	,	O	,	_	0	SENT_139	[p9l595t3086r678b3151],
9	Ishida	NNP	PERSON	Ishida	appos	27	SENT_139	[p9l703t3085r912b3151],
10	,	,	O	,	_	0	SENT_139	[p9l703t3085r912b3151],
11	M.	NNP	O	M.	appos	27	SENT_139	[p9l937t3086r1042b3151],
12	,	,	O	,	_	0	SENT_139	[p9l937t3086r1042b3151],
13	Sasa	NNP	PERSON	Sasa	appos	27	SENT_139	[p9l1069t3086r1227b3151],
14	,	,	O	,	_	0	SENT_139	[p9l1069t3086r1227b3151],
15	H.	NNP	O	H.	appos	27	SENT_139	[p9l1252t3086r1343b3151],
16	,	,	O	,	_	0	SENT_139	[p9l1252t3086r1343b3151],
17	Higuchi	NNP	PERSON	Higuchi	appos	27	SENT_139	[p9l1369t3085r1639b3157],
18	,	,	O	,	_	0	SENT_139	[p9l1369t3085r1639b3157],
19	H.	NNP	O	H.	appos	27	SENT_139	[p9l1664t3086r1755b3151],
20	,	,	O	,	_	0	SENT_139	[p9l1664t3086r1755b3151],
21	Kaneko	NNP	PERSON	Kaneko	appos	27	SENT_139	[p9l1781t3085r2042b3151],
22	,	,	O	,	_	0	SENT_139	[p9l1781t3085r2042b3151],
23	S.	NNP	O	S.	appos	27	SENT_139	[p9l2069t3086r2145b3151],
24	,	,	O	,	_	0	SENT_139	[p9l2069t3086r2145b3151],
25	Fukushima	NNP	PERSON	Fukushima	appos	27	SENT_139	[p9l126t3184r493b3250],
26	,	,	O	,	_	0	SENT_139	[p9l126t3184r493b3250],
27	Y.	NNP	O	Y.	_	0	SENT_139	[p9l522t3186r613b3250],
28	,	,	O	,	_	0	SENT_139	[p9l522t3186r613b3250],
29	1993	CD	DATE	1993	appos	27	SENT_139	[p9l650t3185r815b3241],
30	.	.	O	.	_	0	SENT_139	[p9l650t3185r815b3241],

1	Prolactin	NN	O	prolactin	nn	2	SENT_140	[p9l844t3184r1129b3240],
2	response	NN	O	response	_	0	SENT_140	[p9l1154t3202r1430b3256],
3	to	TO	O	to	_	0	SENT_140	[p9l1456t3192r1515b3240],
4	zotepine	NN	O	zotepine	prep_to	2	SENT_140	[p9l1542t3184r1809b3256],
5	in	IN	O	in	_	0	SENT_140	[p9l1835t3184r1895b3239],
6	schizophrenic	JJ	O	schizophrenic	amod	7	SENT_140	[p9l1923t3184r2146b3240, p9l125t3283r362b3355],
7	patients	NNS	O	patient	prep_in	2	SENT_140	[p9l387t3283r650b3355],
8	.	.	O	.	_	0	SENT_140	[p9l387t3283r650b3355],

1	Hum	NNP	O	Hum	_	0	SENT_141	[p9l679t3284r851b3338],
2	.	.	O	.	_	0	SENT_141	[p9l679t3284r851b3338],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_142	[p9l881t3282r1459b3355],
2	.	.	O	.	_	0	SENT_142	[p9l881t3282r1459b3355],

1	8	CD	NUMBER	8	_	0	SENT_143	[p9l1492t3283r1543b3348],
2	,	,	O	,	_	0	SENT_143	[p9l1492t3283r1543b3348],
3	35-39	CD	NUMBER	35-39	appos	1	SENT_143	[p9l1573t3282r1793b3339],
4	.	.	O	.	_	0	SENT_143	[p9l1573t3282r1793b3339],

1	Petty	NNP	O	Petty	nn	3	SENT_144	[p9l7t3382r185b3453],
2	,	,	O	,	_	0	SENT_144	[p9l7t3382r185b3453],
3	R.G.	NNP	LOCATION	R.G.	_	0	SENT_144	[p9l253t3381r418b3447],
4	,	,	O	,	_	0	SENT_144	[p9l253t3381r418b3447],
5	1999	CD	DATE	1999	appos	3	SENT_144	[p9l494t3382r658b3438],
6	.	.	O	.	_	0	SENT_144	[p9l494t3382r658b3438],

1	Prolactin	NN	O	prolactin	nn	4	SENT_145	[p9l727t3381r1013b3437],
2	and	CC	O	and	_	0	SENT_145	[p9l1080t3381r1191b3437],
3	antipsychotic	JJ	O	antipsychotic	nn	4	SENT_145	[p9l1258t3381r1676b3453],
4	medications	NNS	O	medication	_	0	SENT_145	[p9l1744t3381r2142b3437],
5	:	:	O	:	_	0	SENT_145	[p9l1744t3381r2142b3437],

1	mechanism	NN	O	mechanism	_	0	SENT_146	[p9l126t3480r487b3536],
2	of	IN	O	of	_	0	SENT_146	[p9l513t3480r582b3536],
3	action	NN	O	action	prep_of	1	SENT_146	[p9l603t3480r810b3536],
4	.	.	O	.	_	0	SENT_146	[p9l603t3480r810b3536],

1	Schizophr	NNP	O	Schizophr	_	0	SENT_147	[p9l842t3480r1175b3552],
2	.	.	O	.	_	0	SENT_147	[p9l842t3480r1175b3552],

1	Res	NNP	O	Res	_	0	SENT_148	[p9l1204t3482r1337b3536],
2	.	.	O	.	_	0	SENT_148	[p9l1204t3482r1337b3536],

1	35	CD	NUMBER	35	_	0	SENT_149	[p9l1369t3480r1461b3546],
2	,	,	O	,	_	0	SENT_149	[p9l1369t3480r1461b3546],
3	S67-S73	NN	O	s67-s73	appos	1	SENT_149	[p9l1492t3480r1798b3537],
4	.	.	O	.	_	0	SENT_149	[p9l1492t3480r1798b3537],

1	Ravichandran	NNP	MISC	Ravichandran	nn	9	SENT_150	[p9l7t3579r463b3645],
2	,	,	O	,	_	0	SENT_150	[p9l7t3579r463b3645],
3	G.K.	NNP	LOCATION	G.K.	appos	9	SENT_150	[p9l500t3580r667b3645],
4	,	,	O	,	_	0	SENT_150	[p9l500t3580r667b3645],
5	Lu	NNP	PERSON	Lu	appos	9	SENT_150	[p9l702t3581r806b3645],
6	,	,	O	,	_	0	SENT_150	[p9l702t3581r806b3645],
7	R.B.	NNP	LOCATION	R.B.	appos	9	SENT_150	[p9l842t3581r1002b3645],
8	,	,	O	,	_	0	SENT_150	[p9l842t3581r1002b3645],
9	Shvartsburd	NNP	O	Shvartsburd	_	0	SENT_150	[p9l1039t3579r1436b3645],
10	,	,	O	,	_	0	SENT_150	[p9l1039t3579r1436b3645],
11	A.	NN	O	a.	appos	9	SENT_150	[p9l1471t3580r1563b3645],
12	,	,	O	,	_	0	SENT_150	[p9l1471t3580r1563b3645],
13	Misra	NNP	LOCATION	Misra	nn	27	SENT_150	[p9l1597t3579r1798b3645],
14	,	,	O	,	_	0	SENT_150	[p9l1597t3579r1798b3645],
15	C.H.	NNP	LOCATION	C.H.	appos	27	SENT_150	[p9l1834t3580r1998b3645],
16	,	,	O	,	_	0	SENT_150	[p9l1834t3580r1998b3645],
17	Ho	NNP	O	Ho	appos	27	SENT_150	[p9l2034t3581r2145b3645],
18	,	,	O	,	_	0	SENT_150	[p9l2034t3581r2145b3645],
19	B.T.	NNP	O	B.T.	appos	27	SENT_150	[p9l126t3679r282b3743],
20	,	,	O	,	_	0	SENT_150	[p9l126t3679r282b3743],
21	Kahn	NNP	PERSON	Kahn	appos	27	SENT_150	[p9l310t3678r495b3743],
22	,	,	O	,	_	0	SENT_150	[p9l310t3678r495b3743],
23	M.	NNP	O	M.	appos	27	SENT_150	[p9l521t3679r626b3743],
24	,	,	O	,	_	0	SENT_150	[p9l521t3679r626b3743],
25	Smith	NNP	PERSON	Smith	appos	27	SENT_150	[p9l655t3677r857b3743],
26	,	,	O	,	_	0	SENT_150	[p9l655t3677r857b3743],
27	R.C.	NNP	LOCATION	R.C.	appos	9	SENT_150	[p9l883t3678r1043b3743],
28	,	,	O	,	_	0	SENT_150	[p9l883t3678r1043b3743],
29	1984	CD	DATE	1984	appos	9	SENT_150	[p9l1078t3678r1243b3734],
30	.	.	O	.	_	0	SENT_150	[p9l1078t3678r1243b3734],

1	Prolactin	NN	O	prolactin	nn	2	SENT_151	[p9l1270t3677r1555b3733],
2	response	NN	O	response	_	0	SENT_151	[p9l1577t3695r1853b3750],
3	to	TO	O	to	_	0	SENT_151	[p9l1877t3686r1936b3733],
4	single	JJ	O	single	amod	7	SENT_151	[p9l1963t3677r2147b3750],
5	and	CC	O	and	_	0	SENT_151	[p10l128t20r240b76],
6	multiple	JJ	O	multiple	amod	7	SENT_151	[p10l279t20r543b92],
7	doses	NNS	O	dose	prep_to	2	SENT_151	[p10l584t20r756b76],
8	of	IN	O	of	_	0	SENT_151	[p10l799t20r867b76],
9	haloperidol	NN	O	haloperidol	prep_of	2	SENT_151	[p10l902t20r1262b92],
10	in	IN	O	in	_	0	SENT_151	[p10l1303t20r1363b75],
11	schizophrenic	JJ	O	schizophrenic	amod	12	SENT_151	[p10l1406t20r1840b92],
12	patients	NNS	O	patient	prep_in	2	SENT_151	[p10l1881t20r2144b92],
13	.	.	O	.	_	0	SENT_151	[p10l1881t20r2144b92],

1	Psychiatry	NNP	O	Psychiatry	nn	2	SENT_152	[p10l126t119r458b191],
2	Res	NNP	O	Res	_	0	SENT_152	[p10l485t121r618b175],
3	.	.	O	.	_	0	SENT_152	[p10l485t121r618b175],

1	11	CD	NUMBER	11	_	0	SENT_153	[p10l655t120r741b185],
2	,	,	O	,	_	0	SENT_153	[p10l655t120r741b185],
3	61-69	CD	NUMBER	61-69	appos	1	SENT_153	[p10l771t119r991b176],
4	.	.	O	.	_	0	SENT_153	[p10l771t119r991b176],

1	Rubin	NNP	PERSON	Rubin	nn	23	SENT_154	[p10l7t217r216b283],
2	,	,	O	,	_	0	SENT_154	[p10l7t217r216b283],
3	R.T.	NNP	LOCATION	R.T.	appos	23	SENT_154	[p10l256t219r412b283],
4	,	,	O	,	_	0	SENT_154	[p10l256t219r412b283],
5	Forsman	NNP	PERSON	Forsman	appos	23	SENT_154	[p10l452t219r745b283],
6	,	,	O	,	_	0	SENT_154	[p10l452t219r745b283],
7	A.	NNP	O	A.	appos	23	SENT_154	[p10l785t218r877b283],
8	,	,	O	,	_	0	SENT_154	[p10l785t218r877b283],
9	Heykants	NNP	O	Heykants	appos	23	SENT_154	[p10l917t218r1232b290],
10	,	,	O	,	_	0	SENT_154	[p10l917t218r1232b290],
11	J.	NNP	O	J.	appos	23	SENT_154	[p10l1272t219r1337b283],
12	,	,	O	,	_	0	SENT_154	[p10l1272t219r1337b283],
13	Chman	NNP	O	Chman	appos	23	SENT_154	[p10l1379t204r1626b283],
14	,	,	O	,	_	0	SENT_154	[p10l1379t204r1626b283],
15	R.	NNP	O	R.	appos	23	SENT_154	[p10l1667t219r1754b283],
16	,	,	O	,	_	0	SENT_154	[p10l1667t219r1754b283],
17	Tower	NNP	O	Tower	appos	23	SENT_154	[p10l1795t219r2017b283],
18	,	,	O	,	_	0	SENT_154	[p10l1795t219r2017b283],
19	B.	NNP	O	B.	appos	23	SENT_154	[p10l2057t219r2145b283],
20	,	,	O	,	_	0	SENT_154	[p10l2057t219r2145b283],
21	Michiels	NNP	PERSON	Michiels	appos	23	SENT_154	[p10l126t316r419b382],
22	,	,	O	,	_	0	SENT_154	[p10l126t316r419b382],
23	M.	NNP	O	M.	_	0	SENT_154	[p10l479t317r584b382],
24	,	,	O	,	_	0	SENT_154	[p10l479t317r584b382],
25	1980	CD	DATE	1980	appos	23	SENT_154	[p10l653t317r817b373],
26	.	.	O	.	_	0	SENT_154	[p10l653t317r817b373],

1	Serum	NN	O	serum	nn	3	SENT_155	[p10l881t317r1085b372],
2	haloperidol	NN	O	haloperidol	nn	3	SENT_155	[p10l1141t316r1501b388],
3	determinations	NNS	O	determination	_	0	SENT_155	[p10l1560t316r2028b372],
4	in	IN	O	in	_	0	SENT_155	[p10l2088t316r2148b371],
5	psychiatric	JJ	O	psychiatric	amod	6	SENT_155	[p10l125t415r471b487],
6	patients	NNS	O	patient	prep_in	3	SENT_155	[p10l514t415r778b487],
7	:	:	O	:	_	0	SENT_155	[p10l514t415r778b487],
8	comparison	NN	O	comparison	dep	3	SENT_155	[p10l825t415r1194b487],
9	of	IN	O	of	_	0	SENT_155	[p10l1236t415r1305b471],
10	methods	NNS	O	method	prep_of	8	SENT_155	[p10l1341t415r1607b471],
11	and	CC	O	and	_	0	SENT_155	[p10l1652t415r1764b471],
12	correlation	NN	O	correlation	prep_of	8	SENT_155	[p10l1806t415r2148b471],
13	with	IN	O	with	_	0	SENT_155	[p10l126t514r266b569],
14	serum	NN	O	serum	nn	16	SENT_155	[p10l337t531r527b569],
15	prolactin	NN	O	prolactin	nn	16	SENT_155	[p10l594t514r876b586],
16	level	NN	O	level	prep_with	8	SENT_155	[p10l945t514r1113b569],
17	.	.	O	.	_	0	SENT_155	[p10l945t514r1113b569],

1	Arch	NNP	O	Arch	_	0	SENT_156	[p10l1186t514r1358b569],
2	.	.	O	.	_	0	SENT_156	[p10l1186t514r1358b569],

1	Gen.	NNP	O	Gen.	_	0	SENT_157	[p10l1432t514r1576b569],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_157	[p10l1649t513r1982b586],
3	37	CD	NUMBER	37	num	2	SENT_157	[p10l2053t514r2145b579],
4	,	,	O	,	_	0	SENT_157	[p10l2053t514r2145b579],
5	1069-1074	CD	DATE	1069-1074	num	2	SENT_157	[p10l134t613r507b669],
6	.	.	O	.	_	0	SENT_157	[p10l134t613r507b669],

1	Rubin	NNP	PERSON	Rubin	nn	3	SENT_158	[p10l7t710r216b776],
2	,	,	O	,	_	0	SENT_158	[p10l7t710r216b776],
3	R.T.	NNP	LOCATION	R.T.	_	0	SENT_158	[p10l248t712r404b776],
4	,	,	O	,	_	0	SENT_158	[p10l248t712r404b776],
5	1987	CD	DATE	1987	appos	3	SENT_158	[p10l444t711r608b767],
6	.	.	O	.	_	0	SENT_158	[p10l444t711r608b767],

1	Prolactin	NN	O	prolactin	_	0	SENT_159	[p10l641t710r927b766],
2	and	CC	O	and	_	0	SENT_159	[p10l958t710r1069b766],
3	schizophrenia	NN	O	schizophrenia	conj_and	1	SENT_159	[p10l1101t710r1553b782],
4	.	.	O	.	_	0	SENT_159	[p10l1101t710r1553b782],

1	In	IN	O	in	_	0	SENT_160	[p10l1586t712r1667b766],
2	:	:	O	:	_	0	SENT_160	[p10l1586t712r1667b766],
3	Meltzer	NNP	PERSON	Meltzer	dep	9	SENT_160	[p10l1701t710r1964b776],
4	,	,	O	,	_	0	SENT_160	[p10l1701t710r1964b776],
5	H.Y.	NNP	O	H.Y.	nn	7	SENT_160	[p10l1996t712r2144b766],
6	(	NNP	O	(	nn	7	SENT_160	[p10l129t808r302b877],
7	Ed	NNP	PERSON	Ed	appos	3	SENT_160	[p10l129t808r302b877],
8	.	.	O	.	_	0	SENT_160	[p10l129t808r302b877],
9	)	NN	O	)	pobj	1	SENT_160	[p10l129t808r302b877],

1	,	,	O	,	_	0	SENT_161	[p10l129t808r302b877],
2	Psychopharmacology	NNP	O	Psychopharmacology	_	0	SENT_161	[p10l328t808r1025b881],
3	:	:	O	:	_	0	SENT_161	[p10l328t808r1025b881],
4	The	DT	O	the	det	6	SENT_161	[p10l1054t809r1175b864],
5	Third	JJ	ORDINAL	third	amod	6	SENT_161	[p10l1199t809r1374b864],
6	Generation	NN	O	generation	dep	2	SENT_161	[p10l1398t808r1748b864],
7	of	IN	O	of	_	0	SENT_161	[p10l1772t808r1840b864],
8	Progress	NNP	O	Progress	prep_of	6	SENT_161	[p10l1858t810r2144b881],
9	.	.	O	.	_	0	SENT_161	[p10l1858t810r2144b881],

1	Raven	NN	ORGANIZATION	raven	nn	2	SENT_162	[p10l126t909r328b963],
2	Press	NNP	ORGANIZATION	Press	_	0	SENT_162	[p10l352t909r534b973],
3	,	,	O	,	_	0	SENT_162	[p10l352t909r534b973],
4	New	NNP	LOCATION	New	nn	5	SENT_162	[p10l562t909r710b963],
5	York	NNP	LOCATION	York	appos	2	SENT_162	[p10l737t908r914b973],
6	,	,	O	,	_	0	SENT_162	[p10l737t908r914b973],
7	pp	NN	O	pp	appos	5	SENT_162	[p10l941t925r1035b980],
8	.	.	O	.	_	0	SENT_162	[p10l941t925r1035b980],

1	803-808	CD	NUMBER	803-808	_	0	SENT_163	[p10l1068t908r1366b963],
2	.	.	O	.	_	0	SENT_163	[p10l1068t908r1366b963],

1	Steen	NNP	PERSON	Steen	nn	27	SENT_164	[p10l9t1007r199b1072],
2	,	,	O	,	_	0	SENT_164	[p10l9t1007r199b1072],
3	V.M.	NNP	LOCATION	V.M.	appos	27	SENT_164	[p10l236t1008r418b1072],
4	,	,	O	,	_	0	SENT_164	[p10l236t1008r418b1072],
5	Andreassen	NNP	PERSON	Andreassen	appos	27	SENT_164	[p10l456t1007r840b1072],
6	,	,	O	,	_	0	SENT_164	[p10l456t1007r840b1072],
7	O.A.	NNP	O	O.A.	appos	27	SENT_164	[p10l879t1007r1046b1072],
8	,	,	O	,	_	0	SENT_164	[p10l879t1007r1046b1072],
9	Daly	NNP	PERSON	Daly	appos	27	SENT_164	[p10l1084t1007r1253b1079],
10	,	,	O	,	_	0	SENT_164	[p10l1084t1007r1253b1079],
11	A.K.	NNP	PERSON	A.K.	appos	27	SENT_164	[p10l1291t1007r1460b1072],
12	,	,	O	,	_	0	SENT_164	[p10l1291t1007r1460b1072],
13	Tefre	NNP	O	Tefre	appos	27	SENT_164	[p10l1498t1007r1685b1073],
14	,	,	O	,	_	0	SENT_164	[p10l1498t1007r1685b1073],
15	T.	NNP	O	T.	appos	27	SENT_164	[p10l1723t1008r1806b1072],
16	,	,	O	,	_	0	SENT_164	[p10l1723t1008r1806b1072],
17	Borresen	NNP	PERSON	Borresen	appos	27	SENT_164	[p10l1844t1008r2145b1073],
18	,	,	O	,	_	0	SENT_164	[p10l1844t1008r2145b1073],
19	A.L.	NNP	O	A.L.	appos	27	SENT_164	[p10l126t1106r287b1171],
20	,	,	O	,	_	0	SENT_164	[p10l126t1106r287b1171],
21	Idle	NNP	O	Idle	appos	27	SENT_164	[p10l332t1106r471b1171],
22	,	,	O	,	_	0	SENT_164	[p10l332t1106r471b1171],
23	J.R.	NNP	LOCATION	J.R.	appos	27	SENT_164	[p10l515t1107r653b1171],
24	,	,	O	,	_	0	SENT_164	[p10l515t1107r653b1171],
25	Gulbrandsen	NNP	PERSON	Gulbrandsen	appos	27	SENT_164	[p10l700t1106r1118b1171],
26	,	,	O	,	_	0	SENT_164	[p10l700t1106r1118b1171],
27	A.K.	NNP	PERSON	A.K.	_	0	SENT_164	[p10l1163t1106r1332b1171],
28	,	,	O	,	_	0	SENT_164	[p10l1163t1106r1332b1171],
29	1995	CD	DATE	1995	appos	27	SENT_164	[p10l1385t1105r1550b1162],
30	.	.	O	.	_	0	SENT_164	[p10l1385t1105r1550b1162],

1	Detection	NN	O	detection	_	0	SENT_165	[p10l1596t1106r1904b1161],
2	of	IN	O	of	_	0	SENT_165	[p10l1947t1105r2015b1161],
3	the	DT	O	the	det	9	SENT_165	[p10l2052t1105r2147b1161],
4	poor	JJ	O	poor	amod	9	SENT_165	[p10l125t1221r271b1276],
5	metabolizer-associated	JJ	O	metabolizer-associated	amod	9	SENT_165	[p10l297t1204r1025b1259],
6	CYP2D6	NN	O	cyp2d6	nn	9	SENT_165	[p10l1054t1203r1487b1276],
7	(	CD	NUMBER	(	num	9	SENT_165	[p10l1054t1203r1487b1276],
8	qD	NN	O	qd	nn	9	SENT_165	[p10l1054t1203r1487b1276],
9	)	NN	O	)	prep_of	1	SENT_165	[p10l1054t1203r1487b1276],
10	gene	NN	O	gene	nn	12	SENT_165	[p10l1518t1221r1665b1276],
11	deletion	NN	O	deletion	nn	12	SENT_165	[p10l1695t1203r1949b1259],
12	allele	NN	O	allele	dep	9	SENT_165	[p10l1978t1204r2147b1259],
13	by	IN	O	by	prep	1	SENT_165	[p10l125t1302r203b1374],
14	long	RB	O	long	pobj	13	SENT_165	[p10l229t1302r545b1374],
15	.	.	O	.	_	0	SENT_165	[p10l229t1302r545b1374],

1	—	NN	O	—	_	0	SENT_166	[p10l229t1302r545b1374],
2	.	.	O	.	_	0	SENT_166	[p10l229t1302r545b1374],

1	PCR	NN	O	pcr	_	0	SENT_167	[p10l229t1302r545b1374],
2	technology	NN	O	technology	dep	1	SENT_167	[p10l570t1302r937b1374],
3	.	.	O	.	_	0	SENT_167	[p10l570t1302r937b1374],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_168	[p10l965t1302r1540b1374],
2	5	CD	NUMBER	5	num	1	SENT_168	[p10l1569t1301r1622b1367],
3	,	,	O	,	_	0	SENT_168	[p10l1569t1301r1622b1367],
4	215-223	CD	NUMBER	215-223	appos	1	SENT_168	[p10l1651t1302r1951b1357],
5	.	.	O	.	_	0	SENT_168	[p10l1651t1302r1951b1357],

1	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_169	[p10l9t1401r243b1466],
2	,	,	O	,	_	0	SENT_169	[p10l9t1401r243b1466],
3	A.	NN	O	a.	appos	1	SENT_169	[p10l267t1401r358b1466],
4	,	,	O	,	_	0	SENT_169	[p10l267t1401r358b1466],
5	Otani	NNP	LOCATION	Otani	nn	23	SENT_169	[p10l385t1400r575b1466],
6	,	,	O	,	_	0	SENT_169	[p10l385t1400r575b1466],
7	K.	NNP	O	K.	appos	23	SENT_169	[p10l601t1402r692b1466],
8	,	,	O	,	_	0	SENT_169	[p10l601t1402r692b1466],
9	Mihara	NNP	PERSON	Mihara	appos	23	SENT_169	[p10l716t1401r961b1466],
10	,	,	O	,	_	0	SENT_169	[p10l716t1401r961b1466],
11	K.	NNP	O	K.	appos	23	SENT_169	[p10l987t1402r1077b1466],
12	,	,	O	,	_	0	SENT_169	[p10l987t1402r1077b1466],
13	Yasui	NNP	PERSON	Yasui	appos	23	SENT_169	[p10l1103t1401r1302b1466],
14	,	,	O	,	_	0	SENT_169	[p10l1103t1401r1302b1466],
15	N.	NNP	O	N.	appos	23	SENT_169	[p10l1326t1402r1418b1466],
16	,	,	O	,	_	0	SENT_169	[p10l1326t1402r1418b1466],
17	Kaneko	NNP	PERSON	Kaneko	appos	23	SENT_169	[p10l1444t1401r1705b1466],
18	,	,	O	,	_	0	SENT_169	[p10l1444t1401r1705b1466],
19	S.	NNP	O	S.	appos	23	SENT_169	[p10l1732t1401r1808b1466],
20	,	,	O	,	_	0	SENT_169	[p10l1732t1401r1808b1466],
21	Inoue	NNP	PERSON	Inoue	appos	23	SENT_169	[p10l1833t1402r2029b1466],
22	,	,	O	,	_	0	SENT_169	[p10l1833t1402r2029b1466],
23	Y.	NNP	O	Y.	appos	1	SENT_169	[p10l2054t1402r2145b1466],
24	,	,	O	,	_	0	SENT_169	[p10l2054t1402r2145b1466],
25	1997	CD	DATE	1997	appos	1	SENT_169	[p10l134t1499r299b1555],
26	.	.	O	.	_	0	SENT_169	[p10l134t1499r299b1555],

1	Effects	NNS	O	effect	nsubj	13	SENT_170	[p10l346t1498r564b1554],
2	of	IN	O	of	_	0	SENT_170	[p10l610t1498r679b1554],
3	the	DT	O	the	det	4	SENT_170	[p10l718t1499r813b1554],
4	CYPZD6	NN	O	cypzd6	prep_of	1	SENT_170	[p10l861t1498r1140b1555],
5	genotype	NN	O	genotype	_	0	SENT_170	[p10l1182t1507r1470b1571],
6	on	IN	O	on	_	0	SENT_170	[p10l1515t1516r1592b1554],
7	the	DT	O	the	det	11	SENT_170	[p10l1635t1498r1730b1554],
8	steady-state	JJ	O	steady-state	amod	11	SENT_170	[p10l1778t1499r2148b1571],
9	plasma	NN	O	plasma	nn	11	SENT_170	[p10l125t1598r351b1670],
10	concentrations	NNS	O	concentration	nn	11	SENT_170	[p10l383t1598r841b1653],
11	haloperidol	NN	O	haloperidol	prep_on	5	SENT_170	[p10l875t1598r1236b1670],
12	and	CC	O	and	_	0	SENT_170	[p10l1270t1598r1381b1653],
13	reduced	VBD	O	reduce	conj_and	5	SENT_170	[p10l1412t1598r1664b1653],
14	haloperidol	NN	O	haloperidol	dobj	13	SENT_170	[p10l1695t1598r2055b1670],
15	in	IN	O	in	_	0	SENT_170	[p10l2088t1598r2148b1652],
16	Japanese	JJ	MISC	japanese	amod	18	SENT_170	[p10l126t1697r406b1768],
17	schizophrenic	JJ	O	schizophrenic	amod	18	SENT_170	[p10l429t1696r863b1768],
18	patients	NNS	O	patient	prep_in	13	SENT_170	[p10l884t1696r1146b1768],
19	.	.	O	.	_	0	SENT_170	[p10l884t1696r1146b1768],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_171	[p10l1170t1696r1745b1768],
2	7	CD	NUMBER	7	num	1	SENT_171	[p10l1766t1697r1820b1762],
3	,	,	O	,	_	0	SENT_171	[p10l1766t1697r1820b1762],
4	415-418	CD	NUMBER	415-418	appos	1	SENT_171	[p10l1842t1696r2144b1752],
5	.	.	O	.	_	0	SENT_171	[p10l1842t1696r2144b1752],

1	Swigar	NNP	LOCATION	Swigar	nn	20	SENT_172	[p10l9t1794r247b1867],
2	,	,	O	,	_	0	SENT_172	[p10l9t1794r247b1867],
3	M.E.	NNP	O	M.E.	appos	20	SENT_172	[p10l273t1796r447b1860],
4	,	,	O	,	_	0	SENT_172	[p10l273t1796r447b1860],
5	Jatlow	NNP	LOCATION	Jatlow	appos	20	SENT_172	[p10l473t1795r695b1860],
6	,	,	O	,	_	0	SENT_172	[p10l473t1795r695b1860],
7	P.I.	NNP	O	P.I.	appos	20	SENT_172	[p10l721t1796r847b1860],
8	,	,	O	,	_	0	SENT_172	[p10l721t1796r847b1860],
9	Goicoechea	NNP	PERSON	Goicoechea	appos	20	SENT_172	[p10l875t1795r1263b1860],
10	,	,	O	,	_	0	SENT_172	[p10l875t1795r1263b1860],
11	N.	NNP	O	N.	appos	20	SENT_172	[p10l1290t1796r1382b1860],
12	,	,	O	,	_	0	SENT_172	[p10l1290t1796r1382b1860],
13	Opsahl	NNP	PERSON	Opsahl	appos	20	SENT_172	[p10l1411t1795r1649b1867],
14	,	,	O	,	_	0	SENT_172	[p10l1411t1795r1649b1867],
15	C.	NNP	O	C.	appos	20	SENT_172	[p10l1676t1795r1763b1860],
16	,	,	O	,	_	0	SENT_172	[p10l1676t1795r1763b1860],
17	Bowers	NNP	PERSON	Bowers	appos	20	SENT_172	[p10l1790t1796r2028b1850],
18	Jr.	NNP	PERSON	Jr.	nn	20	SENT_172	[p10l2053t1796r2145b1860],
19	,	,	O	,	_	0	SENT_172	[p10l2053t1796r2145b1860],
20	B.M.	NNP	O	B.M.	_	0	SENT_172	[p10l126t1895r304b1959],
21	,	,	O	,	_	0	SENT_172	[p10l126t1895r304b1959],
22	1984	CD	DATE	1984	appos	20	SENT_172	[p10l344t1894r509b1950],
23	.	.	O	.	_	0	SENT_172	[p10l344t1894r509b1950],

1	Ratio	NN	O	ratio	_	0	SENT_173	[p10l542t1894r712b1949],
2	of	IN	O	of	_	0	SENT_173	[p10l743t1894r812b1949],
3	serum	NN	O	serum	nn	4	SENT_173	[p10l839t1911r1030b1949],
4	prolactin	NN	O	prolactin	prep_of	1	SENT_173	[p10l1057t1894r1339b1966],
5	to	TO	O	to	_	0	SENT_173	[p10l1369t1902r1428b1949],
6	haloperidol	NN	O	haloperidol	prep_to	1	SENT_173	[p10l1458t1894r1818b1966],
7	and	CC	O	and	_	0	SENT_173	[p10l1850t1894r1961b1949],
8	early	JJ	O	early	amod	10	SENT_173	[p10l1992t1894r2147b1966],
9	clinical	JJ	O	clinical	amod	10	SENT_173	[p10l127t1992r359b2047],
10	outcome	NN	O	outcome	conj_and	6	SENT_173	[p10l399t2000r669b2047],
11	in	IN	O	in	_	0	SENT_173	[p10l709t1992r769b2047],
12	acute	JJ	O	acute	amod	13	SENT_173	[p10l810t2000r974b2047],
13	psychosis	NN	O	psychosis	prep_in	1	SENT_173	[p10l1012t1992r1334b2064],
14	.	.	O	.	_	0	SENT_173	[p10l1012t1992r1334b2064],

1	Am	NNP	O	Am	_	0	SENT_174	[p10l1376t1992r1509b2047],
2	.	.	O	.	_	0	SENT_174	[p10l1376t1992r1509b2047],

1	J.	NNP	O	J.	_	0	SENT_175	[p10l1552t1993r1596b2048],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_175	[p10l1639t1992r1971b2064],
3	141	CD	NUMBER	141	num	2	SENT_175	[p10l2019t1992r2145b2058],
4	,	,	O	,	_	0	SENT_175	[p10l2019t1992r2145b2058],
5	1281-1283	CD	DATE	1281-1283	num	2	SENT_175	[p10l134t2090r507b2145],
6	.	.	O	.	_	0	SENT_175	[p10l134t2090r507b2145],

1	Tsang	NNP	PERSON	Tsang	nn	11	SENT_176	[p10l7t2191r216b2262],
2	,	,	O	,	_	0	SENT_176	[p10l7t2191r216b2262],
3	M.W.	NNP	LOCATION	M.W.	appos	11	SENT_176	[p10l248t2191r448b2255],
4	,	,	O	,	_	0	SENT_176	[p10l248t2191r448b2255],
5	Shader	NNP	PERSON	Shader	appos	11	SENT_176	[p10l482t2190r716b2256],
6	,	,	O	,	_	0	SENT_176	[p10l482t2190r716b2256],
7	R.I.	NNP	LOCATION	R.I.	appos	11	SENT_176	[p10l748t2191r882b2256],
8	,	,	O	,	_	0	SENT_176	[p10l748t2191r882b2256],
9	Greenblatt	NNP	PERSON	Greenblatt	appos	11	SENT_176	[p10l915t2190r1265b2255],
10	,	,	O	,	_	0	SENT_176	[p10l915t2190r1265b2255],
11	D.J.	NNP	PERSON	D.J.	_	0	SENT_176	[p10l1297t2191r1439b2255],
12	,	,	O	,	_	0	SENT_176	[p10l1297t2191r1439b2255],
13	1994	CD	DATE	1994	appos	11	SENT_176	[p10l1479t2190r1644b2246],
14	.	.	O	.	_	0	SENT_176	[p10l1479t2190r1644b2246],

1	Metabolism	NN	O	metabolism	_	0	SENT_177	[p10l1676t2190r2056b2245],
2	of	IN	O	of	_	0	SENT_177	[p10l2085t2190r2153b2245],
3	haloperidol	NN	O	haloperidol	prep_of	1	SENT_177	[p10l126t2288r503b2360],
4	:	:	O	:	_	0	SENT_177	[p10l126t2288r503b2360],
5	clinical	JJ	O	clinical	amod	6	SENT_177	[p10l536t2288r768b2343],
6	implications	NNS	O	implication	dep	1	SENT_177	[p10l795t2288r1185b2360],
7	and	CC	O	and	_	0	SENT_177	[p10l1215t2288r1326b2343],
8	unanswered	JJ	O	unanswered	amod	9	SENT_177	[p10l1352t2288r1730b2344],
9	questions	NNS	O	question	dep	1	SENT_177	[p10l1756t2288r2069b2360],
10	.	.	O	.	_	0	SENT_177	[p10l1756t2288r2069b2360],

1	J	NN	O	j	_	0	SENT_178	[p10l2099t2289r2128b2344],
2	.	.	O	.	_	0	SENT_178	[p10l2134t2334r2144b2343],

1	Clin	NNP	O	Clin	_	0	SENT_179	[p10l127t2387r277b2443],
2	.	.	O	.	_	0	SENT_179	[p10l127t2387r277b2443],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_180	[p10l307t2387r884b2459],
2	.	.	O	.	_	0	SENT_180	[p10l307t2387r884b2459],

1	14	CD	NUMBER	14	_	0	SENT_181	[p10l922t2387r1008b2453],
2	,	,	O	,	_	0	SENT_181	[p10l922t2387r1008b2453],
3	159-162	CD	NUMBER	159-162	appos	1	SENT_181	[p10l1044t2387r1337b2443],
4	.	.	O	.	_	0	SENT_181	[p10l1044t2387r1337b2443],

1	Ulrich	NNP	PERSON	Ulrich	nn	15	SENT_182	[p10l7t2486r225b2552],
2	,	,	O	,	_	0	SENT_182	[p10l7t2486r225b2552],
3	S.	NNP	O	S.	appos	15	SENT_182	[p10l251t2486r327b2552],
4	,	,	O	,	_	0	SENT_182	[p10l251t2486r327b2552],
5	Neuhof	NNP	O	Neuhof	appos	15	SENT_182	[p10l351t2486r604b2552],
6	,	,	O	,	_	0	SENT_182	[p10l351t2486r604b2552],
7	S.	NNP	O	S.	appos	15	SENT_182	[p10l630t2487r706b2552],
8	,	,	O	,	_	0	SENT_182	[p10l630t2487r706b2552],
9	Braun	NNP	PERSON	Braun	appos	15	SENT_182	[p10l731t2487r940b2552],
10	,	,	O	,	_	0	SENT_182	[p10l731t2487r940b2552],
11	V.	NNP	O	V.	appos	15	SENT_182	[p10l964t2487r1056b2552],
12	,	,	O	,	_	0	SENT_182	[p10l964t2487r1056b2552],
13	Meyer	NNP	PERSON	Meyer	appos	15	SENT_182	[p10l1080t2487r1302b2558],
14	,	,	O	,	_	0	SENT_182	[p10l1080t2487r1302b2558],
15	F.P.	NNP	O	F.P.	_	0	SENT_182	[p10l1326t2487r1468b2552],
16	,	,	O	,	_	0	SENT_182	[p10l1326t2487r1468b2552],
17	1999	CD	DATE	1999	appos	15	SENT_182	[p10l1499t2487r1664b2543],
18	.	.	O	.	_	0	SENT_182	[p10l1499t2487r1664b2543],

1	Reduced	VBN	O	reduce	amod	2	SENT_183	[p10l1689t2486r1967b2542],
2	haloperidol	NN	O	haloperidol	nsubj	5	SENT_183	[p10l1986t2486r2145b2542, p10l125t2586r349b2658],
3	does	VBZ	O	do	aux	5	SENT_183	[p10l411t2586r552b2641],
4	not	RB	O	not	neg	5	SENT_183	[p10l614t2594r715b2641],
5	interfere	VB	O	interfere	_	0	SENT_183	[p10l774t2586r1042b2641],
6	with	IN	O	with	_	0	SENT_183	[p10l1104t2586r1243b2641],
7	antipsychotic	JJ	O	antipsychotic	amod	8	SENT_183	[p10l1305t2586r1723b2658],
8	activity	NN	O	activity	prep_with	5	SENT_183	[p10l1787t2586r2023b2658],
9	of	IN	O	of	_	0	SENT_183	[p10l2085t2586r2153b2641],
10	haloperidol	NN	O	haloperidol	prep_of	8	SENT_183	[p10l126t2684r487b2756],
11	in	IN	O	in	_	0	SENT_183	[p10l520t2684r580b2739],
12	the	DT	O	the	det	13	SENT_183	[p10l612t2684r707b2740],
13	treatment	NN	O	treatment	prep_in	5	SENT_183	[p10l740t2692r1041b2740],
14	of	IN	O	of	_	0	SENT_183	[p10l1073t2684r1141b2740],
15	acute	JJ	O	acute	amod	16	SENT_183	[p10l1169t2692r1334b2740],
16	schizophrenia	NN	O	schizophrenia	prep_of	13	SENT_183	[p10l1370t2684r1822b2756],
17	.	.	O	.	_	0	SENT_183	[p10l1370t2684r1822b2756],

1	Int	NN	O	int	_	0	SENT_184	[p10l1859t2686r1961b2740],
2	.	.	O	.	_	0	SENT_184	[p10l1859t2686r1961b2740],

1	Clin	NNP	O	Clin	_	0	SENT_185	[p10l1998t2684r2148b2740],
2	.	.	O	.	_	0	SENT_185	[p10l1998t2684r2148b2740],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_186	[p10l127t2783r706b2855],
2	.	.	O	.	_	0	SENT_186	[p10l127t2783r706b2855],

1	14	CD	NUMBER	14	_	0	SENT_187	[p10l743t2783r830b2849],
2	,	,	O	,	_	0	SENT_187	[p10l743t2783r830b2849],
3	219-228	CD	NUMBER	219-228	appos	1	SENT_187	[p10l859t2783r1160b2840],
4	.	.	O	.	_	0	SENT_187	[p10l859t2783r1160b2840],

1	Van	NNP	PERSON	Van	nn	2	SENT_188	[p10l7t2883r138b2938],
2	Putten	NNP	PERSON	Putten	_	0	SENT_188	[p10l162t2883r381b2948],
3	,	,	O	,	_	0	SENT_188	[p10l162t2883r381b2948],
4	T.	NNP	O	T.	nn	12	SENT_188	[p10l407t2883r490b2948],
5	,	,	O	,	_	0	SENT_188	[p10l407t2883r490b2948],
6	Marder	NNP	PERSON	Marder	appos	12	SENT_188	[p10l517t2882r767b2948],
7	,	,	O	,	_	0	SENT_188	[p10l517t2882r767b2948],
8	S.R.	NNP	O	S.R.	appos	12	SENT_188	[p10l795t2882r944b2948],
9	,	,	O	,	_	0	SENT_188	[p10l795t2882r944b2948],
10	Mintz	NNP	PERSON	Mintz	appos	12	SENT_188	[p10l970t2882r1176b2948],
11	,	,	O	,	_	0	SENT_188	[p10l970t2882r1176b2948],
12	J	NNP	O	J	appos	2	SENT_188	[p10l1203t2883r1232b2938],
13	.	.	O	.	_	0	SENT_188	[p10l1238t2928r1268b2948],

1	,	,	O	,	_	0	SENT_189	[p10l1238t2928r1268b2948],
2	1991	CD	DATE	1991	_	0	SENT_189	[p10l1303t2883r1467b2939],
3	.	.	O	.	_	0	SENT_189	[p10l1303t2883r1467b2939],

1	Serum	NN	O	serum	nn	2	SENT_190	[p10l1498t2883r1702b2938],
2	prolactin	NN	O	prolactin	_	0	SENT_190	[p10l1724t2882r2007b2954],
3	as	IN	O	as	_	0	SENT_190	[p10l2032t2900r2092b2938],
4	a	DT	O	a	det	5	SENT_190	[p10l2120t2900r2153b2938],
5	correlate	NN	O	correlate	prep_as	2	SENT_190	[p10l128t2981r404b3037],
6	of	IN	O	of	_	0	SENT_190	[p10l440t2981r509b3037],
7	clinical	JJ	O	clinical	amod	8	SENT_190	[p10l538t2981r771b3037],
8	response	NN	O	response	prep_of	5	SENT_190	[p10l805t2999r1082b3053],
9	to	TO	O	to	_	0	SENT_190	[p10l1116t2989r1175b3037],
10	haloperidol	NN	O	haloperidol	prep_to	2	SENT_190	[p10l1210t2981r1588b3053],
11	.	.	O	.	_	0	SENT_190	[p10l1210t2981r1588b3053],

1	J.	NNP	PERSON	J.	nn	2	SENT_191	[p10l1625t2983r1670b3037],
2	Clin	NNP	PERSON	Clin	_	0	SENT_191	[p10l1710t2981r1860b3037],
3	.	.	O	.	_	0	SENT_191	[p10l1710t2981r1860b3037],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_192	[p10l1899t2981r2151b3053, p10l126t3080r476b3152],
2	.	.	O	.	_	0	SENT_192	[p10l1899t2981r2151b3053, p10l126t3080r476b3152],

1	11	CD	NUMBER	11	_	0	SENT_193	[p10l515t3081r601b3146],
2	,	,	O	,	_	0	SENT_193	[p10l515t3081r601b3146],
3	357-361	CD	NUMBER	357-361	appos	1	SENT_193	[p10l632t3080r931b3136],
4	.	.	O	.	_	0	SENT_193	[p10l632t3080r931b3136],

1	Yasui	NNP	PERSON	Yasui	nn	21	SENT_194	[p10l8t3179r208b3245],
2	,	,	O	,	_	0	SENT_194	[p10l8t3179r208b3245],
3	N.	NNP	O	N.	appos	21	SENT_194	[p10l232t3180r324b3245],
4	,	,	O	,	_	0	SENT_194	[p10l232t3180r324b3245],
5	Kondo	NNP	PERSON	Kondo	appos	21	SENT_194	[p10l350t3179r580b3245],
6	,	,	O	,	_	0	SENT_194	[p10l350t3179r580b3245],
7	T.	NNP	O	T.	appos	21	SENT_194	[p10l605t3180r688b3245],
8	,	,	O	,	_	0	SENT_194	[p10l605t3180r688b3245],
9	Otani	NNP	LOCATION	Otani	appos	21	SENT_194	[p10l714t3179r905b3245],
10	,	,	O	,	_	0	SENT_194	[p10l714t3179r905b3245],
11	K.	NNP	O	K.	appos	21	SENT_194	[p10l931t3180r1022b3245],
12	,	,	O	,	_	0	SENT_194	[p10l931t3180r1022b3245],
13	Ishida	NNP	PERSON	Ishida	appos	21	SENT_194	[p10l1047t3179r1256b3245],
14	,	,	O	,	_	0	SENT_194	[p10l1047t3179r1256b3245],
15	M.	NNP	O	M.	appos	21	SENT_194	[p10l1281t3180r1386b3245],
16	,	,	O	,	_	0	SENT_194	[p10l1281t3180r1386b3245],
17	Mihara	NNP	PERSON	Mihara	appos	21	SENT_194	[p10l1411t3179r1655b3245],
18	,	,	O	,	_	0	SENT_194	[p10l1411t3179r1655b3245],
19	K.	NNP	O	K.	appos	21	SENT_194	[p10l1681t3180r1772b3245],
20	,	,	O	,	_	0	SENT_194	[p10l1681t3180r1772b3245],
21	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_194	[p10l1800t3179r2032b3245],
22	,	,	O	,	_	0	SENT_194	[p10l1800t3179r2032b3245],
23	A.	NN	O	a.	appos	21	SENT_194	[p10l2057t3180r2149b3245],
24	,	,	O	,	_	0	SENT_194	[p10l2057t3180r2149b3245],
25	Kaneko	NNP	PERSON	Kaneko	nn	31	SENT_194	[p10l128t3278r389b3344],
26	,	,	O	,	_	0	SENT_194	[p10l128t3278r389b3344],
27	S.	NNP	O	S.	appos	31	SENT_194	[p10l419t3279r495b3344],
28	,	,	O	,	_	0	SENT_194	[p10l419t3279r495b3344],
29	Inoue	NNP	PERSON	Inoue	appos	31	SENT_194	[p10l523t3280r719b3344],
30	,	,	O	,	_	0	SENT_194	[p10l523t3280r719b3344],
31	Y.	NNP	O	Y.	appos	21	SENT_194	[p10l747t3280r838b3344],
32	,	,	O	,	_	0	SENT_194	[p10l747t3280r838b3344],
33	1998	CD	DATE	1998	appos	21	SENT_194	[p10l873t3279r1038b3335],
34	.	.	O	.	_	0	SENT_194	[p10l873t3279r1038b3335],

1	Prolactin	NN	O	prolactin	nn	2	SENT_195	[p10l1066t3278r1352b3334],
2	response	NN	O	response	_	0	SENT_195	[p10l1375t3296r1652b3350],
3	to	TO	O	to	_	0	SENT_195	[p10l1676t3287r1735b3334],
4	bromperidol	NN	O	bromperidol	nn	5	SENT_195	[p10l1760t3278r2152b3350],
5	treatment	NN	O	treatment	prep_to	2	SENT_195	[p10l127t3386r428b3433],
6	in	IN	O	in	_	0	SENT_195	[p10l466t3377r527b3432],
7	schizophrenic	JJ	O	schizophrenic	amod	8	SENT_195	[p10l569t3377r1004b3449],
8	patients	NNS	O	patient	prep_in	2	SENT_195	[p10l1044t3377r1308b3449],
9	.	.	O	.	_	0	SENT_195	[p10l1044t3377r1308b3449],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_196	[p10l1351t3377r1706b3433],
2	.	.	O	.	_	0	SENT_196	[p10l1351t3377r1706b3433],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_197	[p10l1749t3377r2011b3433],
2	.	.	O	.	_	0	SENT_197	[p10l1749t3377r2011b3433],

1	82	CD	NUMBER	82	_	0	SENT_198	[p10l2058t3378r2150b3443],
2	,	,	O	,	_	0	SENT_198	[p10l2058t3378r2150b3443],
3	153-156	CD	NUMBER	153-156	appos	1	SENT_198	[p10l135t3475r428b3531],
4	.	.	O	.	_	0	SENT_198	[p10l135t3475r428b3531],

1	N.	NNP	PERSON	N.	nn	2	SENT_199	[p10l1381t3719r1469b3786],
2	Yasui	NNP	PERSON	Yasui	_	0	SENT_199	[p10l1508t3711r2153b3786],
3	.	.	O	.	_	0	SENT_199	[p10l1508t3711r2153b3786],

1	—	NN	O	—	_	0	SENT_200	[p10l1508t3711r2153b3786],
2	.	.	O	.	_	0	SENT_200	[p10l1508t3711r2153b3786],

1	Furukoria	NNP	LOCATION	Furukoria	_	0	SENT_201	[p10l1508t3711r2153b3786],

1	T.	FW	PERSON	t.	nn	4	SENT_202	[p11l1664t43r1742b111],
2	Kondoa	FW	PERSON	kondoa	nn	4	SENT_202	[p11l1782t22r2146b111],
3	’	FW	O	’	nn	4	SENT_202	[p11l1782t22r2146b111],
4	*	FW	O	*	_	0	SENT_202	[p11l1782t22r2146b111],
5	A.	NN	PERSON	a.	dep	4	SENT_202	[p11l1718t161r1806b230],
6	Suzukia	NNP	PERSON	Suzukia	nn	19	SENT_202	[p11l1846t153r2153b230],
7	K.	NNP	PERSON	K.	nn	19	SENT_202	[p11l1708t281r1795b348],
8	Miharaa	NNP	PERSON	Miharaa	nn	19	SENT_202	[p11l1832t273r2153b348],
9	N.	NNP	PERSON	N.	nn	19	SENT_202	[p11l1617t400r1706b468],
10	Tokinagaa	NNP	PERSON	Tokinagaa	nn	19	SENT_202	[p11l1743t391r2153b488],
11	Y.	NNP	PERSON	Y.	nn	19	SENT_202	[p11l1765t519r1853b586],
12	Inoueb	NNP	PERSON	Inoueb	nn	19	SENT_202	[p11l1891t496r2151b586],
13	K.	NNP	PERSON	K.	nn	19	SENT_202	[p11l1775t638r1861b705],
14	Otani	NNP	PERSON	Otani	nn	19	SENT_202	[p11l1901t630r2151b705],
15	°	NNP	O	°	nn	19	SENT_202	[p11l1901t630r2151b705],
16	S.	NNP	O	S.	nn	19	SENT_202	[p11l1704t755r1773b824],
17	Kanekoa	NNP	O	Kanekoa	nn	19	SENT_202	[p11l1813t747r2153b824],
18	aDepartment	NN	O	adepartment	nn	19	SENT_202	[p11l14t867r518b963],
19	ofNe1/iropsychiatry	NN	O	ofne1/iropsychiatry	rcmod	5	SENT_202	[p11l545t874r1324b963],
20	,	,	O	,	_	0	SENT_202	[p11l545t874r1324b963],
21	Hirosaki	NNP	ORGANIZATION	Hirosaki	nn	23	SENT_202	[p11l1362t874r1709b943],
22	University	NNP	ORGANIZATION	University	nn	23	SENT_202	[p11l1747t876r2151b963],
23	School	NNP	ORGANIZATION	School	appos	19	SENT_202	[p11l816t993r1085b1064],
24	of	IN	ORGANIZATION	of	_	0	SENT_202	[p11l1119t994r1208b1082],
25	Medicine	NNP	ORGANIZATION	Medicine	prep_of	23	SENT_202	[p11l1222t993r1609b1075],
26	,	,	O	,	_	0	SENT_202	[p11l1222t993r1609b1075],
27	Hon-cho	JJ	O	hon-cho	amod	28	SENT_202	[p11l1649t993r1995b1063],
28	53	CD	NUMBER	53	appos	19	SENT_202	[p11l2030t994r2142b1075],
29	,	,	O	,	_	0	SENT_202	[p11l2030t994r2142b1075],
30	Hirosaki	NNP	LOCATION	Hirosaki	appos	19	SENT_202	[p11l1326t1112r1689b1193],
31	,	,	O	,	_	0	SENT_202	[p11l1326t1112r1689b1193],
32	036	CD	NUMBER	036	num	34	SENT_202	[p11l1733t1112r1882b1181],
33	Japan	NNP	LOCATION	Japan	nn	34	SENT_202	[p11l1909t1114r2150b1201],
34	E	NN	O	e	appos	19	SENT_202	[p11l503t1231r774b1301],
35	—	CD	NUMBER	—	num	37	SENT_202	[p11l503t1231r774b1301],
36	mail	NN	O	mail	nn	37	SENT_202	[p11l503t1231r774b1301],
37	address	NN	O	address	dep	34	SENT_202	[p11l806t1231r1141b1301],
38	:	:	O	:	_	0	SENT_202	[p11l806t1231r1141b1301],
39	kon@cc.hirosaki—u.ac.jp	NN	O	kon@cc.hirosaki—u.ac.jp	dep	34	SENT_202	[p11l1177t1231r2150b1321],
40	bPharmaceutical	NNP	O	bPharmaceutical	nn	42	SENT_202	[p11l360t1329r1029b1420],
41	Research	NNP	O	Research	nn	42	SENT_202	[p11l1058t1350r1429b1420],
42	Division	NNP	O	Division	dep	39	SENT_202	[p11l1460t1353r1812b1431],
43	,	,	O	,	_	0	SENT_202	[p11l1460t1353r1812b1431],
44	Welﬁde	NNP	ORGANIZATION	Welﬁde	nn	45	SENT_202	[p11l1860t1350r2149b1439],
45	Corporation	NNP	ORGANIZATION	Corporation	appos	19	SENT_202	[p11l1637t1469r2142b1556],
46	,	,	O	,	_	0	SENT_202	[p11l1637t1469r2142b1556],
47	Fukuoka	NNP	LOCATION	Fukuoka	appos	19	SENT_202	[p11l1505t1587r1868b1669],
48	,	,	O	,	_	0	SENT_202	[p11l1505t1587r1868b1669],
49	Japan	NNP	LOCATION	Japan	nn	51	SENT_202	[p11l1909t1590r2150b1676],
50	‘	NNP	O	‘	nn	51	SENT_202	[p11l390t1699r894b1795],
51	Department	NNP	O	Department	appos	19	SENT_202	[p11l390t1699r894b1795],
52	of	IN	O	of	_	0	SENT_202	[p11l925t1706r1015b1795],
53	Neuropsychiatry	NNP	O	Neuropsychiatry	prep_of	51	SENT_202	[p11l1028t1706r1709b1795],
54	,	,	O	,	_	0	SENT_202	[p11l1028t1706r1709b1795],
55	Yamagata	NNP	ORGANIZATION	Yamagata	nn	57	SENT_202	[p11l1758t1709r2150b1795],
56	University	NNP	ORGANIZATION	University	nn	57	SENT_202	[p11l911t1827r1315b1914],
57	School	NNP	ORGANIZATION	School	appos	19	SENT_202	[p11l1348t1825r1618b1895],
58	of	IN	ORGANIZATION	of	_	0	SENT_202	[p11l1650t1825r1740b1914],
59	Medicine	NNP	ORGANIZATION	Medicine	prep_of	57	SENT_202	[p11l1754t1825r2141b1906],
60	,	,	O	,	_	0	SENT_202	[p11l1754t1825r2141b1906],
61	Yamagata	NNP	LOCATION	Yamagata	appos	19	SENT_202	[p11l1459t1946r1868b2031],
62	,	,	O	,	_	0	SENT_202	[p11l1459t1946r1868b2031],
63	Japan	NNP	LOCATION	Japan	dep	4	SENT_202	[p11l1909t1946r2150b2031],

1	3	CD	DATE	3	_	0	SENT_203	[p11l1428t2181r1467b2249],
2	November	NNP	DATE	November	dep	1	SENT_203	[p11l1504t2180r1925b2249],
3	2000	CD	DATE	2000	num	2	SENT_203	[p11l1957t2181r2151b2249],

1	*	NN	O	*	_	0	SENT_204	[p11l52t2486r81b2519],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_204	[p11l128t2486r596b2558],
3	author	NN	O	author	dobj	2	SENT_204	[p11l628t2486r844b2541],
4	.	.	O	.	_	0	SENT_204	[p11l628t2486r844b2541],

1	Te1.	NNP	O	Te1.	_	0	SENT_205	[p11l877t2486r1018b2541],
2	:	:	O	:	_	0	SENT_205	[p11l877t2486r1018b2541],
3	+81	CD	NUMBER	+81	number	4	SENT_205	[p11l1062t2485r1652b2551],
4	-172	CD	NUMBER	-172	dep	1	SENT_205	[p11l1062t2485r1652b2551],
5	-39	CD	NUMBER	-39	num	6	SENT_205	[p11l1062t2485r1652b2551],
6	-5066	CD	NUMBER	-5066	dep	4	SENT_205	[p11l1062t2485r1652b2551],
7	;	:	O	;	_	0	SENT_205	[p11l1062t2485r1652b2551],
8	fax	NN	O	fax	dep	1	SENT_205	[p11l1685t2485r1801b2541],
9	:	:	O	:	_	0	SENT_205	[p11l1685t2485r1801b2541],
10	+8117239	CD	NUMBER	+8117239	number	11	SENT_205	[p11l1845t2486r2150b2541, p11l9t2601r286b2657],
11	-5067	CD	NUMBER	-5067	dep	8	SENT_205	[p11l1845t2486r2150b2541, p11l9t2601r286b2657],
12	.	.	O	.	_	0	SENT_205	[p11l1845t2486r2150b2541, p11l9t2601r286b2657],

